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Summary 
 
Reversal learning deficits are a feature of many neuropsychiatric disorders, most 
notably schizophrenia. These deficits could be due, in part, to altered ability to dissipate 
either or both associations of previous positive (perseverance) and negative (learned 
non-reward) valence. Studies reported in this thesis developed an egocentric maze task 
and a visuospatial operant task for separate assessments of spatial reversal learning, 
perseverance and learned non-reward in mice. These tasks were subsequently used to 
assess the cognitive causes for altered performance after manipulations to brain systems 
recognised to be involved in reversal learning and relevant for human psychopathology, 
with a specific focus on schizophrenia.  
NMDA receptor (NMDAr) antagonism through acute phencyclidine did not 
affect reversal learning in the operant task, but caused general impairments in the maze 
task. Orbitofrontal (OFC) lesioned mice showed perseverative impairments in the 
operant task. Mice treated with the 5-HT2C receptor (5-HT2CR) antagonist SB242084 
and 5-HT2CR KO mice showed facilitated reversal learning and decreased learned non-
reward in the operant task. In the maze task, SB242084 decreased perseverance but 
increased learned non-reward, while 5-HT2CR KO mice showed perseverance and 
discrimination learning deficits. The final experimental chapter investigated the effect 
of SB242084 on touch-screen visual reversal learning in the rat. SB242084 retarded 
learning in this task.  
These studies demonstrate that previously non-reinforced associations can be of 
considerable importance in tasks of cognitive flexibility. The studies also show that the 
NMDAr, the 5-HT2CR, and the OFC, are involved in reversal learning and can modulate 
mechanisms related to both perseverance and learned non-reward. Moreover, in reversal 
learning, few effects of manipulations affecting PFC-functioning, or activity at the 
NMDAr and 5-HT2CR, generalise across the procedures in the visuospatial, egocentric 
spatial, and visual domains. 
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CHAPTER 1 
INTRODUCTION 
 
 
1.1 INTRODUCTION 
 
Purposeful goal-directed behaviours require organisms to flexibly adapt to 
constantly changing motivational goals and situational demands by overcoming 
previously learned associations. The ability to perform goal-directed behaviours across 
different situations therefore requires flexible associations between stimuli and reward, 
or cognitive flexibility. Disruptions in cognitive flexibility are a common feature of 
neuropsychopathology, which closely correlate with long-term health outcomes (Green, 
1996, 2006; Holthausen et al., 2007; Harvey et al., 1998; Keefe et al., 2006) as well as 
remaining largely unaddressed by currently available therapeutics (Weiss et al., 2002). 
Importantly, the inability to treat these deficits can often be the rate-limiter of treatment 
progression, trapping patients within life-long social and financial dependency despite 
existing medication (Meltzer, 2003). 
This chapter discusses paradigms of cognitive flexibility with a particular focus 
on reversal learning in relation to schizophrenia. It defines the underlying components 
of cognitive flexibility, and stresses that reversal learning can be thought of as a 
schedule of concurrent perseverance and learned non-reward. It reviews previous 
experiments designed to separately assess these mechanisms, and discusses their 
consequence for interpreting reversal learning performances. Finally, the potential 
benefits of reducing reversal learning into it constituent components as well as the aims 
of the thesis are outlined.   
 
1.2 COGNITIVE FLEXIBILITY 
 
Cognitive flexibility is most commonly assessed through reversal learning and 
attentional set-shifting tasks. Both reversal learning and attentional set-shifting are now 
part of the CANTAB ID/ED-task, which can be used with non-human primates and 
human participants, as well as the rodent bowl-digging version. These tasks normally 
consist of seven tests of increasing levels of difficulty. Subjects initially learn a two-
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choice discrimination. This is followed by a compound discrimination, where a second 
superimposed sensory or cognitive dimension is introduced but the correct and incorrect 
stimuli remain constant. Next, subjects are challenged by an intradimensional-shift, 
where learned stimuli are replaced by novel stimuli, with the relevant and irrelevant 
dimensions remaining constant. When acquired, subjects are challenged by an 
extradimentional or attentional-set shift, where the irrelevant dimension becomes 
relevant, and the relevant dimension becomes irrelevant. Each of these tests is typically 
followed by a reversal test where the contingencies reverse.   
Hence, reversal learning involves a single sensory or cognitive domain typically 
containing two different stimuli. After learning an initial CS+ versus CS- 
discrimination, the contingencies reverse. In contrast to reversal learning, attentional 
set-shifting involves at least two different superimposed sensory or cognitive domains 
each containing at least two different stimuli. In an initial acquisition phase, two stimuli 
within one sensory or cognitive domain serves as CS+ and CS- while stimuli within 
other domains are irrelevant. In the following set-shifting phase, the previous CS+ and 
CS- become irrelevant while stimuli within the previous irrelevant domain become the 
relevant CS+ and CS-. Although broadly similar, attentional set-shifting but not reversal 
learning demands attentional relocation, posing demands upon different neuronal and 
cognitive modalities (Bissonette et al., 2008; Dias et al., 1996; Ghods-Sharifi et al., 
2007). As a domain of cognitive flexibility and neuropsychopharmacological 
assessment, reversal learning has been somewhat overshadowed by attentional set-
shifting. One reason is likely to be the relatively greater difficulty of attentional set-
shifting – increasing the likelihood of observing deficits from pathology as well as 
alleviation through treatment. 
However, there is some evidence suggesting that reversal learning may be more 
suited for cross-species translation. For example, attentional set-shifting but not reversal 
learning is related to intelligence and language. If accounting for schizophrenic patients’ 
current IQ, patients still show reversal learning deficits but do not differ from healthy 
controls in attentional set-shifting (Laws, 1999; Leeson et al., 2009). Prompting 
schizophrenic patients to verbalise their decision-making remediates poor set-shifting 
performance (Choi and Kurtz, 2007; Perry et al., 2001; Rossel and David, 1997; Rossi 
et al., 2006; Stratta et al., 1994), and when figural stimuli are replaced by verbal stimuli, 
the performance of schizophrenics patients deteriorates while the performance of 
healthy controls improves (Rossel and David, 1997). Hence, attentional set-shifting is 
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compromised by general verbal and intelligence deficits while reversal learning can be 
relatively independent of verbal and general intelligence (Leeson et al., 2009) and a 
better predictor of social functioning (Shamay-Tsoory et al., 2007).  
 
1.3 REVERSAL LEARNING 
 
Reversal learning has been assessed in many neuropsychiatric disorders and 
their associated animal models. Most or many human psychopathologies been shown to 
display deficits within cognitive flexibility, with reversal learning deficits observed in 
Parkinson’s disease (Cools et al., 2001; Freedman and Oscar-Berman, 1989), 
Alzheimer’s disease (Freedman and Oscar-Berman, 1989), obsessive compulsive 
disorder (Remijnse et al., 2006), autism (Coldren and Halloran, 2003) unipolar 
(Reischies, 1999) and bipolar depression (McKirdy et al., 2009), Huntington’s disease 
(Lange et al., 1995; Lawrence et al., 1999; Oscar-Berman and Zola-Morgan, 1980), 
schizophrenia (Ceaser et al., 2008; Crumpton, 1963; Jazbec et al., 2007; Leeson et al., 
2009; Murray et al., 2008; Nolan, 1974; Pantelis et al., 1997, 1999, 2004, 2009; 
Shamay-Tsoory et al., 2007; Tyson et al., 2004), Korsakoff’s syndrome (Oscar-Berman 
and Zola-Morgan, 1980), attention-deficit hyperactivity disorder (Reeve and Schandler, 
2001) post-traumatic stress disorder (Koenen et al., 2001) and by cocaine abusers 
(Ersche et al., 2008).  
As reversal learning tasks fail to distinguish between pathologies, with patients 
across widely disparate diagnoses and symptom profiles displaying ‘similar’ deficits, 
current reversal paradigms can as a consequence be thought of as rather crude measures 
of cognitive functioning. 
 
1.4 DISSCOCIATING THE COMPONENTS OF COGNITIVE FLEXIBILITY  
 
Yet pathology-related deficits in cognitive flexibility may be due to 
abnormalities in either or both of two separate processes. In attentional set-shifting, the 
initial discrimination can be reduced to conditioned attention towards the relevant 
dimension and conditioned inattention towards the irrelevant dimension. After the 
subsequent contingency shift, the relevant dimension becomes irrelevant, a process 
opposed by perseverance. Conversely, the irrelevant dimension becomes relevant, a 
process opposed by learned irrelevance. In reversal learning, the initial two-choice 
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discrimination could be reduced to an excitatory CS-US association, eliciting approach 
and contact, and an inhibitory CS – ‘no US’ association, eliciting withdrawal 
(Mackintosh, 1983). After the subsequent contingency shift, the CS predicting the US 
becomes associated with ‘no US’, a process opposed by perseverance. Conversely, the 
CS initially predicating ‘no US’ now predicts the US, a process opposed by learned 
non-reward. Reversal learning and attentional set-shifting can hence be thought of as 
schedules of concurrent perseverance and learned non-reward or learned irrelevance, 
with deficits being due to a failure to dissipate either or both associations of previous 
positive (perseverance) and negative (learned non-reward or learned irrelevance) 
valence. 
 
1.4.1 Perseverance 
 
 Perseverance is a hypernym for a range of phenomena related to inappropriate 
repetition or maintenance of an activity, response, or abstract rule. This includes, for 
example, various forms of repetitions or maintenance of motor-outputs akin to catatonia 
(Albert and Sandson, 1986; Freeman and Gathercole, 1966; Helmick and Berg, 1976; 
Luria, 1965). However, in clinical and preclinical studies, perseverance is most often 
used to describe a breakdown of executive functioning whereby abstract information 
encoding relationships between stimuli and behavioural goals are excessively and 
inappropriately repeated or maintained (Garner, 2006). Perseverance is required to 
obtain difficult goals and is therefore an integral part of goal-directed behaviours 
(Albert and Sandson, 1986; Ramage et al., 1999). However, excessive perseveration has 
for long been recognised as a component of psychopathology (Hughlings-Jackson, 
1879; Wilson, 1908). 
 The terminology used to refer to perseverative responding in tasks of cognitive 
flexibility can appear complex. One reason for this complexity is likely to be an 
aspiration to separate the perseverative responding observed in attentional set-shifting 
and reversal learning tasks. For example, deficits have been referred to as stuck-in-set 
perseverance (Sandson and Albert, 1984; Rolls et al., 1994), stimulus-driven 
perseverance (Kodituwakku et al., 2001), paradigmatic or affective perseveration 
(Hauser, 1999), recurrent perseveration (Nagahama et al., 2005) or intentional 
perseveration (Hudson, 1968). 
  Fundamentally, perseverative behaviour is never defined by the valence of the 
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association or behaviour that is inappropriately repeated or maintained. Thus, excessive 
avoidance of a previously negative pairing and excessive approach of a previously 
positive pairing are both perseverative responses. Yet, perseveration has become used 
specifically to specify an inability to overcome positively reinforced rather than 
irrelevant or non-reinforced associations (Boulougouris et al., 2008; Clarke et al., 2007). 
Importantly, the vast majority of preclinical manipulations of cognitive flexibility, as 
well as pathology-related deficits within cognitive flexibility, are interpreted as due to 
altered perseverance. This is often done without considering manipulations or 
alterations in the ability to overcome non-reinforced or irrelevant associations within 
reversal learning and attentional set-shifting tasks.  
 
1.4.2 Non-reinforcement in discrimination and reversal learning  
 
 Learned non-reward is the consequence of a CS – ‘no US’ association formed in 
a two-choice discrimination paradigm. After a contingency shift, learned non-reward is 
the interference from learning a CS – US association from previously experiencing the 
CS in a pairing with ‘no US’. It is closely related to the phenomenon of latent 
inhibition. However, learned non-reward is also different from latent inhibition, since it 
occurs in a context of a second stimulus presentation with opposite reward 
contingencies (Mackintosh, 1983). The inability to overcome a non-rewarded 
association in two-choice reversal learning has recently been referred to as either 
learned avoidance (Clarke et al., 2007) or learned irrelevance (Boulougouris et al., 
2007). However, none of these terms accurately capture the phenomenon taking place in 
appetitive reversal learning (Table 1.1). Although relatively overlooked in modern 
clinical and preclinical studies, avoidance of non-rewarded responses has long been 
recognised as an important component in discriminatory paradigms. As theorists 
stressed that discrimination learning is a two-process phenomenon (Amsel, 1958, 1962; 
Hull, 1952; Spence, 1936; Skinner, 1938; Tolman, 1938), some experimental effort was 
made to determine the relative contribution of learned non-reward and perseverance in 
two-choice discrimination learning. These experiments typically showed that non-
reinforcement exerts greater control upon choice behaviour in appetitive two-choice 
discrimination tasks than reinforcement. 
	   For example, in the rhesus macaque monkey, if an object is presented alone, and 
later paired with a novel object in a two-choice discrimination, performance is best if 
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the object is non-rewarded rather than rewarded (Moss and Harlow, 1947). These 
results, referred to as an example of the ‘Moss-Harlow effect’, led Harlow and 
colleagues to favour a uni-process theory where discrimination learning is achieved 
solely through non-reinforcement without the guidance of reward (Harlow and Hicks, 
1957).  
 The relative importance of the CS+ and the CS- in discrimination learning can 
also be assessed by replacing either the previous CS+ or the CS- with a new CS of the 
same contingency. When the CS+ is replaced, successful performance is dependent on 
avoidance of the CS-. When the CS- is replaced, successful performance is dependent 
on approach to the CS+. Within this paradigm, the rat, cat, and rhesus monkey make 
more errors with a novel CS- than with a novel CS+ (Mandler, 1968; Mandler, 1970; 
Stevens and Fechter, 1968; Riopelle, 1955; Warren and Kimball, 1958). This indicates 
that CS- variability is more detrimental for discrimination learning than CS+ variability, 
and that subjects primarily learn to avoid the CS- rather than to approach the CS+. 
 
 
 
 
 Reinforcement correlation coefficients 
 Conditioning phase Test phase 
Phenomenon Stimulus A Stimulus B Stimulus A Stimulus B 
Reversal learning +1.0 -1.0 -1.0 +1.0 
         Learned non-reward  -1.0  +1.0 
Attentional set-shifting +1.0 +0.5 +0.5 +1.0 
         Learned irrelevance  +0.5  +1.0 
Learned avoidance 1.0† 0 0 0 
Latent inhibition 0 None 1.0 None 
Table 1.1. Reinforcement correlation coefficients in two-stage discrimination paradigms. 
 
In learned irrelevance, a stimulus initially non-correlated with reinforcement becomes correlated 
with reinforcement. In a typical learned avoidance task, a stimulus initially correlated with 
reinforcement becomes neutral. In an appetitive two-stage latent inhibition task, an initially neutral 
stimulus becomes correlated with reinforcement. In learned non-reward, a stimulus initially 
negatively correlated with reinforcement becomes positively correlated with reinforcement. † = 
Aversive.  
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 Moreover, Mason et al. (1980) trained rats on two separate visual two-choice 
discriminations, presented 54 and 6 times respectively. Subsequently, the CS+ and the 
CS- from each discrimination were paired into two new discriminations. Here, longer 
training with the CS- facilitated learning to a greater extent than longer training with the 
CS+. Similar results were also observed using an analogous visual bowl-digging task in 
the blackbird (Mason and Reidinger, 1982). 
 Furthermore, Mullins and Winefield (1979) used a circular apparatus surrounded 
by 12 response boxes blocked by painted doors serving as visual stimuli, and 
systematically varied the number of available CS- or CS+’s. They concluded that while 
learning is guided by constant stimuli and retarded by variable stimuli, variability in the 
number of CS-‘s retard learning more than variability in the number of CS+’s.   
  There is also evidence suggesting that non-reinforcement is an important 
component of reversal learning. Sasaki (1969) trained animals on a visual and a spatial 
two-choice maze discrimination in two separate experiments. Animals subsequently 
received 20 forced-choice trials, either non-rewarded with the previous CS+, or 
rewarded with the previous CS-. A third group received no forced choices. In the 
reversal phase, previous experience of forced choices towards the previous CS-, but not 
the previous CS+, facilitated performance in both the visual and spatial tasks.  
 In a similar set-up, Cross and Brown (1965) trained squirrel monkeys in a two-
choice object discrimination task. Prior to reversal, animals received non-rewarded 
forced-choice trials with the previous CS+, rewarded forced-choice trials with the 
previous CS-, or both forced-choice rewarded and non-rewarded trials. Animals with 
experience of forced trials involving the previous CS- showed better performance in the 
subsequent reversal than animals with experience of forced trials involving only the 
previous CS+. This suggests that experience of non-reward has a greater impact on 
reversal learning than experience of reward.    
 A further procedure has been to train animals on a simple two-choice CS+ and 
CS- discrimination, and subsequently assess performance in a perseverance or learned 
non-reward test. In a perseverance test, the previous CS+ becomes CS- while the 
previous CS- is replaced by a novel CS+. Here, only previous conditioning towards the 
previous CS+ can interfere with performance as the previous CS- has been removed. In 
a learned non-reward test, the previous CS+ is replaced by a novel CS- while the 
previous CS- becomes CS+. Thus, only previous conditioning towards the previous CS- 
can interfere with performance as the previous CS+ has been removed (Table 1.2). In 
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the capuchin, performance has been shown to be worse in the learned non-reward test 
than in the perseverance test, suggesting that learned non-reward contributes more than 
perseverance to the difficulty level of reversal learning (Beran et al., 2008; Goulart et 
al., 2005). This approach has also been used in neuropsychopharmacological studies of 
visual reversal learning in the marmoset (Clarke et al., 2007) and olfactory and 
somatosensory reversal learning in the rat (Tait and Brown, 2007).  
  
 
 Notably, non-reinforcement guided discrimination learning has also been used to 
explain secondary reversal effects. The overtraining reversal effect, the phenomenon 
whereby overtraining on a simple discrimination produces faster reversals, has been 
shown to be consequence of learned non-reward (D’Amato and Jagoda, 1961). During 
overtraining, there is little responding towards the CS-, which weakens its negative 
association, and forcing animals to respond towards the CS- during overtraining 
abolishes any overtraining reversal effect (D’Amato and Jagoda, 1962). Moreover, the 
Table 1.2.  Assessing visual reversal learning, perseverance and learned non-
reward. 
In a full reversal test, the contingencies from the initial simple discrimination 
test reverse. In a perseverance test, the initial CS+ becomes CS-, while a novel 
CS+ replaces the previous CS-. In a learned non-reward test, the initial CS- 
becomes CS+, while a novel CS- replaces the previous CS+ (adapted from 
Clarke et al., 2007). 
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serial reversal effect, the phenomenon observed as a positive correlation between 
learning and the number of reversals completed, has been suggested to be related to a 
decreasing influence of the CS- upon choice behaviour as the animal learn over 
subsequent reversals that no stimuli remains consistently non-rewarded (Allen and Leri, 
2011). In sum, although the vast majority of preclinical paradigms implicitly assume 
that positively reinforced associations guide choice-behaviour, the above experiments 
serve to highlight that non-reinforcement also is likely to be of considerable importance.  
 
1.4.3 Learned irrelevance  
 
Learned irrelevance is the analogue of learned non-reward in an attentional set-
shifting task. In learned irrelevance, a stimulus initially non-correlated with 
reinforcement becomes correlated with reinforcement. That is, a stimulus rewarded 50% 
of the time become rewarded 100% of the time (Table 1.1). Learned irrelevance is more 
difficult to overcome than latent inhibition (Baker and Mackintosh, 1979; Bennett et al., 
1995, 2000). Indeed, the difficulty discrepancy between reversal learning and 
attentional set-shifting has been speculated to be related to the difficulty discrepancy 
between learned non-reward and learned irrelevance (Buss, 1953). Relative to the 
learned non-reward and perseverance dissociation of reversal learning, the learned 
irrelevance and perseverance dissociation of attentional set-shifting is extensively 
investigated. The approach has been to modify the CANTAB ID/ED-task. In these 
tasks, either the previously relevant dimension is replaced by a novel irrelevant 
dimension to probe learned irrelevance, or the previously irrelevant dimension is 
replaced by a novel relevant dimension to probe perseverance (Table 1.3). Notably, 
these investigations have shown pathology-specific dissociations of cognitive causes for 
performance deficits. Prefrontal lesioned (Owen et al., 1993), schizophrenic (Elliot et 
al., 1995, 1998) and Huntington’s patients (Lawrence et al., 1999) all exhibit 
perseverative set-shifting deficits, while unmedicated Parkinson’s patients display 
deficits in both perseverance and learned irrelevance (Owen et al., 1993). However, L-
Dopa medicated Parkinson patients show impaired learned irrelevance but no deficits in 
perseverance (Owen et al., 1993; Slabosz et al., 2006), suggesting that perseverance, but 
not learned irrelevance, is related to dopaminergic hypoactivity. Moreover, in healthy 
subjects, learned irrelevance appears to contribute more than perseverance to the 
difficulty of attentional acquisition (Maes et al., 2009) as well as attentional set-shifting 
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(Maes et al., 2004). Preclinically, this approach has been taken once, assessing 
perseverance in mice using the bowl-digging task (Garner et al., 2006).  
 
 
1.5 NOVELTY CONFOUND 
 
Novelty is a feature in most of the studies cited so far attempting to separately 
probe perseverative versus learned non-reward or learned irrelevance. A manipulation 
of novelty attraction or avoidance could therefore confound any interpretation regarding 
Table 1.3A. Separate assessment of perseverance in attentional set-shifting  
 
Table 1.3B. Separate assessment of learned irrelevance in attentional set-shifting  
 
Separately assessing perseverance and learned irrelevance in attentional set-shifting 
using a modified version of the last two test phases of the CANTAB ID/ED-task 
(adapted from Owen et al., 1993). In the perseverance test (A), the previously 
relevant dimension becomes irrelevant, while the previously irrelevant dimension is 
replaced by a novel relevant dimension. In the learned irrelevance test (B), the 
previously irrelevant dimension becomes relevant, while the previously relevant 
dimension is replaced by a novel irrelevant dimension.  
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the manipulations effect on learning. In a perseverance test, a novel rewarded stimulus 
or dimension is paired with a previously rewarded but now non-rewarded stimulus or 
dimension. In this test condition, increased novelty attraction would be observed as 
facilitated learning while increased novelty avoidance would be observed as retarded 
learning. In a learned non-reward or learned irrelevance condition, a novel non-
rewarded stimulus or dimension is paired with a previously non-rewarded but now 
rewarded stimulus or dimension. In this test condition, increased novelty attraction 
would be observed as retarded learning while increased novelty avoidance would be 
observed as facilitated learning. Hence, one intrinsic control for a manipulation of 
novelty-attraction or avoidance in these tasks is that it would cause opposing effects 
upon learning in the perseverance and learned non-reward or learned irrelevance 
conditions (Clarke et al., 2007). For example, a manipulation-induced or pathology-
related increase of novelty-attraction would give rise to decreased perseverance, where 
the novel CS is correct, and increased learned non-reward, were the novel CS is 
incorrect.  
Moreover, performance in a reversal learning test could also control for effects 
on novelty-attraction or novelty-recognition as no novel stimulus is presented in this 
test. If an effect of a manipulation is observed in perseverance and/or learned non-
reward tests where novelty is a feature, as well as in a reversal learning test which lacks 
novelty, a fitting interpretation would be that the effect is related to shared features of 
the tests and unrelated to differences in the presentation of a novel stimulus. 
A further approach to overcome novelty-related confounds has been to add 
control conditions where increases in perseverance and learned irrelevance facilitates 
learning (Table 1.4). In a perseverance control condition, this can be done by replacing 
the CS- with a novel CS-, while the CS+ remain constant. In a learned non-reward 
control condition, the CS+ is replaced by a novel CS+, while the CS- remain constant 
(Gauntlett-Gilbert et al., 1999). However, it has been noted that this set-up still allows 
for a novelty confound, as it involves a choice between a previously relevant or 
irrelevant dimension and a novel dimension (Slabosz et al., 2006). As yet, this form of 
novelty control has only been performed in the domain of attentional set-shifting, but 
could also be used in reversal learning. 
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1.6 DISCUSSION 
 
This chapter has reviewed previous experimental designs used to separately 
assess the underlying cognitive components of two-choice discrimination learning and 
cognitive flexibility. This work suggests that reversal learning and attentional set-
shifting consists of at least two independent cognitive mechanisms. Here I will note two 
following consequences for reversal learning task design and behavioural 
interpretations.  
Firstly, ‘normal’ learning is expressed as a delay in learning with reversal 
learning, attentional set-shifting, perseveration, learned non-reward, and learned 
irrelevance all being observed as increases in trials and/or time taken to acquire a 
discrimination due to previous conditioning to avoid and approach CSs now associated 
In the learned irrelevance condition, the irrelevant dimension B stays irrelevant 
while the relevant dimension A is replaced by a novel relevant dimension C. In this 
condition, enhanced learned irrelevance should facilitate performance. In the 
perseverance condition, the relevant dimension A stays relevant while the irrelevant 
dimension B is replaced by a novel irrelevant dimension C. In this condition, 
enhanced perseverance should facilitate performance (adapted from Gauntlett-
Gilbert et al., 1999) 	  
Table 1.4. Controlling for novelty-attraction and novelty-avoidance in perseverance 
and learned irrelevance testing in attentional set-shifting. 
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with reward and non-reward, respectively. Although it can be tempting to interpret 
experimentally induced increases and decreases in the speed of learning as representing 
cognitive enhancements and retardations, an equally valid interpretation is that a 
retardation of learning is represented through a increase in the speed of learning, while a 
cognitive enhancement is represented by a decrease in the speed of learning. 
Manipulations of cognitive flexibility in themselves can therefore not be interpreted as 
enhancing or retarding, but only evaluated against the cognitive profile of a given model 
or pathology. 
Secondly, as the domains of perseverance, learned non-reward and learned 
irrelevance are independent, the effect of a manipulation upon the first cognitive domain 
may bear little or no relationship to the effect upon the second cognitive domain. This 
has complex implications for the validity of disease models.  
For example, many animal models of psychiatric diseases, including 
schizophrenia, display reversal learning deficits believed to be due to increased 
perseverance. These animal models can also show predictive validity with established 
pharmaco-therapy blocking reversal deficits, believed to be due to blocking the model’s 
perseverative deficits. However, an alternative interpretation is that the perseverative 
reversal learning deficits are blocked by a co-manipulation disrupting learned non-
reward. Or conversely, a non-reward related reversal learning deficit could be blocked 
by reducing perseverance. The observed deficit within reversal learning could thereby 
be blocked by causing a second deficit. A further possibility is that a strong increase in 
perseverance can be masked through a decrease or no effects within learned non-
reward, giving no observable effects on reversal learning.  
It has been suggested that if a perseverative response strategy is to be modelled, 
a test of perseveration rather than a reversal or set-shifting test, where perseveration and 
learned irrelevance or learned non-reward is combined, may be more suitable (Garner et 
al., 2006). Thus, tests of perseveration and learned non-reward should therefore also be 
viewed as tests in their own right, similar to the tests preceding the attentional set-
shifting test in the ID/ED task.  
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1.7 CONCLUSIONS 
 
Although manipulations of reversal learning traditionally have been interpreted as 
manipulations of perseverance, the element of learned non-reward within typical 
reversal learning tasks should also be considered. This approach has several important 
consequences: 
 
(1)  Highlighting pathology-specific deficits and thereby give indications of relevant 
drug targets. 
 
(2) Aiding translational approaches by clarifying species and task related 
differences in problem solving.  
 
(3) Inferring greater construct and predictive validity by observing that the model 
and potential therapeutic act upon the same or similar cognitive constructs. 
 
 
1.8 THESIS AIMS 
 
The mouse carries the values of being more cost-effective for high-throughput 
tasks, as well as the availability of a great number of available genotypic models 
relevant for psychopathology. As such, the main aims of this thesis were to develop 
tasks of reversal learning, perseverance and learned non-reward in the mouse, and to use 
these tasks to investigate the effects of manipulations to brain systems recognised to be 
involved in reversal learning and relevant to schizophrenia.  
Firstly, Chapter 2 describes a group of experiments designed to explore suitable 
protocols for assessing reversal learning, perseverance, and learned non-reward using 
the radial-arm maze and operant chamber in the mouse. Chapter 3 then outlines the 
method used in the majority of the following neuropharmacological experiments. 
Chapter 4-8 assesses a range of manipulations recognised to be involved in reversal 
learning and relevant for human psychopathology in general, and schizophrenia in 
particular. This includes acute phencyclidine (Chapter 4), medial prefrontal cortical and 
orbitoprefrontal cortical excitotoxic lesioning (Chapter 5), 5-HT2C receptor antagonism 
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(Chapter 6), and 5-HT2C receptor knock-out mice (Chapter 7). The final experimental 
chapter investigates the effects of 5-HT2C receptor antagonism using a visual touch 
reversal learning task in the rat (Chapter 8).  
 
To summarise, there were two main aims of the thesis; 
 
(1) Develop assays for investigating reversal learning, perseverance and learned 
non-reward in the mouse. 
 
(2) Use these tasks to assess the cognitive mechanisms for altered performance after 
manipulations to brain systems recognised to be involved in reversal learning 
and relevant for human psychopathology, with a specific focus on 
schizophrenia.  
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CHAPTER 2  
VISOUSPATIAL AND EGOCENTRIC REVERSAL LEARNING 
 
2.1 INTRODUCTION 
 
As described in Chapter 1, reversal learning, perseverance and learned non-
reward has been explored by replacing either the previously correct or incorrect 
response alternative across reversal trials with a novel response option. The following 
sets of experiments aimed to explore protocols for using this method to investigate 
reversal learning and its cognitive components in the mouse using a spatial dimension. 
These methods are then used in the following empirical studies of the mouse presented 
in this thesis. Experiment 1-3 used an eight-arm radial maze in an egocentric design, 
while experiment 4-6 used the operant chamber in a visuospatial design.  
 
2.2 EXPERIMENT 1: MAZE REVERSAL LEARNING 
 
2.2.1 Method 
 
2.2.1.1 Animals 
 
The animals were 8 C57BL/6J male mice (Charles River, UK) weighing a mean 
24.4g at the start of the experiment. 
 
2.2.1.2 Apparatus and procedure 
 
The experiment used an eight-arm radial maze made of Plexiglas elevated 55 cm 
above the floor. Each arm (33.5 × 5 × 8.3 cm) extended from a circular central platform 
(15.5 cm diameter). Black-painted vial bottle tops (80 mm diameter, 40 mm deep) 
served as food-wells. The maze was surrounded by featureless circular blackout 
material. An around 2m high tripod holding a camcorder was placed behind the curtain 
and the W-arm of the maze. The room was lit by a white-light located in the ceiling.    
Habituation. Before being placed in the maze, the maze was always wiped with 
a sponge moistened with disinfectant to minimise intra-maze olfactory cues. On the first 
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day, each mouse was allowed to explore a cross-maze over 30 min with five pellets 
placed in each of the four arms (three along their lengths and two in the food-wells). 
Over the next four days, each mouse was placed in the maze ≈ 2×10-15 min/day. Again, 
five pellets were initially placed in each of the four arms (three along their lengths and 
two in the food-wells). This was gradually decreased over the week until only one pellet 
was located in each of the four food-wells. If all pellets were consumed within a 10-15 
min interval, the mouse was removed from the maze, the maze was re-baited, and the 
next 10-15 min interval began. The intervals served to habituate the animals to repeated 
handling after consumption and exploration. 
Turn bias. The mouse turn bias was determined in a T-maze prior to 
discrimination learning (Floresco et al., 2006; Ragozzino et al., 1999). The start-arm for 
each of the seven trials was predetermined in a pseudorandom order identical for each 
mouse. The start-arm was S (south), E (east), or W (west) across trials but never N 
(north). Each animal was given seven trials. The mouse was placed in the start-arm and 
always had the choice of turning 90° left or 90° right, with both arms baited in order to 
delay association between response and reinforcement. One trial comprised one left and 
one right response. For example, if the mouse turned left, it was allowed to consume the 
pellet and thereafter immediately returned to the start-arm to make a new choice. If the 
animal turned left again, it was again returned to the start-arm. This continued until the 
mouse had turned right. After the animal had made both a left and a right turn, it was 
returned to the cage while the maze was prepared for the next trial. This was repeated 
seven times. To calculate the mouse turn-bias, the directions of the first turn of each trial 
were summed, with the majority of responses being the mouse turn-bias. 
Spatial discrimination (Fig. 2.1A). Again, the mouse always had the choice of 
turning 90° to the left or 90° to the right. The start arm for each trial was predetermined 
in a pseudorandom order identical for each mouse, and was S, E, or W across trials but 
never N. However, the start-arm never remained the same for more than two 
consecutive trials. Only the arm opposite the mouse turn bias was baited. Each animal 
was given 25 trials/day. After every ≈ 7th trial, the maze was turned 90° to minimise the 
use of extra-maze cues. After making a response, the mouse was removed from the 
maze and returned to its home-cage while the maze was set up for the next trial. The ITI 
was approximately 30s. If the mouse failed to leave the start-arm within ≈ 10s or choose 
to reverse into the start-arm from the centre of the maze it was given a gentle push. The 
criterion in this and all subsequent tests were nine consecutive correct responses. If a 
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mouse made nine consecutive correct responses it was given a probe-trial. In the probe-
trial, N figured as start-arm. If successful, the spatial discrimination was completed. If 
unsuccessful, a further five correct responses lead to a new probe-trial. Each mouse was 
given a maximum of 200 trials. When completed, all animals were assessed in a full 
reversal condition. The data collected was trials, correct responses and incorrect 
responses to criterion. 
Full reversal test (Fig. 2.1B). Now the bait was moved to the opposite arm. 
Thus, an animal trained to turn 90° right now had to turn 90° left without any additional 
changes to the maze-configuration. When completed, half of the animals were tested in 
a learned non-reward test while the other half were tested in a perseverance test. 
 
 
 
Figure 2.1. Example of the experimental procedure used in Experiment 1. All 
animals completed an initial spatial discrimination (A) followed by a full reversal 
test (B). After reaching criterion, animals were assigned to either a perseverance 
test (C) or a learned non-reward test (D). 
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Perseverance test (Fig. 2.1C). Here the previously correct arm remained opened 
while a novel arm replaced the previously incorrect arm. For example, a previously 
incorrect arm 90° to the left was replaced by a novel correct arm straight on. Only the 
novel arm was baited. Hence, altered performance in this test must be due to a 
manipulation of the association of reward, as the previously incorrect alternative no 
longer is present. That is, the only error the mouse could make was to enter the previously 
correct arm.  
Learned non-reward test (Fig. 2.1D). Here the previously incorrect arm remained 
opened while a novel arm replaced the previously correct arm. For example, a previously 
correct arm 90° to the right was replaced by a novel incorrect arm straight on. Only the 
previously incorrect arm was baited. Hence, altered performance in this test must be due 
to a manipulation of the association of non-reward, as the previously correct alternative 
no longer is present. That is, the only error the mouse could make was to avoid the 
previously incorrect arm. 
 
2.2.2 Results and discussion 
 
Seven of the eight animals reached criterion on the spatial discrimination within 
200 trials. Six of the seven remaining animals reached criterion in the full reversal test. 
Animals required significantly more trials (t6 = 2.6, p < .05) and made more incorrect 
responses to criterion (t6 = 2.6, p < .05) in the full reversal test compared to the spatial 
discrimination (Fig. 2.2). They also made more correct responses in the full reversal 
test, although the difference failed to reach significance (t6 = 2.1, p < .09). 
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Two of the three animals assessed in the perseverance test reached criterion 
within 200 trials. In the learned non-reward test, all three animals reached criterion. 
There were no significant effects of test condition (perseverance and learned non-
reward) on trials, correct responses or incorrect responses to criterion.  
These results suggest that mice can be taught egocentric spatial discrimination 
and reversal learning in the maze. Animals required more trials to criterion in the full 
reversal test than in the initial spatial discrimination, showing that choice-behaviour 
during reversal is guided by the reward contingencies established during the spatial 
discrimination. Rats typically learn egocentric maze discriminations and reverse in 
about 60 trials (Floresco et al., 2006; Ragozzino et al., 1999). Here, mice seem to 
require almost twice as many trials to reverse.  
There were signs that animals used non-egocentric spatial cues to navigate the 
maze. Two animals had a deficit in locating the reward when a specific start-arm was 
Figure 2.2 Mean trials (A) correct (B) and incorrect (C) responses to 
criterion in the three test conditions of Experiment 1. Broken line 
represents mean spatial discrimination performance. 
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used. For example, these animals persisted in taking left only when starting from the W-
arm. It is possible that the location of the maze in relation to the room lighting gave 
each of the four arms particular shadowing and visual cues. Keeping the camera behind 
the W-arm throughout the experiment also provided a prominent visual cue. It is also 
possible that animals were guided by intra-maze cues. During the ITI, the animals were 
held in their home-cages containing sawdust that often transferred to the maze and were 
not completely removed between trials.  
The perseverance test appeared to be more difficult than the learned non-reward 
test. Under the current protocol, there are two critical differences between the 
perseverance and learned non-reward tests. In the initial spatial discrimination and full 
reversal tests, animals had been trained to turn 90°. This is still true in the learned non-
reward test, but not in the perseverance test, where animals now have to go straight on. 
Also, the response required in the spatial discrimination and non-reward test are 
identical while they differ between the spatial discrimination and the perseverance test 
(Fig 2.1). This could account for the relative difficulty of the perseverance test and ease 
of the non-reward test.  
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2.3. EXPERIMENT 2: MAZE REVERSAL LEARNING  
 
2.3.1 Introduction and method 
 
The experiment used 18 C57BL/6J male mice (Charles River, UK) weighing a 
mean 23.5g at the start of the experiment.  
 
Steps were taken to limit the availability of visual cues present in Experiment 1: 
• The maze was completely enclosed in a ‘tent’-like structure of blackout material, with a 
red light and bullet-camera hanging directly above the central platform of the maze. The 
ceiling light was also changed from white to red.  
• During the inter-trial interval, the mouse was placed in a sawdust free holding-cage 
containing heavy-absorbent paper to avoid contamination of the test apparatus and 
intra-maze cues. 
 
Further changes were made to the protocol to avoid confounds between the 
perseverance and learned non-reward tests: 
• The novel path in the perseverance and learned non-reward tests was introduced as a 
45° turn rather than a non-turn. This meant that both the perseverance and learned non-
reward tests consist of a two-choice simultaneous discrimination between two turning 
directions rather than a discrimination between a turn and a non-turn. 
• The three test conditions were run between-subjects to avoid the spatial discrimination 
and learned non-reward test requiring identical responses.  
• The maximum trials allowed within each condition was changed from 200 to 250. 
 
2.3.2 Results and discussion 
 
Sixteen of the 18 animals reached criterion on the spatial discrimination phase 
within 250 trials, while all remaining animals reached criterion in the following test 
conditions (Fig. 2.3). There were significant effects of test condition on trials to 
criterion (F2,18 = 5.5, p < .05), as well as correct (F2,13 = 5, p < .05) and incorrect 
responses to criterion (F2,13 = 4.9, p < .05). Post-hoc comparisons using Fisher’s LSD 
test showed that animals required significantly fewer trials to complete the perseverance 
(p = .03) and learned non-reward tests (p = .02) than the full reversal test. Animals also 
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made fewer incorrect and correct responses in the perseverance (p = .03; p = .04) and 
the learned non-reward tests (p = .02; p = .02) than in the full reversal test. 
An issue in Experiment 1 was the use of non-spatial cues to navigate in the maze 
as, for some animals, start-arm predicted choice of response-arm. To minimise the use 
of non-spatial cues, the maze was enclosed in black material, the room and ‘tent’ 
lighting was changed from white to red, and the animals were held in a sawdust-free 
cage between trials. In this experiment there were no signs indicating the use of non-
spatial cues. 
However, a possible further issue is the order the animals encounter the novel 
and now blocked arms. In the learned non-reward test, after a turn towards the 
previously correct arm the animal encounters the unexpectedly blocked arm first  
followed by the novel non-rewarded arm. In the perseverance test condition, after a turn 
towards the previously incorrect arm the animal encounters the unexpectedly blocked 
arm first followed by the novel rewarded arm. To account for the order at which the 
correct and incorrect arms could be encountered in the perseverance and learned non-
reward tests, it would be appropriate to counterbalance the task as such the animal also 
can encounter the novel arm first followed by the now blocked arm after making 
incorrect and correct turns in both the learned non-reward and perseverance tests.   
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Figure 2.3. Mean trials (A) correct (B) and incorrect (C) responses to 
criterion in the three test conditions of Experiment 2. Broken line represents 
mean spatial discrimination performance.  
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2.4 EXPERIMENT 3: MAZE REVERSAL LEARNING  
 
2.4.1 Introduction and method 
 
The experiment used 16 C57BL/6J male mice (Charles River, UK) weighing a 
mean 25g at the start of the experiment. Now the egocentric turning directions were 
counterbalanced. For one half of the animals, the spatial discrimination phase 
constituted a T-maze with the novel turning option being a 45° turn. For the other half, 
the spatial discrimination constituted a Y-maze with the novel turning option being a 
90° turn. Now, animals could encounter the novel arm first after making a turn in the 
incorrect or correct direction in the learned non-reward or perseverance tests. The maze 
habituation was also changed, taking place over 4 days at 3×12 min/day with the initial 
day of 30 min free exploration omitted.  
 
2.4.2 Results and discussion 
 
Fifteen of the 16 animals reached criterion on the spatial discrimination phase 
within 250 trials, while all animals reached criterion on the following three tests (Fig. 
2.4). There were no significant differences in trials, correct or incorrect responses to 
criterion in the three test conditions or two maze-configurations. 
Compared to animals in Experiment 2, animals in Experiment 3 learned the 
spatial discrimination and full reversal faster while requiring more trials to reach 
criterion in the learned non-reward test. Yet, none of these differences reached 
significance (all p > .05). Here, an issue is the degree of independence of the full 
reversal, learned non-reward, and perseverance tests. Generalisations between a 45° and 
a 90° turn in the same direction would cause the perseverance and learned non-reward 
tests to measure reversal learning rather than the components of reversal learning. 
However, as there were no differences in learning between animals exposed to the Y-
maze or T-Maze, this cannot be attributed to the different maze-configurations.    
 
 
 
 
 
 
	   26	  
  
Figure 2.4. Mean trials (A) correct (B) and incorrect (C) responses to 
criterion in the three test conditions of of Experiment 3. Broken line 
represents mean spatial discrimination performance. 
	   27	  
2.5 EXPERIMENT 4: OPERANT REVERSAL LEARNING  
 
2.5.1 Introduction 
 
The following set of experiments used a similar rationale to the experiments in 
the radial-arm maze to explore protocols for assessing reversal learning, perseverance 
and learned non-reward in the operant chamber, with the location of the previously 
correct or incorrect nosepoke-hole location being changed across trials.  
 
2.5.2 Method 
 
2.5.2.1 Animals  
 
The experiment used 24 C57BL/6J male mice (Charles River, UK) weighing a 
mean 25g at the start of the experiment.   
 
2.5.2.2 Apparatus and procedure  
 
The experiments used eight operant chambers (22.5 × 18 × 13 cm; Med 
Associates, Georgia, VT, USA) placed in sound-attenuating wooden chambers with fans 
for purpose of ventilation and attenuating external noise. Each chamber was fitted with a 
central magazine (W = 2.5 cm, H = 2 cm) connected to an external pellet dispenser 
delivering 20 mg sucrose pellets (Sandown Scientific, Middlesex, UK). The chambers 
contained two nosepoke-holes (3.2 cm diameter), located 16.2 cm apart and 5.5 cm above 
a grid-floor, initially placed on the distal side of the chamber relative to the food 
dispenser. A houselight was located centrally above the nosepoke-holes 9 cm above the 
floor.  
Training stage 1. Each trial began with the illumination of a single nosepoke-
hole and the houselight. The illuminated nosepoke-hole was counterbalanced across the 
left and right sides. The lit-up nosepoke-hole remained the same across all trials. A 
nosepoke in the lit-up nosepoke-hole led to pellet delivery, the houselight turning off, 
and the beginning of a 10s ITI when the chamber was kept dark. The criterion was ≥ 20 
correct responses over a single 40 min session. On the fifth day of this schedule, only 
two animals had passed criterion, with animals making a mean three correct responses 
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over 40 min. The program was therefore changed in order to find a more effective way 
of getting the mice to nosepoke for reward.  
Training stage 2. The houselight-cycle was now reversed. Each trial began with 
the offset of the houselight and illumination of a single nosepoke-LED. A correct 
response now led to pellet delivery, the houselight turning on, and the beginning of a 
10s ITI when the houselight was kept on. All animals reached the criterion of ≥ 20 
correct responses in a 40 min session over a mean 3 days. After criterion was achieved, 
this stage was repeated the next day with the opposite nosepoke-hole activated. All 
animals now reached criterion on the first day.  
Training stage 3. The animals were now required to nosepoke in the magazine 
within 20s, which activated a single nosepoke-LED and the houselight. A response in 
the correct nosepoke-hole within 10s led to pellet delivery, the nosepoke-LED turning 
off, and the beginning of a 10s ITI when the chamber was kept dark. However, the 
houselight stayed on for an additional 4s after a correct response. Failure to respond in 
the magazine within 20s or failure to respond in the nosepoke-hole within 10s counted 
as an omission and led to the immediate onset of the 10s ITI. The criterion was ≥ 75 
correct responses over 40 min.   
 After eight days on this schedule, only seven animals had reached criterion. 
Moreover, the number of correct responses seemed to reach a plateau around day 4 or 5 
and subsequently dwindle. This again prompted changes to the protocol. 
Training stage 4. Each mouse was now exposed to 50 trials/day. A trial began 
with the onset of the houselight and a single nosepoke-LED. Thus, an initial nosepoke 
in the magazine was no longer required. A nosepoke in the lit-up nosepoke-hole within 
10s led to pellet delivery, the nosepoke-LED turning off and the beginning of a 30s ITI. 
This longer ITI was used to increase the motivation for animals to nosepoke. The 
criterion was ≥ 35 correct responses for two consecutive sessions of 50 trials or ≥ 40 
correct responses in a single session of 50 trials. All animals reached criterion in a mean 
4 days. When criterion was achieved, this stage was repeated with the opposite 
nosepoke-hole activated. All animals now reached criterion in a mean 3 days.   
Training stage 5. The ITI was now adapted to the test condition of 15s. The 
criterion was 40 correct responses over 50 trials for two consecutive sessions. 
Everything else was identical to the previous stage. All animals reached criterion in a 
mean 3 days. When criterion was achieved, the stage was repeated with the opposite 
nosepoke-hole activated. All animals now reached criterion in a mean 2 days.  
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Spatial discrimination (Fig. 2.5A). A trial began with the onset of the houselight 
and both nosepoke-LEDs. A nosepoke in the correct nosepoke-hole within 10s led to 
pellet delivery, the nosepoke-LED turning off, and the beginning of a 15s ITI when the 
chamber was dark. Failure to respond within 10s counted as an omission. The correct 
and incorrect nosepoke-holes were counterbalanced. A nosepoke in the incorrect 
nosepoke-hole counted as an incorrect response and leads to immediate onset of the 15s 
ITI.  Each animal was exposed to five 10-trial blocks. The criterion in the spatial 
discrimination and all subsequent conditions was at least 9 correct responses in a 10-
trial block. When achieved, the session ended and the animals were removed from the 
chambers. If the animal failed to reach criterion this was repeated the following day 
until criterion was reached. When achieved, a retention test followed when animals 
again required to reach criterion on the same contingencies. All animals successfully 
reached criterion on day 1 of retention. Subsequently, the animals were allocated to one 
out of three test conditions. 
Figure 2.5. Example of the experimental procedure used in Experiment 4. 
All animals initially completed a spatial discrimination (A), followed either 
by a full reversal (B), a perseverance (C) or a learned non-reward test (D).   
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Full reversal test (Fig. 2.5B). Here the previously incorrect nosepoke-hole 
become correct while the previously correct nosepoke-hole became incorrect. 
Everything else was identical to the spatial discrimination phase. 
Perseverance test (Fig. 2.5C). Here the previously correct nosepoke-hole 
became incorrect, while the previously incorrect nosepoke-hole became correct and 
moved to the opposite side of the chamber. Hence, the only error the mouse could make 
was to nosepoke in the previously correct nosepoke-hole. The established non-rewarded 
association should not influence the performance as the previous CS- had been 
removed. 
Learned non-reward test (Fig 2.5D). Here the previously incorrect nosepoke-
hole became correct, while the previously correct nosepoke became incorrect and 
moved to the opposite side of the chamber. Hence, the only error the mouse could make 
was to avoid the previously incorrect nosepoke-hole. The established rewarded 
association should not influence the performance as the previous CS+ had been 
removed. 
 
2.5.3 Results and discussion 
 
All animals reached criterion on the initial spatial discrimination phase and the 
following test conditions (Fig. 2.6). There were significant main effects of test condition 
on trials (F2,21 = 7.1, p < .01) and incorrect responses to criterion (F2,21 = 6.6, p < .01). 
Animals required significantly fewer trials and made less incorrect responses in the 
learned non-reward test than in the perseverance and full reversal tests (all p ≥ .04). 
There were no significant differences in correct responses or omissions across the three 
test conditions. 
This study suggests that reversal learning, perseverance and learned non-reward 
can be assessed in the mouse using the operant chamber. Although a lack of difference in 
any performance index between the spatial discrimination and full reversal tests, animals 
made more incorrect responses and omissions in the full reversal test. This study also 
highlights important protocol parameters relevant to training and testing. Mice more 
readily learn to nosepoke for reward when stimuli saliency is increased by turning the 
houselight off.  
However, the current design also allows for critical confounds between the 
perseverance and learned non-reward tests. As animals are required to nosepoke on the 
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left wall of the chamber throughout training, there were signs of mediating behaviour to 
the left wall of the chamber during the test conditions.  
Moreover, in the learned non-reward test, the animals are required to nosepoke in 
the only nosepoke-hole present on the left wall of the chamber, a hole that has been 
repeatedly associated with reward during training, whereas the perseverance test requires 
a shift to responding next to the magazine. This could partly be overcome through trial 
self-initiation, where animals have to start each trial through a nosepoke in the magazine. 
 
 
 
 
 
 
Figure 2.6. Mean trials (A) incorrect (B) correct (C) and omissions (D) to 
criterion in the three test conditions of Experiment 4. Broken line represents 
mean spatial discrimination performance. 
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2.6 EXPERIMENT 5: OPERANT REVERSAL LEARNING  
 
2.6.1 Introduction 
 
This experiment attempted to counterbalance the location of the correct and 
incorrect nosepoke-hole across the two walls of the chamber. Initially, two nosepoke-
holes were placed in two out of four possible location, on opposite sides on the operant 
chamber, creating four different possible nosepoke-hole combinations (Fig. 2.7). In the 
subsequent perseverance and learned non-reward tests, the previously incorrect or 
correct nosepoke-hole was moved to the adjacent side of the chamber. 
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2.6.2 Method 
 
The experiment used 18 C57BL/6J male mice (Charles River, UK) weighing a 
mean 25.6g at the start of the experiment.   
Training stage 1. Trial onset was signalled by the houselight turning off and a 
single nosepoke-LED turning on. This houselight-phase was initially used in order to 
Figure 2.7. Example of counterbalance of nosepoke-locations in Experiment 5. One 
nosepoke-hole was always located in one out of two possible position on each wall 
of the chamber, giving four possible arrangements. The correct and incorrect 
nosepoke-hole was determined by the animals side-bias (see text). In the 
perseverance and learned non-reward tests, the previously incorrect or correct 
nosepoke-hole, respectively, is moved to the adjacent location in the chamber. In 
this example, the animals side-bias is to the left throughout.  SD = spatial 
discrimination, NP = nosepoke-hole.  
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increase the saliency of the nosepoke-LED and more effectively get the animals to 
begin to nosepoke for pellet delivery. A nosepoke in the lit-up nosepoke-hole led to a 
pellet delivery, the houselight turning on, and the beginning of a 30s ITI when the 
houselight was kept on. However, after a correct response, the houselight stayed on for 
a further 4s, before it turned off and stayed off until the end of the ITI. All animals 
reached the criterion of ≥ 20 correct responses over 40 min over a mean 3 days. After 
criterion was achieved, this stage was repeated the following day with the opposite 
nosepoke-hole activated. All animals now reached criterion on day one. 
Training stage 2. The animals were required to nosepoke in the magazine within 
20s, which activated the houselight and a single nosepoke-LED. A response in the lit-up 
nosepoke-hole within 10s lead to pellet delivery, the nosepoke-LED turning off, and the 
beginning of a 30s ITI when the chamber was kept dark. After a correct response, the 
houselight stayed on for an additional 4s. Failure to either respond in the magazine 
within 20s or to respond in the nosepoke-hole within 10s counted as an omission and 
caused immediate onset of the 30s ITI. The criterion was ≥ 35 correct responses over 
two consecutive sessions or ≥ 40 correct responses in a single session of 50 trials. All 
animals reached criterion over a mean 7 days. After criterion was achieved, this stage 
was repeated the following day with the opposite nosepoke-hole activated.  All animals 
now reached criterion over a mean 6 days. 
Training stage 3. This was as stage 2, except that the ITI was now adapted to the 
test condition of 15s. The criterion was ≥ 40 correct responses over 50 trials for two 
consecutive sessions. Everything else was identical to the previous stage. All animals 
reached criterion over a mean 3 days. When criterion was achieved, this stage was 
repeated the following sessions with the opposite nosepoke-hole activated. All animals 
again reached criterion over a mean 3 days.  
Side-bias. The mouse side-bias was determined prior to the spatial discrimination 
(Floresco et al., 2006). A nosepoke in the magazine activated both nosepoke-LEDs. On 
the first attempt, a nosepoke in either nosepoke-hole resulted in pellet delivery. On the 
second attempt, only a nosepoke in the nosepoke-hole opposite the one responded to in 
the first attempt resulted in pellet delivery. For example, if the mouse initially responded 
in the left nosepoke-hole, it was rewarded with a pellet and a new trial commenced. If 
choosing left once more, no pellet was delivered and the houselight was extinguished. 
This continued until the mouse responded in the right nosepoke-hole. The second trial 
began once the animal had responded in both the left and the right nosepoke-hole. Thus, 
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one trial comprised at least one left and one right response. Each animal was given seven 
trials. To calculate the mouse side-bias, the first response of each trial was added together, 
with the majority of responses being the mouse side-bias. 
Spatial discrimination. A trial began with the offset of the houselight. A 
nosepoke in the magazine lead to the onset of the houselight and both nosepoke-LEDs. 
A nosepoke in the correct nosepoke-hole within 10s lead to pellet delivery, nosepoke-
light turning off, and beginning of a 15s ITI when the chamber was dark. Failure to 
respond within 10s counted as an omission. Nosepoke in the inactive nosepoke-hole 
counted as an incorrect response and lead to immediate onset of the 15s ITI. Each 
animal was exposed to five 10-trial blocks. After reaching criterion, animals where 
assigned to one of three test conditions.  
Full reversal test. The previously incorrect nosepoke-hole became correct while 
the previously correct nosepoke-hole became incorrect. Everything else was identical to 
the spatial discrimination phase.  
Perseverance test. The previously correct nosepoke-hole became incorrect, while 
the previously incorrect nosepoke-hole became correct and moved to the adjacent location 
of the operant chamber.  
Learned non-reward test. The previously incorrect nosepoke-hole became correct, 
while the previously correct nosepoke-hole became incorrect and moved to the opposite 
side of the operant chamber.  
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2.6.3 Results and discussion 
 
All animals side-bias were to the right side of the chamber, towards the 
nosepoke-hole next to the food magazine. Sixteen of the 18 animals reached criterion on 
the spatial discrimination phase, and the remaining 16 animals also reached criterion in 
the three following test conditions (Fig. 2.8). Animals required significantly more trials 
on the spatial discrimination phase compared to any of the following test conditions. 
There were no significant differences in performance across the three test conditions (all 
p >. 05). In sum, there was a strong bias for animals to respond in the nosepoke-hole 
located next to the food magazine, making this protocol unsuitable for assessing 
cognitive flexibility.   
Figure 2.8. Mean trials (A) incorrect (B) correct (C) and omissions 
(D) to criterion in the three test conditions of Experiment 5. Broken 
line represents mean spatial discrimination performance. 
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2.7 EXPERIMENT 6: OPERANT REVERSAL LEARNING  
  
2.7.1 Introduction and method 
 
In order to avoid wall related confounds, three nosepoke-holes were now placed 
on a single wall of the operant chamber. The houselight-phase was also reversed 
throughout training and testing in order to increase the saliency of the nosepoke-LEDs. 
Animals. The experiment used 24 C57BL/6J male mice (Charles River, UK) 
weighing a mean 24.9g at the start of the experiment.  
Counterbalancing. Three nosepoke-holes where placed on a single wall of the 
chamber, located opposite to the food magazine (Fig. 2.9). For each animal, the initial 
training and spatial discrimination took place using two of these three nosepoke-holes, 
with the location of the two nosepoke-holes fully counterbalanced. Thus, animals 
completed training and spatial discrimination using either the left and right, central and 
right, or the central and left nosepoke-holes. The third nosepoke-hole remained idle, 
never lighting up. A response in this idle nosepoke-hole was always without 
consequence. 
Training stage 1. Trial onset was signalled by the houselight turning off and a 
single nosepoke-LED turning on. A nosepoke in the lit-up nosepoke-hole led to pellet 
delivery, houselight turning on, and beginning of a 30s ITI when the houselight was 
kept on. All animals reached criterion of ≥ 20 correct responses over 40 min in a mean 3 
days. After the criterion was achieved, this stage was repeated the following day with 
the second nosepoke-hole activated. All animals now reached criterion on day one. 
Training stage 2. As stage 1, however, animals were now required to nosepoke 
in the magazine within 20s, which activated a single nosepoke-LED. A response in the 
lit-up nosepoke-hole within 10s lead to pellet delivery, nosepoke-light turning off, and 
the beginning of a 30s ITI when the chamber was kept lit-up. However, after a correct 
response, the houselight stayed off for a further 4s before it turned on and stayed on 
until the end of the ITI. Failure to either respond in the magazine within 20s or to 
respond in the nosepoke-hole within 10s counted as an omission and caused immediate 
onset of the 30s ITI. The criterion was ≥ 35 correct responses over two consecutive 
sessions or ≥ 40 correct responses in a single session of 50 trials. All animals reached 
criterion in a mean 7 days. After the criterion was achieved, this stage was repeated the 
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following day with the opposite nosepoke-hole activated. All animals now reached 
criterion over a mean 6 days.  
Training stage 3. As stage 2, however, the ITI was now adapted to the test 
condition of 15s. Criterion was ≥ 40 correct responses over 50 trials for two consecutive 
sessions. Everything else was identical to the previous stage. All animals reached 
criterion over a mean 3 days. When criterion was achieved, this stage was repeated with 
the second nosepoke-hole activated. All animals again reached criterion in a mean 3 
days. Animals required a mean 20 days in total to complete training. 
Side-bias and spatial discrimination. As in experiment 4 and 5, each animals 
side-bias was assessed prior to the spatial discrimination, and this was followed by the 
acquisition of spatial discrimination (Fig. 2.9A).  
Full reversal test (Fig. 2.9B). Here the previously incorrect nosepoke-hole became 
correct while the previously correct nosepoke-hole became incorrect.  
Perseverance test (Fig. 2.9C). Here the previously correct nosepoke-hole became 
incorrect, while the previously idle nosepoke-hole became correct and the previously 
correct nosepoke-hole became idle.  
Learned non-reward test (Fig. 2.9D). Here the previously incorrect nosepoke-
hole became correct, while the previously correct nosepoke-hole became idle and the 
previously idle nosepoke-hole became incorrect. 
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Figure 2.9. Example of the experimental procedure used in Experiment 6. 
Animals initially completed a spatial discrimination (A). This was followed by 
either a full reversal (B) perseverance (C) or learned non-reward test (D). 
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2.7.2 Results and discussion 
 
Two animals were omitted after failing to reach criterion in pretraining stage 3, 
while one animal was omitted after failing to reach criterion in the full reversal test after 
23 days of testing. There were no significant differences in performance between 
animals exposed to the three different nosepoke-hole combinations.   
There was a significant effect of test condition on trials (F2,18 = 4.49, p < .05), 
correct (F2,18 = 6.19, p < .01), and incorrect (F2,18 = 12.9, p < .0001) responses to 
criterion (Fig. 2.10). Post-hoc comparisons using Fisher’s LSD test showed that animals 
in the learned non-reward test reached criterion faster than animals in the full reversal (p 
< .05) and perseverance tests (p < .05). Animals required significantly more correct 
responses to criterion in the full reversal test compared to the learned non-reward (p < 
.01) and perseverance tests (p < .01). Animals also committed significantly more errors 
in the perseverance test compared to the learned non-reward (p < .0001) and full 
reversal tests (p < .05). There were no significant differences between test conditions on 
latencies to response in the magazine, the nosepoke-hole, or for pellet retrieval 
latencies.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.10. Mean trials (A) incorrect (B) correct (C) and omissions 
(D) to criterion in the three test conditions of Experiment 6. Broken 
line represents mean spatial discrimination performance. 
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Animals required significantly more trials to reach criterion in the perseverance 
test compared to the learned non-reward test. This was mainly due to a large difference 
in incorrect responses between the two test conditions. Indeed, animals also made more 
incorrect responses in the perseverance than the full reversal test.  
In studies of reversal learning, it is implicitly assumed that only learning in the 
spatial discrimination proactively interferes with learning in the test phase. However, if 
one treats two-choice simultaneous discrimination learning as excitatory and inhibitory 
conditioning to the CS+ and the CS-, the high and low numbers of incorrect responses 
in the perseverance and learned non-reward tests could be explained by proactive 
interference from the training stages (Table 2.1).  
In the perseverance test, only A+ proactively interferes with new learning A-N+, 
while previous learning of B+ and B- interfere minimally as B is absent in the test 
condition. In the learned non-reward test, both B- and B+ proactively interfere with new 
learning B+N-, while previous learning of A- and A+ interfere minimally as A is absent 
in the test condition. Thus, there is previous excitatory conditioning to the incorrect 
stimulus in the perseverance test, and previous excitatory and inhibitory conditioning to 
the correct stimulus in the learned non-reward test.  
Further, animals may treat the nosepoke-holes rather than the nosepoke-LEDs as 
stimuli. This would cause the development of latent inhibition towards N throughout 
training and in the spatial discrimination, and the development of latent inhibition 
towards B and A in half of the training phases (Table 2.1). Importantly, latent inhibition 
towards N would further facilitate learning in the learned non-reward test, where N is 
non-rewarded, and further impair learning in the perseverance test, where N is 
rewarded. This could explain the relative ease and difficulty of the perseverance and 
learned non-reward tests. In order to avoid this, idle nosepoke-holes could be covered to 
avoid responses to them.  
 The animals should also be trained to nosepoke over a shorter time. This can be 
done by reducing the criterion in each training phase, training animals to nosepoke in 
one rather than two nosepoke-holes, and omitting assessment of animal side-biases. 
This would shorten the training and minimise its effects upon learning in the test 
conditions. 
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2.8 GENERAL DISCUSSION 
 
The experiments in this chapter have evaluated different protocols for spatial 
reversal learning, perseverance and learned non-reward testing in the mouse using the 
operant chamber (Experiments 4-6) and the eight-arm radial maze (Experiments 1-3). 
Importantly, across these experiments, it is clear that procedural differences can have a 
large effect on the relative strength of learned non-reward versus perseverance on 
reversal learning. Moreover, although the operant chamber and eight-arm radial maze 
tasks appear analogous, they differ in important parameters that are likely to affect the 
outcome of any manipulation used.  
In the maze, the animal is required to make a turn relative to its body. Thus, 
reliable information for successful performance can only be provided internally through 
proprioceptive systems. The use of egocentric cues is determined by limiting the 
number of visouspatial cues and a final ‘probe-trial’, where egocentric guidance is 
pitted directly against the use of exteroceptive cues. 
The operant task, however, is a visuospatial reversal learning task. Visuospatial 
cues are available, most clearly through the locations of the two lit-up nosepoke-holes. 
As opposed to the maze task, this task can be solved with a variety of place, allocentric 
or egocentric spatial strategies. This is important, since both the neuroanatomy of 
reversal learning and pathology-related reversal learning deficits can depend upon 
modality of input (e.g., Brigman et al., 2008; Hölscher and Schmidt, 1994; Oscar-
Berman and Zola-Morgan, 1980; Wirtshafter and Asin, 1986). 
The two tasks also differ in constrains upon response-time and length of the 
inter-trial interval. In the operant chamber, animals are forced to respond faster and 
more often and animals can omit responses in the operant chamber but not in the maze. 
Table 2.1. Stimuli reward contingencies across the different training and test stages. 
Condition/Stage Training 1, 3, & 5 Training 2, 4, & 6 Discrimination Test  
Full reversal A+(NLI/BLI) B+(NLI/ALI) A+B-(NLI) A-B+(NLI) 
Perseverance A+(NLI/BLI) B+(NLI/ALI) A+B-(NLI) A-N+(BLI) 
Non-reward A+(NLI/BLI) B+(NLI/ALI) A+B-(NLI) B+N-(ALI) 
Stimuli in bold signify interfering associations relevant to the specific test condition.  LI 
signify latent inhibition effects formed at each training phase.  
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Thus, the operant task may carry a greater sensitivity to manipulations of impulsivity 
than the maze task.  
Moreover, in the maze, animals only perceive the CS- when responding to it. In 
the operant chamber however, the animal is visually exposed to the CS- during each 
trial regardless of outcome. Thus, as the CS- also is present in positively reinforced 
trials, the association formed may be closer in form to learned irrelevance, an 
association of greater magnitude than other non-reinforced associations (Baker et al., 
1979; Bennett et al., 1995, 2000).  
The two tasks also differ in a range of parameters known to be important in 
latent inhibition and extinction. This includes the number of positive and negative 
reinforcements prior to the contingency shift (Lubow et al., 1973), stimuli intensity 
(Crowell and Anderson, 1972; Schnur and Lubow, 1976), length of context experience 
(Escobar et al., 2002; Hall and Channell, 1985; Hall and Minor, 1984), handling 
(Weiner et al., 1985), and the length of the ITI (Schnur and Lubow, 1976; Crowell and 
Anderson, 1972; Lantz, 1973).  
In conclusion, this chapter has shown that mice can be taught egocentric and 
visuospatial reversal learning in the maze and operant chamber. It has further been 
shown that variations in training and testing protocols can have a large affect the 
relative loading upon perseverance and learned non-reward. Although the tasks have 
considerable theoretical similarity, they differ in many parameters likely to affect the 
results of any manipulation used. The fully developed versions of each paradigm, 
(derived from Experiments 1 to 3 for the maze and 4 – 6 for the operant chamber) are 
outlined in the next chapter and will be used to explore the neurochemical and 
anatomical substrates of reversal learning in the remaining chapters of this thesis. 
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CHAPTER 3 
EXPERIMENTAL METHODS  
 
3.1 INTRODUCTION 
 
This chapter outlines the protocols chosen for the majority of experiments 
investigating the neuropharmacology of reversal learning, perseverance and learned non-
reward in the maze and operant chamber. These protocols derive both from previously 
published studies and the preliminary experiments of Chapter 2. This chapter also 
includes detailed explanations of additional techniques and methods used in the 
experiments reported in Chapters 4-8 of this thesis. Methods only relevant to individual 
chapters, including drug administration methods, lesioning procedures and genotyping 
techniques, are included in the relevant chapter. 
 
3.2 ANIMALS 
 
Animals were C57BL6/J male mice (Charles River, UK) housed in solid-
bottomed cages (North Kent Plastics, type M2) with sawdust-lined flooring and paper 
bedding. They were housed in a controlled environment held at 21 ± 2°C and 50 ± 15% 
relative humidity with a 12:12h light-dark period (lights on: 07:00h) and 15-20 air-
changes/min. Animals had ad libitum access to standard laboratory chow (Special Diet 
Service Ltd, Witham, UK) and tap water, with home cages being cleaned weekly. On 
arrival, animals were allowed an acclimatisation period of at least 1 week before the 
beginning of food deprivation. Food deprivation started 7 days before behavioural 
training, with animals being kept at around 85-90% of their ad libitum weight 
throughout testing. During this first week, animals were given 2-3 sucrose pellets daily 
for habituation to the test diet. Behavioural training and testing took place six days a 
week (Mon-Sat) between 7am and 7pm with animals being fed 1h after testing. In 
pharmacological experiments using mice, subcutaneous sham saline injections (4 ml/kg) 
for habituation to the injection procedure were given in the nape of the neck on the day 
before commencing behavioural training. All procedures in this thesis were conducted 
in accordance with the requirements of the UK Animals (Scientific Procedures) Act 
1986 (Project License 70/6654) following internal review by the University of Sussex 
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Local Ethical Review Committee.  
3.3 OPERANT TASK 
 
3.3.1 Apparatus 
 
The experiments were conducted in eight operant chambers (22.5 × 18 × 13 cm; 
Med Associates, Georgia, VT, USA) placed in sound-attenuating wooden boxes with fans 
for the purpose of ventilation and concealing external noise (Fig. 3.1). Each box was fitted 
with a central magazine (W = 2.5 cm, H = 2 cm) connected to an external pellet dispenser 
delivering 20 mg sucrose pellets (Sandown Scientific, Middlesex, UK). The opposite side 
of the chamber contained three nosepoke-holes (3.2 cm diameter), located 6.5 cm apart 
and 5.5 cm above a grid-floor. A houselight was located centrally above the nosepoke-
holes 9 cm above the floor. Nosepoke-holes and magazine entries were detected through 
the breaking of infrared photocell beams located horizontally across the entrances. The 
chambers where controlled by Med-PC (version 5) and the tasks programmed in Medstate 
notation.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1.  Photo of the operant chamber set-up. Three nosepoke-holes 
(all open) can be seen on the left side and a central magazine-tray on the 
right side of the photo. A houselight was located centrally above the 
nosepoke-holes. A board-camera was mounted centrally behind the 
operant chamber. An infrared-light was placed on top of the operant box 
to make video-recordings in the dark possible. 
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3.3.2 Procedure 
 
Training stage 1. On the first day, animals were exposed to the apparatus for 1h 
in the dark with the fan on and the magazine loaded with pellets. Training to nosepoke 
for food-reward began on day 2. A trial began with the offset of the houselight and the 
onset of a single nosepoke-hole LED (fully counterbalanced across the left or right 
nosepoke-holes). The other two nosepoke-holes remained covered with metallic plates. 
Training and initial testing was restricted to these two nosepoke-holes, as earlier work 
(Chapters 2 and 4) had shown this to be sufficient. Responding in the nosepoke-hole 
caused the nosepoke-LED to turn off, delivery of a single 20 mg sucrose pellet, and the 
beginning of a 15s ITI. After a correct response, the houselight remained on for an 
additional 4s before turning off and remaining off for the rest of the ITI. Animals 
reached criterion when completing ≥ 20 correct responses over 60 min.   
 Training stage 2. As stage 1, except animals were now required to self-initiate 
each trial with a nosepoke in the magazine. The available nosepoke-hole stayed the 
same as in the previous training phase. A nosepoke in the magazine triggered the onset 
of a single nosepoke-hole LED. Failure to self-initiate a trial within 20s counted as an 
omission and caused the immediate onset of the 15s ITI. Responding in the nosepoke-
hole lead to the nosepoke-LED turning off, pellet delivery, and the beginning of the ITI. 
Failure to respond in the lit-up nosepoke-hole within 12s counted as an omission and 
caused the offset of the nosepoke-LED and the immediate onset of the ITI. Animals 
were required to complete 49 correct responses over 70 trials to meet criterion (≥ 70%). 
After reaching criterion, each animal received a single session with the opposite 
nosepoke-hole available (left or right). Animals had no problems transferring 
responding to a different location of a single lit-up nosepoke hole. Animals were 
subsequently trained on a two-choice discrimination  
Spatial discrimination (Fig. 3.2A). Now both the left and right nosepoke-holes 
were presented while the central nosepoke-hole remained covered (see Figure 3.2 for 
flow-chart of the discrimination and reversal procedures). 
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The correct nosepoke-hole was the opposite nosepoke-hole to which the animal 
had been trained to respond in stages 1 and 2 of training. A nosepoke in the correct 
nosepoke-hole within 12s lead to pellet delivery, nosepoke-lights turning off, and the 
beginning of the 15s ITI. A nosepoke in the incorrect nosepoke-hole counted as an 
incorrect response and led to the immediate onset of the 15s ITI. Failure to either self-
initiate a trial within 20s or  
 
Initiation period - 20s 
 
Figure 3.2. Trial sequence in the operant visual discrimination and reversal learning 
task. A trial is initiated when the mouse enters its head into the food magazine. Trial 
initiation leads the onset of two nosepoke-hole LEDs (CS+, CS-). Failure to initiate a 
trial within 20s is scored as an omission and causes the immediate onset of the 
houselight. A response towards the CS+ is scored as a correct response, and leads to 
the immediate offset of the two nosepoke-hole LED’s, reward delivery, and beginning 
of a 20s ITI. A response towards the CS- is scored as an incorrect response, which 
triggers the immediate onset of the houselight. Failure to respond in a nosepoke-hole 
within 13s is scored as an omission and leads to the offset of the nosepoke-hole LED’s 
and the onset of the houselight. 
 
ITI - 20s 
All lights OFF 
  Choice 
Correct  Incorrect  
Omission 
Stimuli 
off 
Stimuli 
off 
Reward delivery Houselight ON 
Omission  
Response period – 13s 
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respond in the lit-up nosepoke-hole within 12s counted as omissions and caused 
the immediate onset of the ITI. A trial was scored as either correct, incorrect or an 
omission, and the criterion for this and all subsequent conditions were at least nine 
correct responses within a single block of 10 trials (Boulougouris et al., 2008; 
Boulougouris and Robbins, 2010). Each session consisted of seven 10-trial blocks and 
each animal received one session per day. If the animal failed to reach criterion the 
schedule was repeated on the following day until criterion was reached.  
Full reversal test (Fig. 3.3B). Here the contingencies from the previous phase 
were reversed. A response in the previously incorrect nosepoke-hole was now correct 
while a response in the previously correct nosepoke hole now was incorrect. 
 Perseverance test (Fig. 3.3C). Here the previously correct nosepoke-hole 
became incorrect, while the previously incorrect nosepoke-hole was covered and 
replaced by a new correct nosepoke-hole. Thus, avoidance of the previously incorrect 
nosepoke-hole could no longer interfere with performance as the previously incorrect 
nosepoke-hole had been removed. 
Learned non-reward test (Fig. 3.3D). Here the previously incorrect nosepoke-
hole became correct, while the previously correct nosepoke-hole was covered and 
replaced by a new incorrect nosepoke-hole. Thus, approach towards the previously 
correct nosepoke-hole could no longer interfere with performance as the previously 
Figure 3.3. Diagram of the four types of discrimination in the operant task. 
All animals initially completed a spatial discrimination test (A). Example of 
a subsequent full reversal test (B), perseverance test (C) or learned non-
reward test (D). 
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correct nosepoke-hole had been removed. 
 Experimental designs. Pharmacological experiments used a three-stage between-
subjects serial design (Fig. 3.4A). After completing the spatial discrimination drug-free, 
animals were matched in pairs for trials to criterion and randomly assigned to a drug and 
test condition. Animals subsequently completed three tests, each proceeded by a drug-free 
retention test. Lesion and transgenic experiments used a within-subjects serial design (Fig. 
3.4B). After reaching criterion in the spatial discrimination test, all animals completed a 
full reversal test followed either by a learned non-reward test and a perseverance test. The 
relative order of the perseverance and the learned non-reward tests where counterbalanced 
across the experimental groups. Again, each test was preceded by a retention test of the 
previously learned response.  
 Data analyses and statistics. Measures collected from each test phase were trials 
to criterion, omissions, correct and incorrect responses as well as latencies to respond in 
the nosepoke-hole, trial self-initiation through a magazine entry and latency to retrieve 
pellet reward. Moreover, incorrect responses to criterion was further analysed as ‘early-
errors’ and ‘late-errors’ (Boulougoris et al., 2008; Brigman et al., 2008; Gastambide et al., 
2012; Jones and Mishkin, 1972; Ragozzino et al., 2002). Early-errors were defined as 
errors made while the animals responding still was biased towards the previously correct 
stimulus. That is, when animals still made more than 50 % incorrect responses in a 10-
trial bin. This corresponds to what other studies refer to as ‘perseverative errors’. Late-
errors were defined as errors made after making 50% or more correct responses in a 10-
trial bin. This corresponds to what other studies refer to as ‘learning-errors’, ‘regressive-
errors’, or ‘maintenance-errors’. These labels ‘early’ and ‘late’ were adopted to avoid 
potential confusion with the different conditions.      	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Figure 3.4. Example of the between-subjects and within-subjects experimental 
designs used in the operant procedure. (A) Between-subjects. Across each test in the 
full reversal condition, the contingencies reversed between the left and right 
nosepoke-hole. The central nosepoke-hole remained blocked. Across each test in the 
learned non-reward condition, the previously incorrect nosepoke-hole became 
correct, the previously correct nosepoke-hole was blocked, and a previously blocked 
nosepoke-hole was introduced as a incorrect alternative. Across each test in the 
perseverance condition, the previously correct nosepoke-hole became incorrect, the 
previously incorrect nosepoke-hole was blocked, and a previously blocked nosepoke-
hole was introduced as a correct alternative. (B) Within-subjects. Each animal was 
initially exposed to a full reversal test. This was followed by a learned non-reward 
test and a perseverance test with order of tests counterbalanced. 
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3.4 MAZE TASK 
 
3.4.1 Apparatus 
 
The experiments used an eight-arm radial maze made of clear Plexiglas elevated 
55 cm above the floor. Each arm (33.5 × 5 × 8.3 cm) extended from a circular central 
platform (15.5 cm diameter). Access to each arm was controlled by inserting or removing 
a clear Plexiglas insert at its entrance. Black-painted vial bottle tops (80 mm diameter, 40 
mm deep) figured as food-wells. The maze was enclosed by a featureless circular ‘tent’ of 
blackout material. A red light bulb and bullet-camera was located 63 cm above the central 
platform. The camera connected to a monitor and DVD recorder located in the corner of 
the room. Animal choice-behaviour were observed through the monitor, which was kept 
at minimal luminance to minimise visual-cues.  
 
3.4.2 Procedure 
 
Maze habituation. Each animal 
received four days of habituation to the 
cross-maze, for a maximum of 3×12 
min/day. Before being placed in the maze, 
the maze was always wiped with a sponge 
moistened disinfectant to minimise intra-
maze olfactory cues. Initially five pellets 
were placed in each of the four arms (three 
along their lengths and two in the food-
wells located at the end of each arm). This 
was gradually decreased over the week 
until only one pellet was located in each of 
the four food-wells. If all pellets were 
consumed within a 12 min interval, the 
mouse was removed from the maze, the 
maze was re-baited, and the next interval 
began. During the interval, the mouse was 
Figure 3.5. Photo of the radial-arm 
maze set-up used for the reversal 
learning and novelty experiments. For 
clarity, the red light used for the 
experiments has been replaced by a 
white light.  
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placed in a holding cage with heavy-absorbent paper to avoid intra-maze cues 
contaminating the test apparatus. The intervals served to habituate the animals to 
repeated handling after consumption and exploration. 
 Turn bias. The mouse turn-bias was determined prior to spatial discrimination 
(Floresco et al., 2006; Ragozzino et al., 1999). The maze was given a T- or Y-
configuration with the start-arm being South (S), West (W) or East (E) across trials but 
never North (N). The maze-configuration (Y-maze vs. T-maze) was counterbalanced 
across the different test conditions and experimental groups. The mouse was placed in the 
start-arm and always had the choice of turning left or right, with both arms baited in order 
to delay any association between response and reinforcement. The start-arm for each trial 
was predetermined in a pseudorandom order identical for each mouse. Each animal was 
given seven trials. One trial comprised one left and one right response. For example, if the 
mouse turned left, it was allowed to consume the pellet and thereafter returned to the 
start-arm to make a new choice. If choosing left once more, the mouse was immediately 
returned to the start-arm. This continued until the mouse turned right. To calculate the 
mouse turn-bias, the first turn of each trial were added together, with the majority of 
responses being the mouse turn-bias. 
 Spatial discrimination (Fig. 3.6A). Again, the start-arm was S, W or E across trials 
but never N. The start-arm for each trial was predetermined in a pseudorandom order 
identical for each mouse. Over every nine trials, each arm figured as start-arm equal 
number of times but the same arm never figured as start-arm for more than two 
consecutive trials. The mouse always had the choice of turning 90° (T-maze) or 45° (Y-
maze) to the left and right. Only the arm opposite the mouse turn-bias was baited. After 
every ≈7th trial, the maze was turned 90° to minimise intra-maze cues. After making a 
response, the mouse was removed from the maze and returned to the holding cage while 
the maze was set up for the next trial. The inter-trial interval was approximately 40s. If a 
mouse made nine consecutive correct responses it was given a probe-trial (Ragozzino et 
al. 1999; Floresco et al. 2006). In the probe-trial, the use of an egocentric response 
strategy was pitted against the use of exteroceptive cues by using N as the start-arm. If 
successful, spatial discrimination was completed and the animal was returned to its home-
cage. If unsuccessful, a further five correct responses lead to a new probe-trial. Each 
animal was given 25 trials/day. However, if the animal had completed ≥ 6 consecutive 
correct responses after 25 trials, it was given the chance to reach criterion. 
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 Full reversal (Fig 3.6B). An animal trained to turn right now had to turn left. 
Thus, the bait was moved to the opposite arm. Everything else was identical to the 
preceding spatial discrimination, with no additional changes to the maze-configuration. 
 Perseverance test (Fig. 3.6C). Here the previously correct arm remained open 
while the previously incorrect arm was replaced by a novel arm. For example, a 
previously incorrect arm 90° to the left was replaced by a novel correct arm 45° to the 
left. Only the novel arm was baited. A learning deficit in this test must be due to a failure 
in suppressing the association of reward, as the previously incorrect alternative no longer 
is present. That is, the only mistake the mouse can make is to enter the previously correct 
arm.  
 
 
 
Figure 3.6. Diagram of the four types of discrimination in the maze task. All animals 
initially completed a spatial discrimination test (A). Example of a subsequent full 
reversal test (B), perseverance test (C) or learned non-reward test (C). 
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Learned non-reward test (Fig. 3.6D). Here the previously incorrect arm remained 
open while the previously correct arm was replaced by a novel arm. For example, a 
previously correct arm 90° to the right was replaced by a novel incorrect arm 45° to the 
right. Only the previously incorrect arm was baited. Hence, a learning deficit in this test 
must be due to a failure in suppressing the association of non-reward, as the previously 
correct alternative no longer is present. That is, the only mistake the mouse can make is to 
avoid the previously incorrect arm. 
 Experimental designs. Pharmacological experiments assessed reversal learning, 
perseverance and learned non-reward using a three-stage between-subjects serial design. 
After completing the spatial discrimination drug free, animals were pair-matched for trials 
to criterion and randomly assigned to a drug and test condition. Animals subsequently 
completed one of the three test conditions. Lesion and transgenic experiments assessed 
reversal learning, perseverance and learned non-reward using a within-subjects serial 
design. After reaching criterion in the spatial discrimination phase, all animals completed 
a full reversal test followed by a learned non-reward test and a perseverance test. The 
relative order of the perseverance and the learned non-reward tests were counterbalanced 
across the experimental groups. 
 Data analyses and statistics. Total trials and probe trials to criterion and total 
incorrect and correct responses to criterion at each phase of the experiment were collected 
from each animal. As in the operant task, errors were further analysed as early-errors and 
late-errors. Before making five correct responses within a block of ten trials, errors were 
coded as early-errors. After making five or more correct responses within a block of ten 
trials, errors were coded as late-errors. Animals failing to reach criterion in a test within 
250 trials were counted as 250 and removed from further testing. Video analyses of mean 
trial times were done using JWatcher (version 1.0) 
 
3.5 MAZE NOVELTY RECOGNITION 
 
Novelty recognition and attraction was assessed using the eight-arm radial maze 
described earlier in this chapter (Fig 3.5). Animals were initially habituated to a T-maze 
or a Y-maze for 3×12 min/day for three days. After each 12 min interval, the maze was 
wiped with a disinfectant to eliminate intra-maze cues. On the last two days of maze 
habituation, animals received sham saline injection for habituation to the injection 
procedure (4 ml/kg). 
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Testing took place on the fourth day over 2×15 min intervals. In the first 15 min 
interval, the maze was maintained in the same configuration as during maze habituation. 
In the second 15 min interval, one of the previously open arms was closed while an arm 
45° to the north or south was opened. The maze-configuration (T-maze vs. Y-maze) and 
location of the novel arm (N vs. S) was counterbalanced across the experimental groups. 
The 2×15 min test-phase was recorded and analysed using JWatcher (version 
1.0). Total and proportion of time and arm entries in each arm was scored before and 
after the 45° change in arm location. An arm-entry was scored when an animal placed 
its back-paws behind the small regress separating the central platform from the 
extending arm. With high degree of similarity, only proportions and change in 
proportions of arm-entries and time is reported.  
 
3.6 LOCOMOTOR ACTIVITY 
 
 
 Locomotor activity was monitored in nine 
polypropylene cylinders (H = 25.5 cm, D = 24.5 cm) 
with a central hollow tube and a circular runway (D 
= 7.5 cm; Fig. 3.6). The cylinders were placed on a 
transparent table above a video camera. Between 
each test, the cylinders and table were wiped with a 
disinfectant followed by hot water. Recordings from 
each session were analysed using software (written 
by John Anderson, School of Life Sciences 
Workshop, University of Sussex) running on Matlab 
(version 15). Total number of full 360° and total 
number of 45° turns where collected from each 
animal and summed into 15 min time-bins. 
However, as full 360° turns and 45° turns 
consistently showed high similarity, only 45° turns are reported. Studies using this 
system have previously been reported by Dalton et al. (2004) and Clifton et al. (2003). 	  	  	  
 
Figure 3.7. Example of the 
locomotor-box. The dotted lines 
represents ¼ turns.  	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CHAPTER 4 
PHENCYCLIDINE AND REVERSAL LEARNING 
 
 
4.1 INTRODUCTION 
 
Schizophrenia is characterised by independent disturbances within three 
domains; perception, emotion and thinking. These reflect the positive, negative and 
cognitive symptoms, respectively, described in diagnostic schema such as the DSM IV. 
Of these, cognitive symptoms precede and outlast all other symptoms and are the best 
predictors of long-term health (Barch, 2005). Although available neuroleptics can show 
good efficacy against the positive symptoms as well as moderate efficacy against the 
negative symptoms, they have frequently been found to have no effects or even 
detrimental effects on cognition (Weiss et al., 2002). The inability of available 
neuroleptics to ameliorate these deficits severely limits treatment progression and is 
believed to be the cause of the often poor long-term health outcomes associated with 
diagnosis despite existing medication (Green, 1996, 2006; Harvey et al., 1998; 
Holthausen et al., 2007; Keefe et al., 2006).  
One of these cognitive deficits is what Bleuler (1905) referred to as ‘adhesive 
thoughts’ producing behaviour resistant to change across situations. This form of 
cognition can be assessed in reversal learning tasks, in which schizophrenic patients 
repeatedly have been shown to express deficits (Ceaser et al., 2008; Crumpton, 1963; 
Jazbec et al., 2007; Leeson et al., 2009; Murray et al., 2008; Nolan 1974; Pantelis et al., 
1999, 1997, 2004, 2009; Shamay-Tsoory et al., 2007; Tyson et al., 2004). These deficits 
appear to be due to increased perseverance. Within attentional set-shifting, 
schizophrenic patients have been challenged with separate tests of perseverance and 
learned irrelevance. In a perseverance test, the previously correct dimension becomes 
incorrect while a novel dimension becomes correct. In a learned irrelevance test, a novel 
correct dimension is introduced while the previously incorrect dimension becomes 
correct. Here schizophrenic patients display deficits attributable to perseveration 
towards the previous correct dimension rather than a potentiation of irrelevant 
associations (Elliott et al., 1995, 1998).  
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4.1.1 Schizophrenia NMDA-receptor functioning 
 
Schizophrenia is associated with compromised glutamatergic and N-methyl-D-
aspartate-receptor (NMDAr) functioning. NMDArs’ are heteromeric assemblies 
consisting of multiple NR1 subunits coupled with at least one NR2 and/or NR3 subunit. 
Four NR2, eight NR1 and two NR3 splice variants has so far been identified. NMDAr 
subunit composition is tightly controlled throughout development, shows subregion-
specific distributions, and determines ligand affinity. Conductance is regulated through 
a central Ca+-channel which at rest is gated by a voltage-dependent Mg2+ blockade. 
Glycine and d-serine also function as endogenous agonists at the NMDAr, with binding 
being a prerequisite for glutamate-induced hyperpolarisation (Cull-Candy et al., 2001). 
There is a wealth of evidence for decreased glutamatergic and NMDAr activity 
in schizophrenia. Prefrontally, there are altered levels of NR2C and NR2D (Akbarian et 
al., 1996) and decreased NR1 mRNA-expression correlating with cognitive impairments 
(Humphries et al., 1996; Sokolov, 1998). Specific gene variants of the neuregulin-1 and 
dysbindin-1 genes, controlling for NMDAr subunit expression, have also been 
associated with schizophrenia (Stefansson et al., 2002; Straub et al., 2002).  
Furthermore, schizophrenic patients have lower levels of the NMDAr co-
agonists glycine (Neeman et al., 2005; Sumiyoshi et al., 2004) and d-serine (Bendikov 
et al., 2007; Hashimoto et al., 2003; Yamada et al., 2005) as well as increased levels of 
the d-serine catabolic enzyme DAAO in the parietal cortex and cerebellum (Madeira et 
al., 2008; Verrall et al., 2007). G72, a gene controlling DAAO transcription, has also 
been linked to susceptibility to schizophrenia (Chumakov et al., 2002). Kyneurenic acid 
and homocystein, two endogenous NMDAr antagonists, are elevated in the brains of 
schizophrenic patients (Erhardt et al., 2001; Neeman et al., 2005; Nilsson et al., 2005; 
Schwarcz et al., 2001). Reduced levels of glutamate in the cerebrospinal fluid (Kim et 
al., 1980) and prefrontal cortex (Tsai et al., 1995), and reduced levels of the NMDAr 
and glutamate in the hippocampus (Pilowsky et al., 2005; Tsai et al., 1995) have also 
been observed. Most of these alterations correspond to a NMDAr hypoactivation, which 
has been suggested as sufficient for the expression of schizophrenic symptoms 
(Moghaddam, 2003). Yet, there is evidence using proton magnetic resonance 
spectroscopy of region and disease-stage dependent variations of glutamate-levels in the 
brains of schizophrenic patients. Levels of glutamine, a glutamate precursor, are 
elevated in the medial prefrontal cortex (mPFC) and thalamus of never-treated first 
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episode schizophrenics (Bartha et al., 1997; Théberge et al., 2002) and in patients 
treated with antipsychotic medication for 9 months (Williamson et al., 2001). In chronic 
patients, however, glutamate and glutamine levels are decreased in the anterior 
cingulate while glutamine levels remain elevated in the thalamus (Théberge et al., 
2003).   
The mechanism underlying the symptom expression is believed to be altered 
activity at NMDArs’ located on prefrontal GABAergic interneurons (chandelier and 
basket cells), causing aberrant glutamatergic pyramidal cell firing, related to the 
cognitive deficits, which subsequently produce a downstream striatal 
hyperdopaminergic state, related to the positive symptoms (Moghaddam and Pehrson, 
2010; Morris et al., 2005). 
 
4.1.2 Modelling schizophrenia through NMDA receptor antagonism 
 
The anesthetic Sernyl (phencyclidine hydrochloride, or PCP) was early noted to 
cause acute post-operative psychosis (Johnstone et al., 1959) and exacerbate symptoms 
in schizophrenic patients (Luby et al., 1959). The psychotomimetic effects of PCP are 
now considered to be due to its non-competitive antagonist effects at the NMDAr (Javitt 
and Zukin, 1991; Olney and Farber, 1995), and PCP is now widely used to preclinically 
model the neurochemical disturbances and symptoms observed in schizophrenic 
patients.  
In healthy subjects, NMDAr antagonism induces a spectrum of symptoms 
analogous to schizophrenia, including the cognitive deficits (Adler et al., 1998; Lahti et 
al., 1995; Krystal et al., 1994). However, dosing regimens differ substantially across 
labs and studies, making interpretations regarding its effect on cognition difficult. 
Subchronic PCP-treatments are commonly viewed to have greater construct validity 
than acute treatments to the pathophysiology of schizophrenia (Jentsch et al., 1997a, 
1997b). These dosing protocols also retard cognitive flexibility. Rats challenged with 5 
mg/kg twice daily for 7 days followed by a 7-day washout period show deficits in maze 
visual reversal learning (Jentsch and Taylor, 2001). In the bowl-digging task, rats 
treated with 0.63 or 1.3 mg/kg once daily across 5 days prior to testing and throughout 
testing show discrimination and reversal deficits (Laurent and Podhorna, 2004). 
Subchronic PCP-treatment at 2 mg/kg twice daily for 7 days followed by a 7-day 
washout period also retards learning in a visuospatial lever reversal task (Abdul-Monim 
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et al., 2006, 2007; Idris et al., 2010; McLean et al., 2009, 2010).  
That said, an acute dose of PCP or alternative NMDAr antagonists also produces 
cognitive impairments in a range of tasks believed to be relevant to the deficits observed 
in schizophrenia. In humans, acute ketamine impairs working memory (Adler et al., 
1998; Malhotra et al., 1996) and attentional set-shifting (Krystal et al., 1994). Acute 
PCP similarly impairs working memory (Bakker and Amini 1961), associative memory 
and recall (Davies and Beech, 1960). Acute PCP also retards delayed matching-to-
sample in the primate (Hudzik and Wenger, 1993), while acute PCP, ketamine, or MK-
801 impairs spatial delayed alternation in the rat (Verma and Moghaddam 1996) and 
water-maze spatial learning and memory in the mouse (Wesierska et al., 1990). In the 5-
choice serial reaction time task (5-CSRTT), performance is also disrupted by an acute 
dose of PCP or MK-801 (Amitai et al., 2007, 2010; Auclair et al., 2009; Greco et al., 
2005; Higgins et al., 2003; Le Pen et al., 2003; Paine et al., 2007, 2009). 
Within tests of cognitive flexibility, acute PCP or MK-801 disrupts performance 
in the response sequence reversal task (Shannon and Love, 2004) and acute ketamine 
retards attentional set-shifting in the bowl-digging task (Nikiforuk et al., 2010). MK-
801 also impairs operant attentional set-shifting when administered systemically 
(Darrah et al., 2008) and maze attentional set-shifting when infused into the mPFC 
(Stefani et al., 2003). In the rat, acute doses of PCP have been shown to retard both 
bowl-digging reversal learning (Gastambide et al., 2010) and water maze reversal 
learning (Wass et al., 2008). Acute PCP also retards performance in a visuospatial 
reversal learning task in the rat, a deficit blocked by a range of compounds, including 
atypical antipsychotics (Abdul-Monim et al., 2003; Idris et al., 2005, 2009). 
However, acute PCP also produces dose-dependent increases in activity in the 
mouse, a response sometimes viewed as analogous to the positive symptoms of 
schizophrenia (Arguello and Gogos, 2006; Powell and Miyakawa, 2006). This 
hyperactivity response can interfere with performance in learning tasks and confound 
interpretations regarding the compounds effect on cognition (Gilmour et al., 2011). 
Acute systemic or PFC-specific NMDAr antagonism leads to increased 
prefrontal pyramidal neuronal burst firing and increased prefrontal glutamate release, 
assumed to be relevant to cognitive impairments, which causes a downstream increase 
of striatal dopamine levels, thought to be related to the positive symptoms (Adams and 
Moghaddam, 1998; Ceglia et al., 2004; Jackson et al., 2004).  
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There is evidence suggesting that the hyperactivity effects are independent from 
the effect of acute PCP on prefrontal and striatal glutamate and dopamine levels, as well 
as its effect on cognition. That is, as activity levels return to baseline, the prefrontally 
elevated levels of glutamate and dopamine and the accumbal elevation of dopamine 
persist (Adams and Moghaddam, 1998). A systemic dose of PCP at 5 mg/kg 
significantly increases prefrontal dopamine levels in the rat, causing a 600% increase 40 
min after treatment. This subsequently declines towards baseline but remains roughly 
doubled compared to vehicle treated controls 140 min post-treatment. Similar effects 
are also seen in the NAc. Its effect on prefrontal glutamate, however, reaches its peak 
and plateaus just under 300% over baseline and remains at this levels 140 min post-
treatment. Just as with elevated prefrontal glutamate and dopamine levels, deficits in 
cognitive flexibility have been shown to be independent of increases in activity. In the 
rat using the bowl-digging task, an acute dose of 2.58 mg/kg PCP retards attentional set-
shifting 24h after treatment (Egerton et al., 2005) and 2.5 mg/kg retards bowl-digging 
reversal learning 2h after treatment (Gastambide et al., 2010). 
Notably, although the cognitive symptoms of schizophrenia and the analogous 
PCP-induced impairments are believed to be related to aberrant glutamate signaling in 
the PFC, the elevated glutamate levels produced by acute PCP is the opposite to the 
reduced levels most often observed in schizophrenic patients (Kim et al., 1980; 
Pilowsky et al., 2005; Tsai et al., 1995). In relation to its effect on glutamate levels in 
the PFC, it may be that acute PCP only appropriately models non-treated first-episode 
schizophrenia (Théberge et al., 2003).   
The cognitive inflexibility deficits seen after both acute and subchronic NMDAr 
antagonism are generally assumed to be due to increased perseverance, and analogous 
to the perseverative deficits seen in schizophrenic patients assessed in attentional set-
shifting (Elliott et al., 1995, 1998). However, NMDAr antagonism also affects latent 
inhibition, and it has been suggested that an inability to overcome non-reinforced 
associations contribute to the deficits induced by NMDAr antagonists in tasks of 
cognitive flexibility. For example, acute PCP potentiates latent inhibition in the 
conditioned taste aversion paradigm (Pålsson et al., 2005; Klamer et al., 2005), while 
MK-801 potentiates latent inhibition in a thirst-motivated conditional emotional 
response task (Gaisler-Solomon et al., 2003, 2008; Lipina et al., 2005). However, as yet, 
the effect of PCP on separate cognitive components in reversal learning has not been 
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assessed. Hence, the experiments in this chapter looked at the effect of acute PCP in the 
mouse on reversal learning, perseverance and learned non-reward. 
Experiment 1 looked at the time and dose-dependent effects of PCP on activity 
levels in order to determine an appropriate dose and pre-treatment time at which PCP 
has no effects on activity levels. Experiment 2 and 3 examined the effect of PCP on 
operant serial reversal learning and maze reversal learning. Furthermore, as PCP has 
been found to retard novelty recognition in the rat (Grayson et al., 2007; McLean et al., 
2010), and novelty is an intrinsic feature of these tasks, Experiment 4 investigated the 
effect of PCP on novelty place recognition in the maze. 
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4.2 METHOD 
 
4.2.1 Drug  
 
Phencyclidine hydrochloride (0, 1, 2.5, 5mg/kg; Sigma-Aldrich, UK) was 
diluted in 0.9% v/w saline and sonicated before being aliquoted and frozen at -80°C in 
quantities needed for each test day. The salt base was corrected for. Saline alone served 
as vehicle control and was prepared and stored in the same way. Solutions were 
administered subcutaneously in the nape of the neck at 4 ml/kg. 
 
4.2.2 Locomotor activity 
 
The experiment used 32 C57BL/6J male mice (Charles River, UK) weighing a 
mean 26.5g at the start of the experiment. The apparatus were as described in Chapter 3. 
A session began with a drug-free 60 min habituation-phase to the test environment. 
Animals were subsequently removed from the boxes and administered a dose of 0, 1, 
2.5 or 5 mg/kg of PCP (N = 8 within each drug condition) and immediately replaced in 
the boxes with their activity monitored for a further 240 min. The number of 45° turns 
was analysed by a 4 (between-subjects: dose) × 16 (within-subjects: time-bin) mixed 
ANOVA.  
 
4.2.3 Operant task 
 
4.2.3.1 Animals and Procedure  
 
The experiment used 24 wild-type male C57BL/6J mice (Charles River, UK) 
weighing a mean 24.2g at the start of the experiment. The training and testing procedure 
differed from the protocol outlined in Chapter 3 and is therefore described below. The 
operant chambers were set-up as depicted in Chapter 3, Figure 3.1. Nosepoke-hole 
blocks were not used.  
Training stage 1. Trial onset was signalled by houselight turning off and one of 
the three nosepoke-lights turning on. The location of the lit-up nosepoke-hole was 
pseudorandom. However, the same nosepoke-hole did not light-up for more than three 
consecutive trials. A nosepoke in the lit-up nosepoke-hole led to pellet delivery, the 
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nosepoke-light turning off and beginning of a 30s ITI when the houselight remained lit. 
However, after a correct response throughout the experiment, the houselight remained 
off for the first 4s of the ITI before switching on and staying on for the remainder of the 
ITI. Responses in un-lit nosepoke-holes were without consequence. The criterion was ≥ 
20 correct responses in a 40 min session. 
Training stage 2. Identical to stage 1, however, animals were now required to 
nosepoke in the magazine within 20s, which activated the single nosepoke-light. A 
response in the lit-up nosepoke-hole within 12s lead to pellet delivery, the nosepoke-
light turning off, and beginning of the 30s ITI when the chamber remained dark. Failure 
to either respond in the magazine within 20s or respond in the nosepoke-hole within 12s 
counted as omissions and caused immediate onset of the 30s ITI. The criterion was ≥ 35 
correct responses over two consecutive days or ≥ 40 correct responses in a single day of 
50 trials. 
Side-bias. As described in Chapter 3, each animals side-bias was assessed prior 
to the spatial discrimination. The location of the two initial nosepoke-holes (right vs 
left, centre vs. left, centre vs. right) was fully counterbalanced across the different drug 
and test conditions. The test conditions constituted full reversal, learned non-reward, 
and perseverance, and were as described in Chapter 3 with the exception of no 
nosepoke-hole blocks being used. 
 
4.2.3.2 Experimental design and statistical analysis  
 
After reaching criterion in the initial drug-free spatial discrimination phase, 
animals were pair-matched for trials to criterion and assigned to a drug and test 
condition. The experiment used a between-subjects serial design, where each animal 
completed three full reversal, perseverance or learned non-reward tests (Fig. 3.2A).  
Each test was preceded by a drug-free retention test of the previously learned 
contingencies. The dependent variables were trials, omissions, correct and incorrect 
responses to criterion. Incorrect responses were further analysed as early-errors and 
late-errors. The data was analysed using 3 (within subjects: test phase) × 2 (between 
subjects: drug) × 2 (between subjects: test condition) mixed ANOVAs. 
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4.2.4 Maze task 
 
4.2.4.1 Animals and procedure 
 
The experiment used 72 wild-type C57BL/6J male mice (Charles River, UK) 
weighing a mean 24.9g at the start of the experiment. The experiment was run in two 
batches of 36, with each animal being tested every other day. The training and testing 
procedure was as exactly as described in Chapter 3. 
 
4.2.4.2 Experimental design and statistical analysis  
 
After reaching criterion in the initial drug-free spatial discrimination phase, 
animals where pair-matched for trials to criterion and assigned to a drug and test 
condition. The maze experiment used a between-subjects single test design where each 
animal completed a single full reversal, perseverance or learned non-reward test. The 
dependent variables were trials, correct and incorrect responses to criterion, and early- 
and late-errors. Mean trial-time when drug-challenged in the test phase was collected 
through video analysis. The data was analysed using a 2 (drug) × 3 (test condition) 
between-subjects ANOVA.  
 
4.2.5 Maze novelty recognition 
 
The experiment used 16 C57BL6/J male mice (Charles River, UK) weighing a 
mean 27.0g at the start of the experiment. The procedure was as as described in Chapter 
3. On the test-day, animals received an acute dose of PCP at 5 mg/kg 2h and 45min 
before being placed in the maze. Thus, the novel response arm location was introduced 
3h after drug administration.  
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4.3 RESULTS  
 
 
4.3.1 Experiment 1: PCP and locomotor activity 
 
PCP significantly increased activity over 180 min (Fig. 4.1). There was a 
significant main effect of dose (F3, 28 = 33.1, p < .0001) and a significant dose × time 
interaction on activity levels over the 240 min test-phase (F45, 420 = 14.7, p < .0001), 
with PCP increasing activity levels in a dose-dependent manner (Fig. 4.1B). Separate 
ANOVAs for each time-bin revealed non-significant effects of dose in the last five 
time-bins. Accordingly, PCP at a dose of 5 mg/kg and a 180 min pre-treatment time was 
chosen for assessing the effects of PCP in the maze, operant and novelty tasks. 
 
 
 
 
 
 
 
Figure 4.1. Effect of PCP on locomotor activity. (A) Activity expressed in 
15 min time-bins. Animals were dosed at time 0, following 60 min of 
habituation to the test environment. Asterisk denote time-point at which drug 
effect upon activity equals p ≥ 0.05. (B) Total activity counts over the 240 
min test phase. PCP significantly increased activity at 2.5 and 5 mg/kg. (*** 
= p < .0001).  
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4.3.2 Experiment 2: PCP and operant reversal learning 
 
There were no significant differences in performance between animals exposed 
to the different nosepoke-hole configurations (left vs right, right vs centre, left vs 
centre). PCP had no effect on learning in the three conditions, but decreased the number 
of omissions as well as trial-initiation and nosepoke-response latencies.  
 There were no significant main effects of drug or drug × condition interactions 
on trials (Fig 4.2; Drug: F1,17 = 2.7, p = ns, Drug × condition: F2,17 = 2.1, p = ns) 
incorrect responses (Fig 4.3; Drug: F1,17 = 1.3, p = ns, Drug × condition: F2,17 = 1.2, p = 
ns) or correct responses to criterion (Fig. 4.4; Drug: F1,17 = 0.4, p = ns, Drug × 
condition: F2,17 = 0.6, p = ns).   
Figure 4.2. Effect of PCP on trials to criterion in the three test phases of the 
full reversal (A) learned non-reward (B) and perseverance conditions (C) in 
the operant procedure. Broken line represents mean performance in the 
initial spatial discrimination phase. Significant main effect of phase (F2,34 = 
3.8, p = .03) and phase × condition interaction (F4,34 = 4.5, p = .005). In the 
first test phase, animals required more trials in the full reversal condition 
than in the perseverance (p = .02) and the learned non-reward conditions (p 
= .01). No main effect of PCP or interactions with test condition or test 
phase. 
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 However, there was a significant effect of drug (F1,17 = 11.9, p < .01) as well as 
significant drug × condition (F2,17 = 5.6, p < .05)  and phase × drug × condition (F4,34 = 
2.9, p < .05) interactions on omissions to criterion (Fig. 4.5). Separate one-way 
ANOVAs within each drug and test condition showed that PCP significantly decreased 
omissions only in phase 2 of the in the perseverance condition (F1,6 = 18.0, p < .01).  
PCP also decreased trial initiation (F1,17 = 13.5, p < .01) and nosepoke-hole response 
times (Table 4.1; F1,17 = 12.8, p < .01). There were no effects of PCP or interactions 
with condition or test phase on early- or late-errors to criterion. 
 
Figure 4.3. Effect of PCP on incorrect responses to criterion in the three test 
phases of the full reversal (A) learned non-reward (B) and perseverance 
conditions (C) in the operant procedure. Broken line represents mean 
performance in the initial spatial discrimination phase. Significant effect of 
phase (F2,34 = 3.3, p = .048) and phase × condition interaction (F4,34 = 3.0, p = 
.032). In the last test phase, animals made fewer incorrect responses in the 
learned non-reward condition than in the full reversal (p = .02) and perseverance 
conditions (p = .02). No main effect of PCP or interactions with test condition or 
test phase. 
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Drug 
    Trial 
initiation 
Nosepoke 
response 
  Pellet  
retrieval 
Vehicle 5.17 ± .18 3.94 ± .13 2.06 ± .05 
PCP 5 mg/kg 4.24 ± .17** 3.29 ± .13** 1.99 ± .05 
Trial initiation: Significant effect of drug (F1,17 = 13.5, p = .002) and drug × test phase 
interaction (F2,34 = 4.5, p = .018). PCP decreased trial initiation-time in the second and 
third test phases.  Nosepoke response: Significant main effects of drug (F1,17 = 12.8, p = 
.002) and condition (F1,17 = 5.7, p = .013).  PCP decreased nosepoke-response times 
while animals in the non-reward condition were slower to respond in the nosepoke-hole 
than animals in the full reversal (p = .009) and the perseverance conditions (p = .008). 
Pellet retrieval: no significant effects.  
 
Figure 4.4. Effect of PCP on correct responses to criterion in the three test 
phases of the full reversal (A) learned non-reward (B) and perseverance 
conditions (C) in the operant procedure. Broken line represents mean 
performance in the initial spatial discrimination phase. No significant main 
effect of PCP or interactions with test condition or test phase. 
Table 4.1. Mean latencies (± SEM) in the operant task collapsed over the three 
test phases and three test conditions. 
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Figure 4.5. Effect of PCP on omissions to criterion in the three test phases of 
the full reversal (A) learned non-reward (B) and perseverance conditions (C) in 
the operant procedure. Broken line represents mean performance in the initial 
spatial discrimination phase. Significant main effects of drug (F1,17 = 11.92, p = 
.003) and phase (F1,34 = 5.3, p = .01)  and drug × condition (F2,17 = 5.6, p = .014) 
and phase × drug × condition interactions (F4,34 = 2.9, p = .035). Animals made 
fewer omissions in phase three than phase 1 (p = .002) and phase 2 (p = .017) . 
PCP significantly decreased omissions only in phase 2 of the perseverance test 
(F1,6 = 18.0, p = .005).   
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4.3.3 Experiment 3: PCP and maze reversal learning 
 
Acute PCP caused a non-condition dependent increase in trials and incorrect 
responses to criterion (Fig. 4.6). PCP also decreased mean trial times across all test 
conditions. PCP had no effect on late-errors, but significantly increased the number of 
early-errors.  
There was a significant main effect of drug on trials (F1,44 = 8.0, p < .01) and 
incorrect responses to criterion (F1,44 = 10.2, p < .01) but no effects on correct trials to 
criterion. To further investigate how PCP affected learning in the three test conditions, 
incorrect responses was broken down and analysed in terms of pre- and post > 50% 
correct responses in a nine-trial `bin. PCP significantly increased the number of early-
errors (F2,44 = 7.6, p < .01) but not late-errors across all conditions, with no significant 
effect of test condition or drug × test condition interaction.   
For mean trial times, there was a significant effect of drug (Vehicle, 4.9s ± 0.3; 
PCP, 3.8 ± 0.1; F1,44 = 10.1, p < .01) but no effect of test condition or drug × test 
condition interaction. 
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Figure 4.6. Effect of PCP in the three test conditions of the maze procedure. Asterisk denote 
differences at which p < .05. Broken line represents mean performance in the initial spatial 
discrimination phase.  (A) Trials to criterion. Significant main effects of drug (F1,44 = 8.1, p = 
.007) and test condition (F2,44 = 3.7, p = .032). Animals in the full reversal test required more 
trials to criterion than animals in the perseverance (p = .012) and learned non-reward tests (p 
= .052). (B) Incorrect responses to criterion. Significant main effect of drug (F1,44 = 10.2, p = 
.003). (C) Correct responses to criterion. No significant effect of drug, test condition, or drug 
× test condition interaction. (D) Early-errors. Significant effect of drug (F2,44 = 7.6, p = .008) 
but no effect of test condition or drug × test condition interaction. (E) Late-errors. No effect 
of drug, test condition, or drug × test condition interaction. 
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4.3.4 Experiment 4: PCP and maze novelty recognition 
 
Animals recognised the 45° shift in response-arm location, seen as significant 
increases in the proportion of arm entries and proportion of time spent in the novel arm. 
PCP had no effect on either measure.  
Before the presentation of a novel arm, animals spent equal proportions of time 
and made equal proportions of arm entries in to each of the three arms (Table 4.2). 
Shifting the arm 45°, significantly increased the proportion of time spent in the arm 
(F1,20 = 23.8, p < .0001) and the proportion of arm entries into the arm (F1,20 = 42.6, p < 
.0001). There were no significant effects of drug on proportion of time spent in the 
novel arm or proportion of arm entries made into the novel arm. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Proportion of time (%) Proportion of entry counts (%) 
 Pre-shift Post-shift Change Pre-shift Post-shift Change 
Vehicle 34.0 ± 2.2 51.8 ± 3.3 +17.8 36.7 ± 1.7 46.4 ± 3.3 +9.74 
5 mg/kg PCP 31.0 ± 3.1 52.2 ± 5.0 +21.2 32.9 ± 0.8 46.0 ± 2.2 +13.14 
Total 32.5 ± 1.9 52.0 ± 2.9 +19.5** 34.8 ± 1.0 46.2 ± 2.0 +11.44** 
Table 4.2. Effect of PCP on novelty recognition. Proportion of time and proportion of entries ± 
SEM (in brackets) before a 45° shift (pre-shift) and after a 45° shift (post-shift) in vehicle and 
PCP treated animals. 
 
** p < .001 
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4.4 DISCUSSION 
 
An acute dose of 5 mg/kg of PCP under a 3h pretreatment time had different 
effects on performance in the maze and operant tasks, leaving learning intact in the 
operant procedure while causing general disruptions in the maze. PCP affected latency-
measures in both tasks, with PCP causing reductions in response-latencies and mean 
trial-times.   
 
4.4.1 Locomotor activity 
 
PCP have marked effect on motor function that may influence performance in 
procedures involving complex motor sequences, such as reversal learning tasks 
(Gilmour et al. 2011). In Experiment 1, PCP increases activity levels for 120 min at 2.5 
mg/kg and for 180 min at 5 mg/kg. Most work investigating the effects on acute PCP on 
cognitive flexibility do not assess the dose and pretreatment times affect on activity, and 
it may be that motor disruptions could account for some of the previous reversal 
learning deficits observed. 
 
4.4.2 Operant task  
 
In the operant task, PCP decreased the number of omissions and trial self-
initiation and nosepoke-hole response latencies yet failed to effect learning, with no 
significant effects on trials to criterion, correct or incorrect responses to criterion. 
Previously, O’Neil and collegues have shown that acute treatment with PCP at 
1-1.5 mg/kg 30 min prior to testing potently retards operant visuospatial reversal 
learning performance in the rat (Abdul-Monim et al., 2003; Idris et al., 2005, 2009). 
However, their procedure differs substantially from most other reversal learning 
procedures. In their task, animals do a within-session reversal between levers, with 
contingency shifts being cued by a 1 min dark-out period. Animals undergo repeated 
reversals during training, prior to being drug-challenged. When drug-challenged, the 
protocol remains identical to the protocol of the training phase. Thus, it can be argued 
that successful performance in this task, contrary to standard reversal learning assays, 
require the animal to preserve the response strategy adopted during training rather than 
to acquire an alternative response strategy. The PCP-induced reversal learning deficit in 
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their task is also blocked by a range of compounds, including clozapine, olanzapine, 
ziprasidone, lamotrigine, sertindole, risperidone, asenapine, the 5-HT2A receptor (5-
HT2AR) antagonist M100907, the 5-HT6R antagonist SB742457, the 5-HT2CR 
antagonist SB243213A, the 5-HT7R antagonist SB269970A, the α7 nAChR agonist 
PNU-282987, the Na+-channel inhibitor phenytoin, and the D1R agonist SKF-38393. 
The validity of the task in relation to the cognitive deficits of schizophrenia is unclear, 
as these atypical antipsychotics lack in reliable therapeutic efficacy against the cognitive 
symptoms of schizophrenia.  
Notably, PCP has also repeatedly been shown to be without effect on reversal 
learning. Subchronic PCP has recently been found to be without effect in a touch-screen 
visual reversal learning task in the mouse when administered twice daily at 5 mg/kg for 
7 days followed by a 7 day washout period  (Brigman et al., 2009). In the bowl-digging 
task, a range of subchronic dosing regiments have failed to affect performance in the 
reversal phases (Dawson et al., 2012; Deschenes et al., 2006; Goetghebeur et al., 2008, 
2010; McLean et al., 2008; Rodefer et al., 2005, 2008) Also, an acute dose of 2.58 
mg/kg 24h prior to testing has no effect on bowl-digging reversal (Egerton et al., 2005). 
In maze spatial reversal learning, acute PCP at 1 mg/kg dose 10 min prior to testing has 
no effect on acquisition of reversal learning, but affects retention 24h later (Handelmann 
et al., 1987).  Here acute PCP was similarly found to be without effect on operant 
reversal learning.  
More difficult to reconcile with the current negative data are reports of impaired 
reversal learning from a similar dosing protocol. In the rat, an acute dose of PCP at 2.5 
mg/kg retards reversal learning 120 min post treatment in the bowl-digging task 
(Gastambide et al., 2010). These discrepancies could be explained by differences in 
methodology including task, species and dosing protocol. Notably, 2.5 mg/kg may still 
significantly increase activity levels 2h post-treatment.  
PCP did however significantly reduce the number of omissions, most potently in 
the perseverance condition. With no effects of PCP on measures of trials, incorrect or 
correct responses to criterion in any of the test conditions, the effect is likely to be 
unrelated to learning. Omissions are most often are interpreted as a measure of 
motivation (Robbins, 2002). It is however unlikely that the PCP-induced decrease in 
omissions could be explained by a direct elevation in the motivation for sucrose. PCP 
has been found to decrease or have no hedonic effects when evaluated in licking 
microstructure (Lydall et al., 2010) and sucrose consumption tests (Turgeon and Hodge, 
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2003). Also, PCP failed to affect pellet-retrieval latencies, considered the more potent 
measure of reinforcer evaluation (Robbins, 2002).    
A further possibility is that the decreased omissions is the product of 
exaggerated motivational salience of the reward related stimuli, or impulsive decision-
making. Subchronic PCP has been shown to increase impulsive responding in the vervet 
monkey when having to inhibit reaching towards a barrier (Jentsch et al., 1997, 2000). 
However, the increased impulsivity following subchronic PCP has been explained by 
reduced corticostraital dopamine, with similar effects are seen after MPTP-induced 
dopamine depletions (Schneider and Kovelowski, 1990; Taylor et al., 1990a, 1990b). If 
anything, the opposite effect is produced after an acute treatment of PCP using the 
current dosing protocol, which increases prefrontal and striatal levels of dopamine 
(Adams and Moghaddam, 1999). Moreover, normal acquisition was observed in each of 
the three test conditions following acute PCP. It could be argued that a PCP-induced 
increase in behavioural control of reward related stimuli should cause profound 
perseverative deficits in this task. 
The reduced omissions could also be an effect of increased activity. In the rat, 
the cocaine-induced elevation in responding for sucrose rats under a progressive-ratio 
schedule has been attributed to elevated activity, as cocaine also causes a parallel 
decrease in sucrose consumption and preference (Brown and Stephens 1999). However, 
a direct effect of locomotor activity on omissions is unlikely. Experiment 1 showed that 
5 mg/kg of PCP failed to increase activity 3h post-treatment. Also, PCP had no effect 
on the number of nosepoke-hole responses made. It could be predicted that such effects 
also should increase the number of correct and incorrect responses by PCP-treated 
animals. 
Alternatively, the effect on omissions could be related to motor-impulsivity.  
Motor impulsivity is most often assessed in the 5-CSRTT, where animals have to 
respond in one of five nosepoke-holes signaled by a brief illumination. Prior to the 
illumination, there is an ITI during which the animal must withhold from responding. 
Responses made during the ITI are described as premature, and believed to index motor 
impulsivity. Other performance measures include accuracy, measuring the correct 
response ratio, and ‘perseverative-responses’, measuring excessive non-reinforced 
nosepoke-hole responses.  
In the rat, acute NMDAr antagonism through PCP, MK-801, Ro63-1908 or CPP 
increases premature responses in the 5-CSRTT (Higgins et al., 2003; Le Pen et al., 
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2003; Paine et al., 2007). In the mouse, an acute dose of 3 mg/kg PCP 10 min before 
testing has been found to increase impulsivity in the 5-CSRTT in the mouse without 
significantly affecting other performance measures (Greco et al., 2005) although there is 
likely significant hyperactivity at this point. The decreased accuracy in the 5-CSRTT 
following an 1-2 mg/kg acute dose of PCP 30 min prior to testing has also been 
explained in terms of increased motor impulsivity, as decreased accuracy is independent 
of delay and associated with decreased correct response latencies (Smith et al., 2011). 
The impulsivity effects of NMDAr antagonism are believed to be caused by a 
prefrontal hyperglutamatergic state (Ceglia et al., 2004). The competitive NMDAr 
antagonists CPP and MK-801 increases premature responses in the 5-CSRTT if infused 
into the mPFC (Agnoli and Carli, 2012; Baviera et al., 2008; Lehmann et al., 1987) or 
infralimbic cortex (Murphy et al., 2005). Increased glutamate within the mPFC also 
appears to be selectively involved in motor impulsivity. At lower doses, intra-mPFC 
infusions of CPP increased premature responses without affecting accuracy and 
hyperactivity (Carli et al., 2004, 2006). Also, antagonising CPP-induced glutamate 
release through pretreatment with the 5-HT2AR antagonist M100907 selectively 
decreases premature responses without effecting perseverative responses (Ceglia et al., 
2004, 2006). A hyperglutamatergic prefrontal state is produced by PCP under the 
current dosing protocol (Adams and Moghaddam, 1998), which effect upon motor 
impulsivity could explain the observed reduction in omissions and latencies.   
However, elevated dopamine-levels can also cause increased impulsivity. In the 
rat, amphetamine increases premature responses (Harrison et al., 1997), which is 
blocked by striatal dopamine depletion (van Gaalen et al., 2006) and the D2R antagonist 
eticlopride (Cole and Robins, 1989). In the mouse, amphetamine and the dopamine re-
uptake inhibitor GBR12909 increases premature responses (Loos et al., 2010). The 
effect of acute systemic PCP on premature responses has also been linked to activity 
within the dorsal striatum. Pretreatment with the 5-HT2AR antagonist M100907 
attenuates both PCP-induced increases in premature responses and striatal, but not 
prefrontal, s-133-creb phosphorylation (Pozzi et al., 2010). A 5 mg/kg dose of PCP 
causes a significant elevated of striatal dopamine levels 140 min post-treatment, and it 
may be that this can influence the performance in the current tasks. That said, the 
increase is relatively small in relation to its effect on prefrontal glutamate (Adams and 
Moghaddam 1998).  
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In conclusion, PCP failed to affect learning in the operant task, with no 
significant effects on trials, correct, or incorrect responses to criterion. However, PCP 
decreased the number of omissions made as well as latencies for trial-initiation and 
nosepoke-hole response. These effects could be related to a hyperglutamatergic 
prefrontal state causing elevated motor impulsivity. 
Lastly, the current operant design allows for several possible confounds. First, 
all three nosepoke-holes remained open at all times. This meant that animals could 
respond, without effect, in the inactive un-lit nosepoke-hole at all training and testing 
stages of the experiment. If animals are guided by spatial location to a greater extent 
than the nosepoke-hole light, animals may still treat the inactive nosepoke-hole as a 
valid response option. This would also mean that latent inhibition-like effects develop 
towards the inactive nosepoke-hole as a nosepoke in this hole is without consequence.  
Second, animals are trained to nosepoke across all nosepoke holes within a single 
session (Floresco et al., 2008). Hence, within a single training session, all nosepoke-
holes are occasionally rewarded. This is a direct contradiction to the idea of 
discrimination learning. In the current protocol, proactive interference from the training 
phases could therefore confound learning in the test-phases. An alternative is to train 
animals to with one response alternative only (Boulougouris et al., 2007, 2008, 2009; 
Boulougouris and Robbins, 2009, 2010). 
 
4.4.3 Maze task 
 
Contrary to the operant task, PCP potently retarded performance in the maze 
task. This was seen as significant increases in trials, incorrect responses and early-errors 
across the full reversal, perseverance and learned non-reward conditions. Similar to the 
operant task, PCP also caused a non-condition dependent decrease in mean trial-times. 
It is possible that the retarded learning is due to deficits in novelty recognition, 
as both the perseverance and learned non-reward tests involve the presentation of a 
novel response option. Accordingly, although there were no significant drug × test 
condition interactions, the effect of PCP appeared to be more prominent in the learned 
non-reward and perseverance tests, which involve the presentation of a novel response-
option, than the full reversal test. In support of this, it has previously been shown that 
PCP retards novelty recognition in the rat (Grayson et al., 2007; MacLean et al., 2010). 
However, in Experiment 4, PCP failed to influence the proportion of time spent in the 
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novel arm and the proportion of entries made into the novel arm, indicating equal 
novelty recognition in PCP and vehicle treated animals. A further possible explanation 
for the mild effect within the full reversal condition is the greater difficulty, with the 
relatively high number of trials and incorrect responses of the vehicle treated animals 
partly masking any PCP-related deficits. 
The general impairment in learning was paralleled by decreased mean trial 
times. When assessing the effect of PCP in reversal paradigms, latency effects are 
sometimes not reported (Abdul-Monim et al., 2003, 2006, 2010; Gastambide et al., 
2012; Idris et al., 2005, 2009, 2010; McLean et al., 2009, 2010), or reported to be 
without effect (Brigman et al., 2008; Handelmann et al., 1987). Within other paradigms, 
PCP has disparate effects upon latency indices depending dosing procedures. For 
example, in a delayed matching to position task, 0.5-2 mg/kg 30 min prior to testing has 
been shown to decrease response latencies (Smith et al., 2011). In the 5-CSRTT, acute 
doses of 1-2 mg/kg at a 30 min pretreatment time has been found to decrease correct 
response latencies in the rat (Smith et al., 2011), while acute doses at 2-3 mg/kg at 10-
45 min pretreatment times has been found to increase response latencies (Auclair et al., 
2009; Amitai et al., 2007, 2010; Le Pen et al., 2003). Just as with omissions, the 
decreased latencies are unlikely to be effects of cognitive impulsivity or enhanced 
motivation for sucrose, but could again be related to motor impulsivity. A further 
possibility is that the decreased mean trial times of PCP-treated animals are context 
dependent activations of activity, and therefore observed in the maze but not the 
locomotor runways.   
Impulsivity could also explain the retarded learning. Although PCP failed to 
affect learning in the operant task where decreased response latencies and omissions 
also were observed, elevated motor impulsivity is likely to have a stronger impact on 
choice behaviour in the maze where responses are guided by egocentric motoric cues.  
Nevertheless, the PCP-induced deficits in learning were associated with an increase in 
early-errors without affecting the number of late-errors. If a general increase in motor 
impulsivity was the cause of the retarded learning, the prediction would be of a more 
general impairment in learning, also affecting late-errors. It may be that as well as 
causing motor and impulsive disturbances, PCP retards the ability to overcome previous 
egocentric associations of reward and non-reward. 
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Most often, the retarding effects of PCP on reversal learning are assumed to be 
due to increased perseverance and hence model the perseverative deficits of 
schizophrenic patients (Elliott et al., 1995, 1998). However, NMDAr antagonism has 
also been shown to have potentiating effects upon non-reinforced associations within 
latent inhibition paradigms, and it has been suggested that these deficits are related to 
the cognitive inflexibility induced by PCP and observed in schizophrenia (Gaisler-
Salomon et al., 2008; Gaisler-Salomon and Weiner 2003; Klamer et al., 2005; Lipina et 
al., 2005; Pålsson et al., 2005). In accord with these suggestions, the non-condition 
dependent retardation of learning would indicate that an acute dose of PCP attenuates 
reversal learning by decreasing the ability to overcome both perseverance and learned 
non-reward. 
Although the effect of NMDAr-antagonism on learned non-reward has not 
previously been investigated, the current results may appear to be in discrepancy with 
the idea of PCP as a model of the cognitive deficits of schizophrenia. Specifically, 
schizophrenia has traditionally been associated with a decrease in the strength of CS-
‘no-US’ associations in latent inhibition paradigms (Baruch et al., 1988; Williams et al., 
1998) while the current result would suggest that PCP increases the strength of CS-‘no-
US’ associations. Yet, decreased latent inhibition has been suggested to be a feature of 
only acute, positively symptomatic and untreated patients (Cohen et al., 2004) while 
increased latent inhibition is a feature of chronic patients (Gal et al., 2009) and patients 
with high negative/positive symptoms ratio (Cohen et al., 2004; Rascle et al., 2001). 
Hence, increased latent inhibition can be a feature of both acute NMDAr antagonist 
treatment and schizophrenic symptoms.  
Lastly, PCP caused a selective increase in ‘early-errors’ without affecting ‘late-
errors’. Although the increase in early-errors was most prevalent in the perseverance 
test, it was also present in the full reversal and learned non-reward tests.  It is widely 
assumed that early-errors represent perseverance towards the previous CS+ and not 
related to the ability to overcome previously non-rewarded associations. However, the 
PCP-induced increase of early-errors in the learned non-reward test suggests that early-
errors also are related to the ability to overcome non-reinforced associations. Thus, the 
assumption of early-errors representing perseverance is contradicted by the observation 
that PCP also increased early-errors in the learned non-reward test, showing that ‘early-
errors’ also can be related to the ability to suppress non-reinforced associations. 
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In conclusion, an acute dose of PCP retards egocentric spatial reversal learning 
in the mouse by increasing the interference from both previous CS-US and CS-‘no-US’ 
associations. However, these interpretations remain tentative, as PCP also caused 
parallel decreases in mean trial-times, indicative of concomitant and possibly 
confounding non-cognitive effects of motor impulsivity.  
 
4.4.4 General discussion 
 
A potential problem when investigating the effects of acute PCP is hyperactivity 
confounding interpretations of the drugs effect on cognition. Experiment 1 therefore 
investigated the dose-dependent effects of PCP on activity, showing that 5 mg/kg is 
without effect on activity levels 3h after treatment. Experiments 2 and 3 subsequently 
assessed 5 mg/kg using a 3h pre-treatment time on reversal learning, perseverance and 
learned non-reward in the operant chamber and maze. PCP had no effect on reversal 
learning in the operant task, while causing both perseverance and learned non-reward 
related deficits in egocentric reversal learning assessed in the maze procedure. These 
deficits were primarily related with a non-condition dependent increase in early-errors. 
Finally, Experiment 4 showed that PCP, at the same dose and pre-treatment time, failed 
to affect spatial novelty recognition in the maze.  
PCP decreased response latencies in both the maze and the operant tasks, as well 
as decreasing the number of omissions in the operant task. These effects may be due to 
increased impulsivity through elevated levels of prefrontal glutamate. Interestingly, in 
the operant task, these disturbances occurred in the absence of any deficits in learning. 
Increased impulsivity may however have bigger impact upon indices of learning in the 
maze, where animals make egocentric responses in the dark relative to visuospatially-
guided responses in the operant-chamber. However, PCP also caused a non-condition 
dependent increase in early- but not late-errors. Accordingly, it is tentatively suggested 
that PCP retards egocentric reversal by impairing the ability to overcome both 
perseverance and learned non-reward.    
A further possibility is that the discrepant effects of PCP in the maze and 
operant tasks are due to the tasks being dependent upon different brain regions. The 
currently used dosing protocol causes elevated prefrontal glutamatergic levels, but also, 
to a lesser extent, increased prefrontal and accumbal levels of dopamine (Adams and 
Moghaddam, 1998). While elevated levels of prefrontal glutamate and striatal dopamine 
	   81	  
is believed to be relevant for an understanding of the symptoms of schizophrenia, 
elevated levels of prefrontal dopamine can have pro-cognitive effects (Stefani and 
Moghaddam, 2006). Thus, PCP may not disrupt learning in tasks tapping primarily on 
prefrontal regions. The next chapter uses these tasks to investigate the effect of 
prefrontal subregion-specific lesions.  	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CHAPTER 5 
PREFRONTAL CORTEX AND REVERSAL LEARNING 
 
 
5.1 INTRODUCTION 
 
One consequence of damage to the human prefrontal cortex (PFC) is a failure to 
adapt decision-making across situations, with patients repeatedly making decisions with 
adverse consequences despite good knowledge of the negative outcome of that decision 
(Bechara et al., 2001; Harlow, 1868). Perturbations within the PFC have been 
interpreted as the cause of the majority of cognitive inflexibility deficits observed in 
such psychopathology. Also, most pharmacological manipulations affecting cognitive 
flexibility are believed to act within this circuitry.  
That the symptoms of patients suffering from frontal lobe lesions and dementia 
praecox (or schizophrenia) greatly overlap was noted by Kraeplin (1919) and 
corroborated by post-mortem studies showing corresponding cerebral atrophy in 
schizophrenic patients (Kleinman et al., 1988). More recently, schizophrenia has been 
associated with reduced PFC volume (Turetsky et al., 1995) PFC grey matter density 
(Koutsouleris et al., 2008) orbitofrontal cortical (OFC) volume (Convit et al., 2001) and 
decreased cortical cerebral blood flow (Franzén and Ingvar, 1975a, 1975b).  
The cognitive symptoms associated with schizophrenia appear to be a 
consequence of reduced PFC functioning, or hypofrontality. Schizophrenic patients 
show decreased PFC or dorsal lateral PFC (DLPFC) regional cerebral blood flow when 
performing the Tower of London task (Andreasen et al., 1992), N-back task (Glahn et 
al., 2005) continuous performance task (Volz et al., 1999) and the WCST (Kawasaki et 
al., 1993; Meyer-Lindenberg et al., 2002; Volz et al., 1997). The cognitive inflexibility 
of schizophrenic patients is also paralleled by similar deficits in frontal lobe patients. 
Both groups have been tested in a modified version of the CANTAB ID/ED-task 
allowing separate assessments of perseverance and learned irrelevance by replacing 
either the previously correct or incorrect dimension with a novel dimension across test 
trials (Elliot et al., 1995, 1995; Owen et al., 1993). Here, both frontal lobe and 
schizophrenic patients display prominent perseverative deficits but show little or no 
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impairment in learned irrelevance. This suggests that hypofrontality is related to deficits 
in overcoming prior associations with reward rather than irrelevant associations.  
Furthermore, different PFC-subregions mediate various forms of cognitive 
flexibility, and this functional homology is preserved across species (Bissonette and 
Powell, 2010; Keeler and Robbins, 2010). While the medial wall (the primate DLPFC 
and rodent medial prefrontal cortex, or mPFC) is critical for attentional set-shifting, the 
OFC, including the medial (MO), lateral (LO) and ventral orbital (VO) regions, has 
been shown to be involved in reversal learning (Cools et al., 2002; Hampshire and 
Owen, 2006; Hornak et al., 2004).  
 
5.1.1 Orbitofrontal cortex  
 
Interpretations regarding the cognitive causes of reversal learning deficits 
following experimental OFC perturbations often stem from analyses of response 
tendencies during a series of reversal trials. The number of errors made before 
achieving 50% correct responses in a reversal test, or early-errors, is a typical index 
used to indicate a perseverative response strategy. Conversely, the number of incorrect 
responses made after achieving chance level of responding, or late-errors, is considered 
to be unrelated to perseverance. The prevalent idea is that the OFC is critical for 
overcoming perseveration, and this appears to be primarily based on findings showing 
that OFC-lesions, inactivation, or pathology-related aberrations to selectively increase 
the number of early-errors to criterion. A further method used to dissociate 
perseverative responses has been to employ successive rather than simultaneous 
discrimination and reversal tasks, as successive presentations of stimuli allows for 
separate response analyses when the previous CS+ and the previous CS- are presented 
independently.  
For example, in humans, lesions encompassing the OFC induce deficits in a 
go/no-go reversal task (Rolls et al., 1994). The deficits are characterised by a decreased 
ability to supress responding towards the previous CS+ rather than a failure to instigate 
responding towards the previous CS-. The deficit is therefore argued to be perseverative 
rather than related to decreased ability to overcome associations of non-reinforcement. 
Likewise, aspiration lesions of the OFC in the rhesus leads to impairments in both 
spatial and object discrimination learning and reversal learning (Butter, 1969; Jones and 
Mishkin, 1972), while quinolinic OFC-lesioned marmosets show selective reversal 
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deficits in the visual ID/ED-task (Dias et al., 1996). These deficits are also interpreted 
as perseverative as lesioned animals make more errors while responding still is biased 
towards the previously correct response alternative. 
Using a visual touch-screen reversal task in the rat, quinolinic OFC-lesioning 
has no effect on sessions or trials to criterion yet increases the number of early-errors 
and is therefore suggested to relate to increased perseveration (Chudasama et al., 2003). 
In this task, however, lesions of the infralimbic subregion of the mPFC also increase the 
number of incorrect responses, but selectively after animals have achieved chance levels 
of responding.  
Aspiration lesions of the OFC in the rhesus also leads to deficits in the last four, 
but not the first reversal, using a serial object go/no-go task (McEnaney and Butter, 
1969). While control animals showed a serial-reversal effect, with performance 
improving across reversal tests, the performance of the lesioned group declined over 
subsequent tests. Moreover, OFC-animals showed excessive responding to the 
previously rewarded stimulus, as well as increased omissions when presented with the 
previously non-rewarded but now rewarded stimulus. This would indicate that an intact 
OFC is required to overcome both perseveration and learned non-reward (McEnaney 
and Butter, 1969). 
In a serial operant go/no-go odour discrimination and reversal task in the rat, 
NMDA-induced lesions of the OFC selectively impaired reversal learning but did not 
affect discrimination learning (Schoenbaum et al., 2002). However, the impairment in 
this task is directly opposite to the impairment observed by McEnaney and Butter 
(1969). First, OFC-lesioned, but not controls, showed a serial reversal effect with 
performance improving across tests. Second, the deficit was only apparent in the first 
reversal of five presented, suggesting that the effects of OFC-lesioning on reversal 
learning are transient rather than permanent.  
In a four-phase serial operant lever reversal task, quinolinic OFC-lesioned rats 
showed retarded performance in the first reversal, and facilitated performance in the 
second reversal, and no effects were observed in the third and fourth reversals 
(Boulougouris et al., 2007). Pre-surgical reversal training blocked any reversal deficits 
produced by later OFC-lesioning in this task (Boulougouris et al., 2009), again 
suggesting that the OFC has a transient role in reversal learning. The OFC-induced 
impairment in the first reversal was suggested to be due to perseveration, as animals 
showed an increase in early-errors but not late-errors. 
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Lastly, muscimol-induced OFC-inactivation impaired both two- and four-choice 
reversal learning in an olfactory bowl-digging task (Kim and Ragozzino, 2004). OFC-
inactivation causes a selective increase in errors committed before attainment of chance 
level of responding using two-choices, and a general increase in errors throughout the 
task using four-choices. The OFC was therefore suggested to be selectively involved in 
overcoming perseveration when task difficulty is low, but also involved in other forms 
of learning as task difficulty increases (Kim and Ragozzino, 2004). 
Nevertheless, in many other paradigms, OFC-lesioning or inactivation has no 
affect on early-errors, but selectively increases the number of late-errors. In general, the 
interpretation from these studies has been that although the OFC is involved in reversal 
learning, the area is not critically involved in perseverance.   
For example, Ghods-Sharifi et al. (2008) tested bupivacaine OFC-inactivated 
rats in a maze visual and egocentric attentional set-shifting and reversal paradigm. Here, 
OFC-inactivated rats showed a selective deficit in the reversal test through an increased 
number of late-errors. Based on this, it was speculated that the impairments of OFC-
lesioning are unrelated to perseveration.  
Presumed OFC-inactivation through baclofen/muscimol also impaired reversal 
learning in a go/no-go auditory task (Burke et al., 2006). In this paradigm, animals 
receive successive presentations of a tone or white noise, one of which is associated 
with reward delivery. The contingencies reverse, and the time spent in the food 
magazine during each auditory cue are analysed. OFC-inactivation did not affect 
animals ability to extinguish responding during the previous CS+, but did retard animals 
ability to start responding during the previous CS-. This suggested that the OFC is 
necessary for the ability to overcome learned non-reward rather than perseverance 
(Burke et al., 2006). 
Similarly, in a go/no-go odour discrimination and reversal paradigm in the rat, 
NMDA-induced OFC-lesioning had no effect on two-choice odour discrimination 
learning but selectively impaired performance on two subsequent reversals 
(Schoenbaum et al., 2003). The impairment was caused by a selective increase in late-
errors, and therefore speculated to be unrelated to perseveration.  
Using the ID/ED bowl-digging procedure with three reversal tests in the rat,  
ibotenic OFC-lesioning failed to affect attentional set-shifting yet potently retarded 
performance in all reversal phases by increasing trials to criterion (McAlonan and 
Brown, 2003). This deficit has been further explored in a similar bowl-digging reversal 
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procedure aimed to separately probe perseverance and learned non-reward. Tait and 
Brown (2007) used a within-subject design with all animals exposed to a perseverance 
and learned non-reward test in counterbalanced order. In these tests, the previously 
correct or incorrect stimulus changed contingency and was paired with a novel stimulus 
of opposing contingency in two separate tests. OFC-lesioning was found to the impair 
performance in the learned non-reward test, but to facilitate performance in the 
perseverance test. The authors concluded that the previously observed reversal deficits 
following OFC-lesioning in this task were due to elevated interference by learned non-
reward and were not related to increased perseveration (Tait and Brown, 2007). 
Interestingly, OFC-lesioning also caused a selective increase in ‘refusals to dig’ in the 
learned non-reward test, suggesting that omissions are produced by previous association 
of learned non-reward. 
In sum, lesioning or inactivating the OFC in the rat and primate most often 
impairs reversal learning without affecting attentional set-shifting or discrimination 
learning. These deficits are sensitive to parameters of task difficulty, number of 
reversals and sensory dimension of discriminanda. The deficits have been shown to be 
due to a decrease in the ability to overcome learned non-reward (Tait and Brown, 2007) 
but have also suggested to be effects of increased perseveration due to selective effects 
on early-errors (Boulougouris et al., 2007; Butter, 1969; Chudasama et al., 2003; Dias et 
al., 1996; Jones and Michkin, 1972). 
 
5.1.2 Medial prefrontal cortex 
 
There is debate as to whether rodents have a prefrontal cortical subregion 
homologous to the primate DLPFC. The cytoarchitercture of the PFC in the rodent 
indicate regions corresponding to the primate anterior cingulate, and orbital subregions, 
but a lack of a medial granular zone distinguishing the primate DLPFC (Preuss, 1995). 
However, others have suggested that the rodent has a region corresponding to the 
primate DLPFC based on anatomical connections (Ongür and Price, 2000), and 
behavioural characteristics following prefrontal lesioning (Uylings et al., 2003). 
Indeed, opposite to the effect observed following OFC damage, lesions to the 
mPFC, encompassing the infralimbic (IL), prelimbic (PL) and anterior cingulate 
cortices (ACC), often impair attentional set-shifting without affecting reversal learning 
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in the rodent (Bissonette and Powell, 2010; Brown and Bowman, 2002; Keeler and 
Robbins, 2011). This effect is analogous to DLPFC-lesioning in the primate.  
In the marmoset, quinolinic DLPFC-lesioning had no effect on reversal learning, 
but impaired attentional set-shifting using the visual ID/ED-task (Dias et al., 1996). In 
the rat, ibotenic lesions centred on the IL, but also including the PL, had no effect on 
reversal learning in the bowl-digging task but impaired attentional set-shifting (Birrell 
and Brown, 2000). In an operant procedure, bupivacaine-induced IL-inactivation did not 
affect reversal learning in the rat but impaired attentional set-shifting between a visual 
and a spatial response strategy (Floresco et al., 2008). Others have nevertheless 
observed reversal impairments following lesions to the medial wall in both the rodent 
and primate. DLPFC-lesioning retarded egocentric (Pohl, 1979) and allocentric (Butter, 
1969) spatial reversal learning in the rhesus, and mPFC lesioning in the rat (Chudasama 
et al., 2003; Salazar et al., 2004) and mouse (Brigman et al., 2008) impaired visual 
reversals.  
In conclusion, the OFC appears to be critical for reversal learning but not 
attentional set-shifting, while intact mPFC function is most often is required for 
attentional set-shifting but not reversal learning. Observed reversal learning 
impairments are generally considered to be caused by increased perseveration. It 
appears that this idea primarily is based on observations of lesions selectively increasing 
the number of early-errors in simultaneous discrimination and reversal tasks, or 
responding towards the previous CS+ in successive discrimination and reversal tasks. 
However, data also show that PFC-lesions can increase late-errors in simultaneous 
discrimination and reversal tasks (Ghods-Sharifi et al., 2008; Kim and Ragozzino, 
2004) and impair responding towards the previous CS- in successive discrimination and 
reversal tasks (Burke et al., 2006; McEnaney and Butter, 1969). Further, the single 
published study investigating the effect of rodent OFC-lesioning in perseverance and 
learned non-reward found increased learned non-reward and a concurrent facilitation of 
perseverance (Tait and Brown, 2007).   
Relative to the rat and primate, there have been few studies of cognitive 
flexibility following prefrontal lesioning in the mouse. One study found that mPFC-
lesions induce pattern, but not luminance visual reversal learning deficits (Brigman et 
al., 2008). Recently, dissociable effects of mPFC- and OFC-lesioning   
on reversal learning and attentional set-shifting were observed using a bowl-digging 
procedure in the mouse with NMDA-induced OFC-lesions selectively retarding reversal 
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learning and mPFC-lesions specifically disrupting attentional set-shifting (Bissonette et 
al., 2009). 
The aim of the current chapter was to investigate the role of the PFC in reversal 
learning, perseverance and learned non-reward in the mouse. The first experiment 
assessed OFC-lesioned mice in the egocentric maze task. The second experiment 
assessed both OFC and mPFC lesioned mice in the visuospatial operant task. 
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5.2. METHOD 
 
5.2.1 Experiment 1: Maze reversal learning 
 
5.2.1.1 Experimental design and statistical analysis 
 
The experiment used 18 C57BL/6J male mice (Charles River, UK) weighing a 
mean 25.7g at the start of the experiment. After completing the initial spatial 
discrimination, animals were pair-matched for trials to criterion and randomly assigned 
to a lesion group. Animals subsequently went through surgery and were allowed a 
minimum recovery period of one week after which animals again were required to 
retain criterion on the previously acquired reward contingencies. This was followed by a 
full reversal test, and subsequent perseverance and a learned non-reward tests. The 
order of the perseverance and the learned non-reward tests was counterbalanced across 
the two lesion groups (see Chapter 3). Performance in the reversal test was analysed 
using one-way between-subjects ANOVAs with lesion as the independent variable. The 
perseverance and learned non-reward tests were analysed by separate 2 (within-
subjects: test condition) × 2 (between-subjects: lesion) × 2 (between-subjects: test order) 
mixed ANOVAs. 
 
5.2.1.2 Surgery 
 
One animal was omitted from the study after failure to reach criterion on the 
spatial discrimination phase. In the remaining animals, bilateral stereotaxic lesions were 
made in the OFC-region (AP, +2.8 mm; ML, ±1.2 mm; DV, +2.2 mm) of anesthetised 
(isoflurane) animals. The coordinates were chosen as pilot studies suggested them to be 
the most accurate with reference to Paxinos and Franklin (2001). The skull surface was 
exposed through a razor incision and the dura was carefully removed. Bilateral burr-
holes were drilled directly above the OFC-region, and a 33-gauge needle was slowly 
inserted at the appropriate coordinates. The needle was left in place for 1 min to allow 
for the brain to set. 0.3 µl of sterile NMDA (20 mg/ml in 0.9% saline; Tocris, Bristol, 
UK) was injected at a rate of 0.2 µl/min using a 10 µl Hamilton glass syringe and a 
syringe pump (802, Univentor, Malta). After the infusion, the needle was left in place 
for an additional 3 min to allow for dispersion from the infusion-site. Saline vehicle 
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alone was infused in the sham group. Animals were placed in a warm recovery-box 
after surgery with water available until they completely regained all motor functions. 
Testing began after a recovery period of at least one week (7-17 days).   
 
5.2.1.3 Histology 
 
At the end of the experiment, mice were killed through gradually increasing 
levels of exposure to carbon dioxide and immediately perfused with 4% 
paraformaldehyde. Brains were then placed in a 4% formalin solution for at least 2 
weeks before sectioning. Brains were sectioned (30 µm thick) using a Leica Jung 
cryostat. Sections were mounted onto gelatin-coated glass slides and air-dried. The 
tissue was then defatted, Nissl stained with thionine (Sigma-Aldrich, Poole, UK), 
dehydrated and cover-slipped. Sections and extent of lesions were examined with 
reference to Paxinos and Franklin (2001) using a Feldt light microscope. Images were 
obtained with a Leica DMRX microscope and schematic drawings assembled in Gimp 
(version 2.6). 
 
5.2.2 Experiment 2: Operant reversal learning 
 
5.2.2.1 Experimental design and statistical analysis 
 
The experiment used 35 C57BL/6J male mice (Charles River, UK) weighing a 
mean 27.0g at the start of the experiment. As in the maze experiment, after reaching 
criterion in the spatial discrimination, animals were matched for trials to criterion and 
randomly assigned to a lesion group. Animals subsequently went through surgery and 
were allowed a minimum recovery period of one-week (7-12 days), after which animals 
again were required to retain criterion on the previously acquired reward contingencies. 
This was followed by a full reversal test, and subsequent perseverance and learned non-
reward test, all proceeded by retention phases on the previously acquired reward 
contingencies. The order of the perseverance and the learned non-reward tests was 
counterbalanced across the lesion groups. Performance in the full reversal test was 
analysed using one-way between-subjects ANOVAs with lesion as the independent 
variable. The perseverance and learned non-reward tests were analysed by separate 2 
(within-subjects: test condition) × 3 (between-subjects: lesion) × 2 (between-subjects: 
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test order) mixed ANOVAs. With no significant differences in performance between the 
OFC-sham and mPFC-sham operated animals, the groups were collapsed for 
behavioural analyses.  
 
5.2.2.2 Surgery and histology 
 
The maze experiment was confounded by two OFC-lesions extending into 
medial areas. There was also some suggestion that animals showing lesions extending 
both OFC- and mPFC-regions had greater difficulties in maze reversal learning. The 
operant experiment therefore included a further group of mPFC-lesioned animals. 
Moreover, in order to avoid concurrent OFC/mPFC-lesions, the OFC coordinates were 
moved +0.1 mm laterally from bregma. Thus, bilateral stereotaxic lesions were made in 
OFC-regions (AP, + 2.8 mm; ML, ±1.3 mm; DV, +2.2 mm) or mPFC regions (AP, +2.1 
mm; ML, ± 0.2 mm; DV, +2.2 mm). Again, these coordinates were chosen after pilot 
lesions showed them to be the most accurate with reference to Paxinos and Franklin 
(2001). Saline vehicle alone was injected in the two sham control groups. Animals were 
killed with an overdose of pentobarbitone before being perfused with 4% 
paraformaldehyde. All other surgical and histological methods remained identical to the 
maze experiment. 
 
5.2.3 Neurological screen 
Following surgery and prior to cognitive testing, the sensory and motor abilities 
of each mouse were assessed in a series of tests derived from Dunnett et al. (1987). The 
screen included assessments of general posture, startle response, orientation to 
stimulation of the whiskers, placement reflexes and motor ability on an inclined grid. 
All animals performed well and there were no differences between the experimental 
groups in either experiment. 
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5.3 RESULTS 
 
5.3.1 Experiment 1: OFC-lesioning and maze reversal learning 
 
Lesions (Fig. 5.1). Three animals were culled after experiencing post-surgery 
seizures. Two further animals in the lesion group were omitted from behavioural 
analyses after showing a limited unilateral lesion and no visible lesion, respectively. Of 
the remaining five lesioned animals, three had lesions restricted within the lateral, 
ventral, and medial orbital regions, while two animals showed lesions extending 
medially into infralimbic, prelimbic and anterior cingulate regions. These medial lesions 
were largely within the left hemisphere. The final number in each group for behavioural 
analyses were: sham = 7, OFC = 3, OFC + mPFC = 2.  Thus, the small final group sizes 
made the experiment underpowered, and any inferences made about the effects of PFC-
lesioning on egocentric reversal learning have to be considered preliminary.     
Behavioural performance. Excitotoxic lesion of the OFC-region had no 
significant effect on reversal learning, perseverance or learned non-reward in the maze. 
However, lesioned animals displayed poorer performance in retention of a 
discrimination acquired pre-surgery (Fig. 5.2). In retention, OFC-lesioned animals made 
significantly more incorrect responses to criterion (F1,10 = 6.0, p < .05). They also 
required more trials and more correct responses to criterion, but these differences did 
not reach significance (p > .05). OFC-lesioning failed to affect performance in the full 
reversal, perseverance and learned non-reward tests (Fig. 5.3; all p > .05). However, as 
two animals had lesions extending into the mPFC, the behavioural data was further 
analysed using lesion extent as a between-subjects variable (Fig. 5.4).  
Lesion extent failed to affect trials and incorrect responses to criterion. There 
was a significant effect of lesion extent on correct responses to criterion in the full 
reversal test (F2,9 = 5.9, p < .05). mPFC/OFC-lesioned animals required more correct 
responses to criterion than both sham (p < .05) and OFC-lesioned animals (p < .01). 
OFC/mPFC-lesioned animals also made more late-errors (23.5 ± 1.5) than sham (11.3  
± 3.7) and OFC-lesioned animals (7.7  ± 6.7) in the full reversal test. Again, this 
difference failed to reach significance. 
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Figure 5.1. Experiment 1: NMDA-induced excitotoxic 
lesions of the OFC in the maze procedure. (A) Distribution 
of OFC-lesions with reference to distance from Bregma. 
The maximum extent of the lesion, present in at least one 
animal, is shaded in lightest grey. The representative lesion 
extent, present in ≥ 50% of the animals, is shaded in 
medium grey. The minimum lesion extent, present in all 
animals, is shown in black. Drawings adapted from Paxinos 
and Franklin (2001). (C) Thionine stained sections of OFC-
lesion (left) and sham control (right). Arrow point to 
lesioned area. 
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Figure 5.2. Post-operative retention of a two-choice discrimination acquired pre-
surgery in the maze procedure. Non-significant effect of lesion on trials (F1,10 = 
4.9, p = .051) and correct responses to criterion (F1,10 = 4.3, p = .064). OFC-
lesioned animals made significantly more incorrect responses to criterion  (F1,10 = 
6.0, p = .034). 
Figure 5.3. Effect OFC-lesioning in the maze procedure. Broken line represents 
mean performance in the initial spatial discrimination phase. No significant main 
effects of lesion or lesion × test condition interactions on trials to criterion (A) 
incorrect responses to criterion (B) or correct responses to criterion (C) in the full 
reversal, perseverance and learned non-reward tests. 
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The maze experiment was underpowered and any inferences remain tentative. 
There were however some suggestion of differential effects, with lesions including the 
mPFC producing greater reversal deficits than OFC-lesioning alone. Based on this, two 
separate experimental groups of independent OFC- and mPFC-lesioned animals were 
assessed in the operant reversal task.  
 
 
 
 
 
 
Figure 5.4.  Performance of OFC-lesioned and OFC/mPFC-lesioned animals in the 
maze procedure. Significant effect of lesion extent on correct responses to criterion in 
the full reversal test (F2,9 = 5.9, p = .02). No other significant main effects of lesion 
extent or lesion extent × test condition interactions. 
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5.3.2 Experiment 2: OFC and mPFC-lesioning in operant reversal leaning 
 
Lesions (Fig. 5.5). Four animals were culled after failing to completely recover 
motor functions following surgery. One OFC-lesioned animal was omitted from the 
analysis after failing to complete the reversal test after 25 sessions. Of the remaining 10 
animals in the OFC group, nine animals had lesions restricted to the lateral and ventral 
orbital regions. One animal showed a lesion with limited extension into infralimbic and 
prelimbic regions.	  All animals in the mPFC group had lesions restricted to the medial 
wall concentrated on anterior cingulate and prelimbic regions. The majority of animals 
in the mPFC-group also showed lesions of the infralimbic-region. The final group sizes 
were sham-mPFC = 4, sham-OFC = 6, mPFC = 10, OFC = 10. 
Behavioural performance. Although there were few significant main effects of 
lesion or lesion × test condition interactions, OFC-lesioning retarded reversal learning 
relative to sham-lesioned controls and these deficits where more pronounced in the 
perseverance test than in the learned non-reward test (Fig. 5.6). There were no 
significant effects of the lesion on retention of previously acquired reward 
contingencies. 
In the full reversal test, there were no significant effects of lesion on trials (F2,27 
= 3.1, p = ns), correct responses (F2,27 = 3.3, p = ns), incorrect responses (F2,27 = 1.9, p = 
ns) or omissions to criterion (F2,27 = 1.7, p = ns). The lesion also failed to affect the 
number of early-errors (F2,27 = 0.6, p = ns) and late-errors (F2,27 = 2.6, p = ns). However, 
separate one-way ANOVAs comparing each lesion group against sham-lesioned 
controls showed that OFC-lesioning increased trials to criterion (F1,18 = 5.1, p < .05) 
incorrect responses to criterion (F1,18 = 5.6, p < .05) and late-errors (F1,18 = 4.8, p < .05) 
in the full reversal test. mPFC-lesioning failed to affect any measure of learning on the 
full reversal test (p ≥ .35), although there was a trend for increased late-errors to 
criterion relative to sham-lesioned controls (p = .07). 
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Figure 5.5. Experiment 2: NMDA-induced excitotoxic lesions of the OFC and mPFC 
in the operant procedure. (A-B) Distribution of OFC (A) and mPFC (B) lesions with 
reference to distance from bregma. The maximum extent of the lesions, present in at 
least one animal, is shaded in lightest gray. The representative lesion extent, present in 
≥ 50% of the animals, is shaded in medium grey. The minimum lesion extent, present in 
all animals, is shown in black. Drawings adapted from Paxinos and Franklin (2001). (C) 
Thionine stained sections of OFC-lesion (left) and sham-control (right). (D) Thionine 
stained sections of mPFC-lesion (left) and sham-control (right). Arrows point to 
lesioned area. 
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Figure 5.6. Performance of OFC-, mPFC- and sham-lesioned animals in the operant 
procedure. Asterisk denote differences at which p < .05 relative to sham lesioned controls (* p 
< .05). Broken line represents mean performance in the initial spatial discrimination. (A) Trials 
to criterion. No effect of lesion in the full reversal test (F2,27 = 3.1, p = .059). Main effect of 
lesion (F2,27 = 4.1, p = .028) but no lesion × test condition interaction in the perseverance and 
learned non-reward tests (F2,27 = 0.4, p = .65) (B) Correct responses.  No effect of lesion in the 
full reversal test (F2,27 = 3.3, p = .052). No effect of lesion (F2,27 = 3.1, p = .063) or lesion × test 
condition interaction (F2,27 = 0.9, p = .39) in the perseverance and learned non-reward tests. (C) 
Omissions. No effect of lesion in the full reversal test (F2,27 = 1.7, p = .2). Main effect of lesion 
(F2,27 = 3.8, p = .035) but no lesion × test condition interaction (F2,27 = 0.6, p = .57) in the 
perseverance and learned non-reward tests. (D) Early-errors. No effect of lesion (F2,27 = 0.6, p 
= .54) in the full reversal test. No effect of lesion (F2,27 = 0.5, p = .63) or lesion × test condition 
interaction (F2,27 = 0.2, p = .81) in the perseverance and learned non-reward tests. (E) Late-
errors. No effect of lesion (F2,27 = 2.6, p = .09) in the full reversal test. Main effect of lesion 
(F2,27 = 4.8, p = .016) but no lesion × test condition interaction (F2,27 = 0.7, p = .51) in the 
perseverance and learned non-reward tests. 
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 In the perseverance and learned non-reward tests, there was a significant main 
effect of lesion (F2,27 = 4.1, p < .05), but no lesion × test condition interaction (F2,27 = 
0.4, p = ns) on trials to criterion. OFC-lesioned animals required more trials than sham-
lesioned controls (p = .01) and mPFC-lesioned animals, although the difference 
between OFC- and mPFC-lesioned animals failed to reach statistical significance (p = 
.06). Similarly, there was a significant main effect of lesion (F2,27 = 4.8, p < .05), but no 
lesion × test condition interaction (F2,27 = 0.7, p = ns) on late-errors. OFC-lesioned 
animals made more late-errors than both sham-controls (p < .05) and mPFC-lesioned 
animals (p < .01). There was also a significant main effect of lesion on omissions to 
criterion (F2,27 = 3.8, p < .05) but no lesion × test condition interactions (F2,27 = 0.6, p = 
ns). OFC-lesioned animals made more omissions than sham-lesioned controls (p = .01).  
Moreover, there were no effects of lesion or lesion × test condition interactions 
on correct responses to criterion (Lesion: F2,27 = 3.1, p = ns, Lesion × Condition: F2,27 = 
1.5, p = ns) incorrect responses to criterion (Lesion: F2,27 = 1.1, p = ns, Lesion × 
Condition: F2,27 = 0.1 p = ns) or early-errors (Lesion: F2,27 = 0.5, p = .ns, Lesion × 
Condition: F2,27 = 0.2, p = ns) in the perseverance and learned non-reward tests.  
Separate one-way ANOVAs for the perseverance and learned non-reward tests 
comparing each lesion group against sham lesioned controls showed that mPFC-
lesioning failed to affect any measure of learning in either test condition (all p ≥ .33). 
Furthermore, OFC-lesioned animals did not differ from sham-lesioned controls in the 
learned non-reward condition (all p ≥ .34).  
In the perseverance condition, however, OFC-lesioning significantly increased 
late-errors to criterion (F1,18 = 6.4, p < .05), as well as showing non-significant trends 
for increased trials to criterion (F1.18 = 4.0, p = .06) correct responses to criterion (F1.18 = 
4.3, p = .054) and omissions to criterion (F1.18 = 4.0, p = .07).  
                             Group   
 Sham OFC mPFC p 
Trial initiation 7.01 ± .17 6.87 ± .13 6.90 ± .22 ns 
Nosepoke-hole response  4.22 ± .22 4.11 ± .15 4.11 ± .16 ns 
Pellet retrieval 2.54 ± .20 2.91 ± .16 2.69 ± .12 ns 
Table 5.1 Mean latencies (± SEM) in the operant procedure collapsed over the three 
test conditions.  
No effects of lesion (p ≥ .24) or lesion × test condition interactions (p ≥ .31) 
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5.4 DISCUSSION 
 
The deficits in cognitive flexibility observed in neuropsychiatric disorders, such 
as schizophrenia, are believed to be due to disruptions within PFC-areas, with the 
primary cognitive consequence being the inability to supress previous associations of 
reward, or perseverative responding. In the mouse, there have been few studies 
investigating anatomical loci of reversal learning, and no published studies looking at 
the effect upon the separate cognitive components of perseverance and learned non-
reward. This chapter therefore assessed animals with sub-region specific prefrontal 
lesions in egocentric and visuospatial tests of reversal learning, perseverance and 
learned non-reward.   
In the maze, OFC-lesioning had no effects on learning in the three test 
conditions, although the two animals with lesions extending both the OFC and mPFC 
showed a transient and largely non-significant trend for a deficit in the initial full 
reversal test. However, the experiment was underpowered. Therefore group sizes were 
increased and an mPFC-lesioned group was included in the operant experiment.  
In the operant task OFC-lesioned animals were impaired. The impairment was 
observed as significant increases in trials to criterion and late-errors in the full reversal 
test. Although no significant lesion × test condition interactions were found, the deficits 
were more prominently expressed in the perseverance test than the learned non-reward 
test.  
 
5.4.1 Maze task 
 
In the maze, OFC-lesioning had no effect on learning in the full reversal, 
perseverance or learned non-reward tests. Surprisingly, the lesions impaired retention of 
a two-choice discrimination acquired pre-surgery by increasing the number of incorrect 
responses to criterion. It should however be emphasised that the experiment was 
underpowered and the results, together with any conclusions, are tentative.  
Although lesioned animals showed retention deficits in the maze task, both 
OFC- and mPFC-lesioning failed to affect retention of acquired visuospatial 
discriminations in the operant procedure. This would indicate that combined 
OFC/mPFC-lesions have more disruptive effects on post-surgery retention. However, 
the effect in the maze was independent of lesion extent and observed in animals with 
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OFC as well as OFC/mPFC lesions, suggesting that the retention deficit not is 
attributable to mPFC damage. A further possible explanation is different lesion sites 
across the two experiments. The OFC-lesions in the maze experiment was placed 0.1 
mm medially relative to the operant experiment, and therefore covered the MO-
subregion to a greater extent than in the operant experiment.  
There are, to my knowledge, no published studies looking at retention of 
egocentric discriminations in the rodent following OFC- or mPFC-lesions. However, 
manipulations of the PFC in general, and OFC in particular, typically fail to affect 
retention of previously acquired two-choice discriminations in both rodents and 
primates. In the rhesus, MO-lesions does not affect auditory successive retention 
discrimination (Iversen and Mishkin, 1970) and DLPFC- or OFC-lesions are without 
effect on visual, allocentric spatial, and egocentric spatial two-choice discrimination 
retention in the marmoset (Dias et al., 1996; Pohl, 1973). Also, OFC-lesions in the rat 
has no effect on retention of a two-choice visuospatial lever discrimination 
(Boulougouris et al., 2008) or a two-choice odour discrimination acquired pre-surgery 
(Shoenbaum et al., 2002, 2003). 
That said, OFC-lesioning has been shown to disrupt retention in working 
memory tasks. In a visuomotor task requiring rhesus monkeys to control a joystick in 
response to visual stimuli, ventral PFC- and OFC-lesions impaired post-surgery 
retention (Bussey et al., 2001). OFC-lesions in the rhesus also potently retards retention 
following surgery in a delayed non-match-to-sample task (Meunier et al., 1997). In the 
rat, OFC-lesions impaired compound discrimination retention in a task requiring 
animals to discriminate between two strings based on odour and size (Whishaw et al., 
1992), combined PL, MO, and VO-lesioning retarded retention of spatial delayed 
alternation (Brito et al., 1982), and combined mPFC and MO-lesioning retarded visual 
object discrimination retention in the rat (Becker and Olton, 1980). Hence, in agreement 
with the currently observed retention deficit, damage restricted to the OFC or in 
combination with mPFC-subregions, can delay or disrupt reacquisition of task-
performance successfully acquired pre-surgery. 
The data presented here would indicate that OFC-lesioning in the mouse fails to 
affect egocentric reversal learning, learned non-reward and perseverance. Although 
there are no published studies of egocentric reversals in mouse following PFC-lesions, 
the current results are in apparent conflict with data showing that excitotoxic OFC-
lesioned mice show selective reversal impairments in the bowl-digging paradigm 
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(Bissonette et al., 2008). Compared to the current study, the lesions in the study by 
Bissonette et al. (2008) were smaller and largely contained within the VO and LO, 
although a majority of their animals had lesions extending into lateral parts of the PL. 
Their lesions also appear to be further anterior and more ventral the current lesions. It is 
therefore possible that different lesion sites or extents could explain the discrepant 
findings.  
Furthermore, in the study by Bissonette et al. (2008), animals were challenged 
by a simple olfactory or somatosensory discrimination followed by a compound 
discrimination and four subsequent intra-dimensional shifts before a single reversal test 
(Bissonette et al., 2008). This paradigm is clearly very different to the currently used 
task. A possibility is that the OFC-dependence of reversal learning in the mouse does 
not generalise across sensory dimensions, and is not critical for egocentric reversal 
learning. This idea is supported by the deficits produced by OFC-lesioning in the 
operant procedure.  
In agreement with this interpretation, Corwin et al. (1994) tested VO/LO-
lesioned rats in an allocentric cheeseboard reversal task and an egocentric delayed 
alternation task. OFC-lesioning did not affect performance in the egocentric task, but 
impaired performance in the allocentric cheeseboard reversal task. Moreover, in a 
egocentric serial maze task, VO-lesioning in the rat has been found to retard reversal 
performance only in the fifth reversal, but not the first four reversals (Kolb et al., 1974), 
and differ significantly from sham-lesioned animals only when the five reversals are 
summed (Nonneman et al., 1974). Taken together, these data suggest that although the 
OFC is critical for visuospatial allocentric reversal learning, the region has a limited, or 
no role in egocentric discrimination and reversal learning. This would also be in line 
with the regions strong connection with temporal and parietal areas involved in visual 
and visuospatial processing, respectively (Cavada et al., 2000).   
Yet, in conflict with this line of reasoning, bupivacaine-induced OFC-
inactivation has been shown to selectively retard egocentric maze reversal learning in 
the rat (Ghods-Sharifi et al., 2008). In this task, animals initially acquired a two-choice 
visual discrimination and were subsequently challenged by an attentional set-shift to a 
use of an egocentric response strategy. This was followed by a final egocentric reversal 
test. Here, OFC-inactivation caused selective deficits in the reversal test by increasing 
the number of trials to criterion and late-errors. However, during the reversal, the 
previously relevant visual stimulus was still present in the maze, and it may be that 
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OFC-inactivation interfere with visuospatial processes rather than with egocentric 
reversals per se. Indeed, the deficits were specifically due to a reversion back to the use 
of a visual response strategy rather than affecting the number of responses in the 
previously correct turning direction (Ghods-Sharifi et al., 2008). 
The two animals with lesions covering the OFC as well as the mPFC appeared 
to show a transient deficit restricted to the initial full reversal test. This deficit is likely 
to be caused by mPFC rather than OFC damage, as the performance of animals with 
lesions restricted to the OFC paralleled or were slightly better than the performance of 
sham-operated controls (Fig 5.4). OFC as well as mPFC-lesioned animals were 
therefore separately assessed in the operant procedure. 
 
5.4.2 Operant task 
 
5.4.2.1 mPFC-lesions  
 
The operant task was better powered, and did not suffer from the small group 
sizes of the maze experiment. mPFC-lesioned animals showed no deficits in the operant 
task, although there was a transient trend for a disruption in the initial full reversal test 
seen as a non-significant increase in late-errors.  
mPFC-lesioning has previously produced disparate results on reversal learning 
in the rodent. Combined lesions of the IL-, PL-, and ACC-subregions retarded 
visuospatial lever reversal learning by increasing the number of days to criterion 
(Salazar et al., 2004). Similar lesions also impaired performance in a three-lever operant 
task (Kosaki and Watanabe, 2012), two-odour go/no-go reversal task (Ferry et al., 2000) 
and a two-choice maze reversal task (Kolb, 1974; Nonneman et al., 1974). mPFC-
lesions, centred on the ACC and PL-regions, retarded visual pattern reversal learning in 
the mouse by increasing the number of late-errors but not early-errors (Brigman et al., 
2008), and induced visual reversal learning deficits observed as a specific increases in 
late-errors in the rat (Bussey et al., 1997). In the water maze, complete mPFC-lesions 
induced deficits in the first out of three reversals (de Bruin et al., 1994), and in maze 
object and spatial tasks, complete mPFC-lesioned rats showed deficits in the first two 
out of five reversals (Becker et al., 1981). 
However, much recent work in the rat has shown mPFC-lesions to be without 
effect on reversal performance. For example, PL- or IL-lesions or inactivations have no 
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effects on visuospatial operant (Boulougouris et al., 2008; Floresco et al., 2008) or 
bowl-digging reversal learning (Birrell and Brown, 2000; Ragozzino et al., 2003) and 
ACC-lesions had no effect on touch-screen visual reversal learning (Bussey et al., 
1997).  
In the mouse, lesioning of the IL- and PL-subregions did not affect bowl-
digging (Bissonette et al., 2008) or visual luminance reversal learning (Brigman et al., 
2008). The current results are in agreement with these studies, suggesting that mPFC-
lesions, centred on the PL and ACC, but also extending into the IL, have little effect on 
visuospatial reversal in the mouse.  
 
5.4.2.2 OFC-lesions 
 
OFC-lesioned mice showed retarded visuospatial reversal learning in the operant 
task. Although no significant lesion × test condition interactions, these deficits were 
most prominently expressed in the full reversal and perseverance tests. As such, the 
effects appear to be analogous to the perseverative cognitive flexibility impairments 
seen in schizophrenic (Elliot et al., 1995, 1998) and PFC-lesioned patients (Owen et al., 
1993) and commonly assumed to be the underlying mechanism of retarded reversal 
learning following experimental perturbations.  
However, the deficits in the full reversal and perseverative tests were 
characterised by an increase in incorrect responses after animals had achieved chance 
level of responding (late-errors), rather than incorrect responses when responding still 
was biased towards the previous correct response alternative (early-errors). Notably, 
late-errors have a stronger impact than early-errors on other measures of learning when 
the criterion is calculated over 10-trial bins, as late-errors are made when animals are 
nearer to achieving criterion. 
The prevalent method for indexing a perseverative response strategy is to 
analyse early-errors, as it is assumed that the number of early-errors strongly reflects the 
stability of the CS-US association, or perseveration. Later phases and incorrect 
responses made during those phases are not believed to be related to perseveration, but 
to measure more general cognitive abilities related to attention and acquiring alternative 
CS-US associations (Boulougouris et al., 2008; Brigman et al., 2008, 2010; Clarke et 
al., 2008; Kim and Ragozzino, 2004). Importantly, a primary reason for OFC-lesions 
being considered to induce perseverative deficits, and thus model the perseverative 
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deficits seen in prefrontal patients, are studies showing selective increases in early-
errors (Boulougouris et al., 2008; Chudasama and Robbins 2003; Kolb et al., 1974; 
Nonneman et al., 1974). Others have nevertheless found OFC inactivation or lesions to 
increase late-errors without affecting early-errors, and these studies typically reject the 
idea that OFC-lesions cause perseverative deficits (Ghods-Sharifi et al., 2003; 
Schoenbaum et al., 2003). 
The assumption that early-errors, but not late-errors, represent perseveration is 
contradicted by the current experiment. This is the first study to analyse early-errors and 
late-errors following separate assessments of reversal learning, perseverance and 
learned non-reward in PFC-lesioned animals. In this experiment, OFC-lesioning caused 
an increase in late-errors in the perseverance test, suggesting that late-errors also can be 
a product of elevated perseverance. These ideas are discussed further in Chapter 9.  
 
5.4.3 General discussion  
 
The current chapter indicates that, as in rats and primates, the ability to reverse 
an established visuospatial two-choice discrimination is dependent upon the integrity of 
the OFC in the mouse. This confirms a recent finding from the bowl-digging task 
(Bissonette et al., 2008). The current work also extends these findings by showing that 
these deficits are more closely related to perseveration than learned non-reward, and 
thus analogous to the deficits displayed by prefrontal (Owen et al., 1993) and 
schizophrenic patients (Elliot et al., 1995, 1998). Yet, these deficits do not generalise 
across tasks, with excitotoxic OFC-lesions failing to affect egocentric spatial reversal 
learning, perseverance and learned non-reward. The maze experiment was nevertheless 
underpowered, and this conclusion remains tentative. 
Moreover, previous work has produced disparate results on reversal learning 
following mPFC-lesioning in the rodent. Here, mPFC-lesions, centred in the ACC and 
PL but also extending into the IL area, were without significant in the operant reversal 
task. mPFC-lesioned animals did however appear to show a transient deficit in the 
egocentric task, although the small group sizes in this experiment prevents any definite 
conclusions.  
Finally, deficits after OFC-lesioning where characterised by increases in late-
errors rather than early-errors. Often, these errors are not considered to be indexing 
perseverance, but rather general failures in attention or to form associations based on 
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stimuli-reward contingencies. However, the currently observed increase in late-errors in 
the perseverance and full reversal tests suggest that these also can be indicative of 
perseverative response tendencies. 
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CHAPTER 6 
5-HT2C RECEPTOR ANTAGONISM AND REVERSAL LEARNING 
 
 
6.1 INTRODUCTION  
 
The suggestion that serotonin (5-hydroxytryptamine, or 5-HT) is involved in the 
pathology of schizophrenia originates in the disturbances resembling the disorder 
created by 5-HT agonists such as LSD (Claridge, 1978; Woolley and Shaw, 1954).  
Altered serotonin levels have since been linked to a range of cognitive and 
anatomical abnormalities in schizophrenic patients. For example, schizophrenics show 
lower brain levels of 5-HT which correlate with cerebral atrophy (Jennings et al., 1985; 
Nybäck et al., 1983; Potkin et al., 1983), severity of cognitive impairment (Powchik et 
al., 1998), severity of negative symptoms (Bowers et al., 1978; Csernansky et al., 1990), 
response to clozapine (Lieberman et al., 1994), hypofrontality during the WCST 
(Weinberger et al., 1988), and poor long-term outcome including decreased social 
contact, increased hospitalisation and unemployment (Wieselgren et al., 1998). 
While classical neuroleptics such as haloperidol and chlorpromazine primarily 
act through the mechanism of D2 receptor (D2R) antagonism, most newer atypical 
antipsychotics, such as clozapine and olanzapine, show additional more potent 
antagonistic affinities at the 5-HT2AR and the 5-HT2CR. Their superior therapeutic 
efficacy has been related to their high-affinity antagonism at the 5-HT2AR relative to the 
D2R, or large 5-HT2AR/D2R binding ratios (Ceulemans et al., 1985; Kane et al., 1988; 
Meltzer et al., 1989; Meltzer and McGurk, 1999). However, some have found no 
cortical 5-HT2AR abnormalities in schizophrenic patients (Trichard et al., 1998a), and 
that chlorpromazine, at higher clinically relevant doses, display greater affinity for the 
5-HT2AR than clozapine (Trichard et al., 1998b). While this suggests that the superior 
efficacy of atypical antipsychotics may be unrelated to 5-HT2AR antagonism, a further 
clinically relevant property of most atypicals is 5-HT2CR antagonism (Meltzer, 2010). 
 
 
	   108	  
6.1.1 The 5-HT2CR and schizophrenia 
The 5-HT2CR is a G-protein-coupled receptor (GPCR) signaling through Gq, 
activating phospholipase C (PLC), causing elevated levels of the second messengers 
inositol triphosphate (IP) and diacylglycerol (DAG) leading to Ca2+ influx and neuronal 
depolarisation. Greatest expression levels of the 5-HT2CR is found in the choroid 
plexus, but high levels are also found in the PFC, nucleus accumbens (NAc), amygdala, 
dorsal striatum (DStr), ventral tegmental area (VTA), substantia nigra (SNc), and 
hippocampus (Barnes and Sharp, 1999; Clemett et al., 2000; Julius et al., 1988). 
The 5-HT2CR undergoes post-transcriptional mRNA editing which is likely to be 
of relevance for both the pathology and treatment of schizophrenia as well as learning 
and memory. 5-HT2CR mRNA is edited though adenosine-to-inosine substitutions at 
five positions rendering 24 different potential protein isoforms (Burns et al., 1997; Price 
and Sanders-Bush 2000). Although humans, rats and different strains of mice express 
different numbers of protein isoforms, both the unedited and edited isoforms are similar 
in structure across species (Dracheva et al., 2009; Du et al., 2006; Englander et al., 
2005; Hackler et al., 2006). Compared to the edited isoforms, the unedited isoform can 
show a four-fold increase in constitutive production of IP (Herrick-Davis et al., 1999) 
and a 5-fold or greater elevation in response to binding of the agonists mCPP, DOI, 5-
HT, LSD, and MK212 (Fitzgerald et al., 1999; Niswender et al., 1999). However, 
fluoxetine, mianserin, clozapine, spiperone and ketanserin, all non-selective 5-HT2CR 
antagonists, either show equal affinity for all 5-HT2CR isoforms, or greater affinity for 
the edited isoforms, thus opposing the characteristics of 5-HT2CR agonists (Niswender 
et al., 1999; Quirk et al., 2001). 5-HT2CR mRNA editing may also be relevant for 
learning and memory, as rats challenged in the water maze, relative to rats exposed to 
swimming alone, show altered 5-HT2CR mRNA editing (Du et al., 2007). 
Disrupted 5-HT2CR mRNA editing, altered 5-HT2CR expression levels, and 5-
HT2CR single nucleotide polymorphisms (SNPs) are all features of schizophrenia. In 
post-mortem studies, schizophrenic patients show decreased 5-HT2R binding in the PFC 
(Bennett et al., 1979) and DLPFC (Arora and Meltzer 1991; Mita et al., 1986), although 
a significant upregulation has been observed in the OFC (Whitaker et al., 1981). There 
is also a 1.5-fold decrease of 5-HT2CR mRNA in the PFC of schizophrenic patients 
(Castensson et al., 2003, 2010), an effect attributed to the pathology rather than 
treatment, as chronic neuroleptic treatment fails to affect 5-HT2CR mRNA levels in the 
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in the PFC of the rat brain (Buckland et al., 1997). However, subregion-specific 
analyses show that chronic clozapine treatment can decrease 5-HT2CR mRNA levels in 
several regions, including the hippocampus (Buckland et al., 1997) and choroid plexus 
(Hietala et al., 1992).  
5-HT2CR gene SNPs and haplotypes also correlate with disease outcome and 
treatment response. The Cys23Ser allele SNP show higher levels of constitutive activity 
(Okada et al., 2004) and has been linked to increased length of hospitalisation (Segman 
et al., 1997), and well as good response to clozapine (Sodhi et al., 1995; Veentra-
VanderWeele et al., 2000). Other 5-HT2CR SNPs, alone or in combination, are 
associated with clinical response to olanzapine, clozapine, risperidone and 
chlorpromazine (Arranz et al., 2000; Reynold et al., 2005). 
Schizophrenic patients also show decreased 5-HT2CR pre-mRNA editing 
corresponding to an upregulation of the more potent unedited 5-HT2CR isoform in the 
PFC (Sodhi et al., 2001). However, other have found no differences between patients 
and controls (Dracheva et al., 2003; Iwamoto et al., 2003) and one study found that 
schizophrenic suicide victims show increased levels of 5-HT2CR pre-mRNA edited 
isoforms in the PFC (Niswender et al., 2001). Thus, schizophrenia is associated with 
abnormal activity at the 5-HT2CR, although studies vary with regard to a corresponding 
up- or downregulations of receptor activity, perhaps due to heterogeneity of patient 
populations, brain area of investigation, and previous neuroleptic use (Arora and 
Meltzer, 1991). 
 
6.1.2 5-HT and reversal learning 
 
Acute tryptophan depletions in healthy subjects impair performance in the 
reversal stages of the CANTAB ID/ED-task (Park et al., 1994; Rogers et al., 1999, but 
see Evers et al., 2005; Finger et al., 2007; Talbot et al., 2005), and 5,7-DHT-induced 
PFC 5-HT depletions in the marmoset selectively impairs reversal learning in the visual 
ID/ED-task (Clarke et al., 2004, 2005). Hence, lowering brain 5-HT content generally 
impairs reversal performance and this may be due to disrupted 5-HT signalling within 
the OFC (Roberts et al., 2011; Boulougouris and Robbins, 2010).  
Accordingly, OFC-specific 5,7-DHT-induced 5-HT depletions, but not OFC-
specific 6-OHDA-induced DA depletions, impair reversal learning in the ID/ED-task 
(Clarke et al., 2007). This reversal impairment has further been shown to be caused by 
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increased perseverance rather than increased learned non-reward. 5-HT depleted 
animals show deficits in a perseverance test, where the previously correct stimulus 
becomes incorrect and is paired with a novel correct stimulus, but perform as well as 
controls in a learned non-reward test, where the previously incorrect stimulus becomes 
correct and is paired with a novel incorrect stimulus (Clarke et al., 2007).  
Lowering brain 5-HT content also retards reversal learning in the rat. PCPA-
induced 5-HT depletions induce deficits in both go/no-go discrimination acquisition and 
reversal learning (Masaki et al., 2006). However, while 5-HT concentrations in the 
mPFC and amygdala correlate both with discrimination and reversal performance, 5-HT 
levels in the OFC correlate with reversal performance only (Masaki et al., 2006). 
Moreover, PCPA- and stress-induced 5-HT depleted rats show deficits in the first of 
three reversals in the bowl-digging procedure (Danet et al., 2009). This stress-induced 
impairment can also be rescued through an acute 5 mg/kg dose of the selective 
serotonin re-uptake inhibitor (SSRI) citalopram, causing a putative increase in OFC 5-
HT-levels (Invernizzi et al., 1992).  
Similarly, a pharmacologically induced transient PFC 5-HT decrease through a 
lower 1 mg/kg dose of citalopram (Adell and Artigas, 1991; Hjorth and Auerbach, 
1994) impairs performance in a probabilistic lever reversal task in the rat (Bari et al., 
2010) while repeated, subchronic or an acute high 10 mg/kg dose of citalopram, all 
increasing PFC 5-HT content (Invernizzi et al., 1992), improves reversal performance in 
this task (Bari et al., 2010). 
The role of 5-HT systems in reversal learning has also been explored in the 
mouse using a visual touch-screen task (Brigman et al., 2010). Contrary to the effect in 
the primate and rat, 5-HT loss through systemic PCPA has no effect reversal 
performance in this task. Similarly, deletion of the Pet-1 transcription factor controlling 
5-HT neuronal development, causes a 89% loss of cortical and hippocampal 5-HT 
content (Hendricks et al., 2003), do not alter reversal learning performance (Brigman et 
al., 2010).  
However, elevating brain 5-HT content through 5-HT transporter (5-HTT) KO 
or subchronic treatment with the SSRI fluoxetine leads to improved performance. While 
the 5-HTT KO mouse show decreased trials and errors to criterion over the complete 
reversal test, the fluoxetine-induced improvement in trials and incorrect responses to 
criterion is only observed in the early-phase of learning when responding still is biased 
	   111	  
towards the previously correct stimuli, and no effects from fluoxetine are seen when the 
complete reversal test is summed (Brigman et al., 2010). 
Similarly, the 5-HTT KO rat shows facilitated performance in a two-choice 
auditory go/no-go task (Nonkes et al., 2011). This improvement appears to be due to 
enhanced suppression of learned non-reward rather than perseverance. The 5-HTT KO 
develops faster responding towards the previous CS- (opposed by learned non-reward) 
but do not differ from wild-types in responding towards the previous CS+ (opposed by 
perseverance). The improvement may be related to the elevated cortical 5-HT levels 
observed in 5-HTT KO animals (Mathews et al., 2004). However, notably, the 5-HTT 
KO rat also show perseverative-like responding in a Pavlovian reinforcer devaluation 
paradigm, suggestively due to OFC and amygdalar overactivation (Nonkes et al., 2010). 
The reversal learning effects of global or subregion-specific manipulations of 5-
HT levels has been suggested to be related to altered activity at the 5-HT2CR (Roberts 
2011; Boulougouris and Robbins 2010). In the rat, the 5-HT2CR antagonist SB243213 
attenuates the disruptive psychotomimetic reversal learning deficits of subchronic PCP 
(McLean et al., 2009), and the 5-HT2CR antagonist SB242084 facilitates performance in 
an operant visuospatial reversal learning task (Boulougouris et al., 2008). As the 
SB242084 induced improvement is associated with a selective decrease in the number 
of early-errors, the authors suggest that the effects are related to decreased 
perseverance. These effects have more recently been shown to be due to activity in the 
OFC, as intra-OFC, but not intra-mPFC or intra-NAc infusions, facilitates performance 
in the same task (Boulougouris and Robbins 2010). However, in this study, higher doses 
of OFC-specific infusions of SB242084 also decreased the number of late-errors. 
 
6.1.3 The neuropharmacology of the 5-HT2CR 
 
Most interest has centered on the receptors control of striatal dopamine (DA) 
signaling though constitutive inhibitory influence on GABAergic cells in the VTA and 
SNc (Eberle-Wang et al., 1997). Systemic, intra-VTA, or intra-PFC infusions of the 5-
HT2CR antagonists SB206553 and SB242084 potently elevate VTA DA-neuronal firing 
and DA dialysate levels in the NAc (Di Giovanni et al., 1999; Di Matteo et al., 1999). 
This is believed to be the cause of the elevated motor impulsivity and hyperactivity 
effects observed following 5-HT2CR antagonist administrations (Fletcher et al., 2007, 
2009; Higgins et al., 2003; Winstanley et al., 2004). 
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Unlike the ventral striatum, the DStr is critically involved in reversal learning 
with lesions retarding reversal learning in the rat and primate (Castañé et al., 2009; 
Clarke et al., 2008; Kirkby, 1969). In the DStr, reversal learning is controlled by DA, 
with subregion-specific DA but not 5-HT depletions retarding visual reversal 
performance in the marmoset (Clarke et al., 2011). Although a role of the 5-HT2CR in 
control of mesolimbic DA is well established, the role of the 5-HT2CR in nigrostriatal 
DA has been a subject of debate (Deurwaerdère and Spampinato, 2001; Di Matteo et al., 
2001). 
A 5-HT2CR involvement in nigrostriatal DA-signalling is supported by its high 
expression levels in the DStr (Clemett et al., 2000) and the elevated striatal DA-levels 
and SNc DA-neuron firing observed in the 5-HT2CR KO mouse (Abdallah et al., 2008). 
Subregion specific infusions of the 5-HT2B/2CR antagonist SB206553 also affects striatal 
DA, although the direction of effect can vary depending on site of infusion (Alex et al., 
2005; Lucas et al., 2000). The 5-HT2CR agonists Ro60175, MK212, and mCPP have 
nevertheless no or limited effect on nigrostriatal DA activity (Di Giovanni et al., 2000; 
Di Matteo et al., 1999).  
Most relevant are studies using the selective 5-HT2CR antagonist SB242084. 
Although elevated DA-signalling has been observed at some higher doses in 
anesthetised animals (De Deurwaerdere et al., 2004; Di Matteo et al., 1999; Navailles et 
al., 2006), SB242084 is most often without effect on nigrostriatal DA-signalling. In the 
anaesthetised rat, systemic doses of SB242084 at 0.3, 5, and 10 mg/kg do not affect DA 
or DOPAC levels in the DStr (De Deurwaerdere et al., 2004; Navailles et al., 2005; Di 
Matteo et al., 1999). In freely moving rats, a 10 mg/kg systemic dose (Gobert et al., 
2000) or systemic doses between 0.16 and 0.64 mg/kg similarly fails to affect SNc basal 
or burst firing and DStr DA-levels. Thus, although 5-HT2CR appears to be involved 
DA-regulation within the nigrostriatal pathway, SB242084 has little effect. The limited 
effect of SB242084 on nigrostriatal DA has been suggested to be due to a stimulatory 
role of the 5-HT2CR in the DStr, which is opposed by an inhibitory role of the receptor 
at the level of the SNc (Di Matteo et al., 2001; Lucas et al., 2000).  
The 5-HT2A/2CR also constitutively inhibits PFC DA-levels. Systemic SB206553 
elevates DA-dialysate levels in the PFC, but do not affect levels of 5-HT (Gobert et al., 
1999, 2000). Long-lasting and immediate elevations of DA, but not 5-HT, are also 
produced by systemic SB242084 at both higher (10 mg/kg; Millan et al., 1998) and 
lower doses (0.63 mg/kg; Gobert et al., 2000). These effects are not dependent upon 
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activity within the PFC, as local infusion of SB206553 (Alex et al., 2005) Ro-60-0175 
(Pozzi et al., 2002) and SB242084 (Pozzi et al., 1999) all fail to affect PFC DA-levels. 
Furthermore, the 5-HT2CR agonists DOI and MK212 increase PFC release of 
acetylcholine (ACh; Nair and Gudelsky, 2004). 5-HT, mCPP, and clozapine also 
increase striatal and hippocampal ACh level, effects that can be blocked by the 5-
HT2CR antagonists RS102221 and mesulergine (Bonsi et al., 2007; Chung et al., 2004; 
Zhelyazkova-Savova et al., 1997). These effects may be of relevance for cognitive 
flexibility, as rats challenged in an egocentric reversal task show striatal ACh-elevations 
(Ragozzino and Choi, 2004) and ACh depletion through excitotoxic lesioning of the 
basal forebrain impair object (Ridley et al., 1985) and visual reversal learning in the 
marmoset (Roberts et al., 1992) and bowl-digging reversals in the rat (Tait and Brown, 
2009). There is however as yet no evidence for any effects of independent 5-HT2CR 
antagonism within these systems. 
5-HT2CR mRNA is also present at higher densities in raphe nuclei (Hoffman and 
Mezey, 1989; Molineaux et al., 1989). Here, targeted administrations of the non-
selective 5-HT2CR agonists WAY100635, DOI, DOB, Ro 60-0175 and co-
administrations with the antagonists SB206553, ritanserin and SB242084 indicates that 
the 5-HT2CR has constitutive inhibitory control over 5-HT neuronal firing within the 
dorsal raphe (Boothman et al., 2003, 2006; Quérée et al., 2009). Furthermore, 
SB242084 alone is without affect within this circuitry, and there is no evidence for its 
relevance to executive functioning. The dorsal raphe is however interconnected with the 
OFC (Goncalves et al., 2009; Morecraft et al., 1992; Porrino and Goldman-Rakic, 
1982), allowing a potential mechanism whereby 5-HT2CR antagonism could augment 
OFC 5-HT levels within tasks of executive functioning.  
Although the 5-HT2CR appears to be involved in reversal learning, little is 
known about the effect of 5-HT2CR antagonism on the separate cognitive components of 
reversal learning. The 5-HT2CR has been suggested in to be involved in processes 
related to perseverance with its effect on early-errors (Boulougouris et al., 2008; 
Boulougouris and Robbins, 2010). There is no published data on the role of the 5-
HT2CR in learned non-reward or the closely related paradigm of latent inhibition. 
However, decreasing 5-HT signalling through medial raphe nucleus lesions (Asin et al., 
1980; Lorden et al., 1983; Loskutova et al., 1990; Solomon et al., 1980) as well as 
global (Solomon et al., 1978) accumbal (Loskutova, 2001) and hippocampal (Cassaday 
et al., 1993b) 5-HT depletions attenuate latent inhibition. Expression of latent inhibition 
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is also associated with increased striatal and limbic 5-HT (Loskutova et al., 1990; 
Molodtsova, 2003). This would suggest that decreasing 5-HT signalling releases 
behaviour suppressed by previous non-reinforcement and indicates that facilitated 
reversal learning through SB242084 could be achieved though attenuated learned non-
reward.  
The current chapter explored the role of the 5-HT2CR in reversal learning 
perseverance and learned non-reward using the selective 5-HT2CR antagonist SB242084. 
It should be noted that most 5-HT2CR agonist and antagonist also have significant 
affinities for the 5-HT2AR, and indeed the 5-HT2BR. Yet, the restricted brain expression of 
the 5-HT2BR (Choi and Maroteaux, 1996) would suggest a lack of involvement of this 
receptor in these compounds effect on neurotransmitter regulation and cognition. 
However, SB242084 has a 100-fold and 158-fold selectivity for the 5-HT2CR over the 5-
HT2BR and 5-HT2AR, respectively, and more than 200-fold selectivity for the 5-HT2CR 
over 5-HT1R, 5-HT4R, 5-HT6R, 5-HT7R, D2R, and D3R (Kennett et al., 1997). There is 
nevertheless some suggestion that SB242084 could have inverse agonist rather than 
antagonist affinity at the 5-HT2CR (Herrick-Davis et al., 2000), but there is as yet no 
evidence to support this.  
Experiment 1 explored the activity levels of mice following SB242084 on its own 
and against the 5-HT2A/2CR agonist mCPP induced hypoactivity in order to assess the 
behavioural effectiveness of the given dose and pre-treatment time. Experiment 2 and 3 
investigated the effects of SB242084 in the operant visuospatial and maze egocentric 
reversal tasks. In order to explore possible mechanism for the effect of SB242084 in 
Experiment 3, Experiment 4 looked at SB242084 and maze novelty recognition. 
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6.2 METHOD 
 
6.2.1 Drug 
 
SB242084 (Tocris, Bristol, UK) was initially dissolved in PEG400 (Sigma-
Aldrich, Poole, UK) at 20% of the final required volume, which was then made up by 
10% (w/v) hydroxypropyl-beta-cyclodextrin (Fluka, Poole, UK). mCPP (Tocris, Bristol, 
UK) was dissolved in saline. Stock solution was aliquoted and frozen at -80°C in vials of 
quantities required for each test day. SB242084 was administered subcutaneously (s.c.) in 
the nape of the neck at a dose of 0.5 mg/kg in a volume of 4 ml/kg 30 min prior to testing. 
mCPP was administered intraperitoneally (i.p.) at a dose of 1 mg/kg in a volume of 10 
ml/kg 5 min prior to testing.  
 
6.2.2 Experiment 1: Locomotor activity 
 
The experiment used 32 C57BL6/J male mice (Charles River, UK) weighing a 
mean 26.5g at the start of the experiment. Animals received SB242084, mCPP, or vehicle 
giving four experiment groups (vehicle vs. vehicle, SB242084 vs. vehicle, SB242084 vs. 
mCPP, vehicle vs. mCPP). Activity was monitored over a 90 min test session, and data 
analysed by a two-way 4 × (between-subjects: drug) 6 (within-subjects: time) mixed 
ANOVA. Significant interactions were explored through LSD post-hoc analyses.  
 
6.2.3 Experiment 2: Operant reversal learning 
 
The experiment used 43 C57BL/6J male mice (Charles River, UK) weighing a 
mean 24.6g at the start of the experiment. After completing the spatial discrimination 
drug-free, animals were matched for trials to criterion and randomly assigned to a drug 
and test condition. Animals subsequently completed three test phases, each proceeded by 
a drug-free retention-phase. Data for the SB242084 experiment was analysed using 3 × 
(between-subjects: test condition) 3 × (within-subjects: test phase) 2 (between subjects: 
drug) mixed ANOVAs. Significant interactions were followed-up by separate ANOVAs 
to establish simple effects. 
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6.2.4 Experiment 3: Maze reversal learning 
 
The experiment used 72 C57BL/6J male mice (Charles River, UK) weighing a 
mean 24.9g at the start of the experiment. Animals were run in two batches of 36, with 
each animal tested every other day. After completing the initial spatial discrimination 
drug-free, animals were matched for trials to criterion and assigned to a drug and test 
condition. Animals which failed to reach criterion within 250 trials where assigned a trial-
score of 250 for that test and removed from further testing. The data was analysed by 2 × 
(drug) 3 (test condition) between-subject ANOVAs. Significant interactions were 
followed-up by separate ANOVAs or LSD post-hoc analyses to establish simple effects.  
 
6.2.5 Experiment 4: Maze novelty recognition and attraction 
 
The experiment used 28 C57BL6/J male mice (Charles River, UK) weighing 
26.5g at the start of the experiment. The experimental design and statistical analysis was 
exactly as described in Chapter 2. In brief, animals were initially habituated to a T-maze 
or a Y-maze for 3×12 min/day for three day. Testing took place on the fourth day over 
2×15 min intervals. In the first 15 min interval, the maze was maintained in the same 
configuration as during maze habituation. In the second 15 min interval, one of the 
previously open arms was closed while an arm 45° to the north or south was opened. 
Animals were dosed with 0.5 mg/kg of SB242084 15 min before testing. Thus 
the novel-arm was introduced 30 min after dosing, similar to the experiments of 
cognitive flexibility. Proportion of time and proportion of arm entries in each arm was 
scored before and after the 45° change in arm location. An arm-entry was scored when 
the animal placed its back-paws behind the small regress separating the central platform 
from the extending arm. The data was analysed by 2 × (within-subject: test phase) 2 
(between subjects: drug) mixed ANOVAs.  
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6.3 RESULTS  
 
6.3.1 Experiment 1: Effect of SB242084 on mCPP-induced hypoactivity 
 
SB242084 at 0.5 mg/kg increased activity on its own as well as in animals pre-
treated with the non-selective 5-HT2CR agonist mCPP, roughly doubling the activity 
levels over the 90 min test phase (Fig 6.1). There were significant main effects of time 
(F5, 140 = 73.7, p < .0001) and drug (F5, 140 = 21.0, p < .0001) and a significant time × 
drug interaction (F5, 140 = 73.7, p < .0001). SB242084 significantly increased (p < .0001) 
while mCPP significantly decreased activity levels (p < .05) relative to animals treated 
with vehicle only. Animals pre-treated with SB242084 and challenged with mCPP 
displayed heightened activity similar to SB242084 alone. 
 
 
  
Figure 6.1 Effect of SB242084 on locomotor activity in animals pre-treated with 
mCPP. Data expressed in 15 min time bins (A) and total activity counts over the 
90 min session (B). Asterisk denote differences at which p < .05 (*p < .05, 
****p< .0001).  
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6.3.2 Experiment 2: SB242084 and operant reversal learning 
 
SB242084 facilitated performance in the full reversal and learned non-reward 
tests but did not significantly affect learning in the perseverance test (Fig. 6.2-6.4).  
Performance improved across each test phase, seen as significant decreases in 
trials to criterion (F2,74 = 8.8, p < .0001), correct responses (F2,74 = 5.9, p < .01) and 
omissions (F2,74 = 12.6, p < .0001) but not incorrect responses to criterion (F2,74 = 1.9, p 
= ns). There were no significant differences between groups on drug-free retentions of a 
learned response, or the number of early-errors or late-errors. 
 
 
 
 
 
 
 
 
Figure 6.2. Effect of SB242084 on trials to criterion in the three test phases of the full 
reversal (A) learned non-reward (B) and perseverance tests (C) in the operant 
procedure. Broken line represents mean performance in the initial spatial 
discrimination. Asterisk denote differences at which p < .05 (*p < .05, **p < .02). 
Significant main effects of test phase (F2,74 = 8.8, p < .0001) test condition (F1,37 = 6.6, 
p = .004) drug (F1,37 = 18.3, p = .0001) and significant test phase × drug (F2,74 = 3.4, p 
= .039) and test phase × test condition interactions (F4,74 = 2.6, p = .044). SB242084 
decreased trials in the first (F1,37 = 15.8, p < .0001) and second (F1,37 = 17.7, p = .002) 
but not the third test phase (p > .70). ANOVA restricted to the two first test phases 
where SB242084 had an effect showed a significant drug × test condition interaction 
(F2,37 = 4, p = .027). 
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SB242084 significantly decreased trials to criterion in the first and second test 
phase (Fig. 6.2; test phase × drug interaction: F2,74 = 4.2, p < .05). An ANOVA 
restricted to the first two test phases where the drug had an effect showed a significant 
drug × test condition interaction (F2,37 = 4, p < .05) where SB242084 decreased trials to 
criterion in the full reversal (F1,14 = 10.7, p < .01) and learned non-reward tests (F1,10 = 
30.5, p < .001) but not in the in the perseverance test (p = .16). 
 
Figure 6.3. Effect of SB242084 on correct responses to criterion in the three test phases 
of the full reversal (A) learned non-reward (B) and perseverance tests (C) of the operant 
procedure. Broken line represents mean performance in the initial spatial discrimination 
phase. Asterisk denote differences at which p < .05 (*p < .05, **p< .02). Significant 
main effects of test phase (F2,74 = 5.9, p < .004) drug (F1,37 = 15.4, p < .0001) test 
condition (F2,37 = 3.3, p < .046) and significant test phase × drug (F2, 74 = 3.4, p < .038) 
and test phase × drug × test condition interactions (F4, 74 = 2.8, p = .032). SB242084 
decreased correct trials the full reversal (Phase 1: F1,14 = 14.2, p = .002) and learned non-
reward tests (Phase 1: F1,10 = 33.2, p < .0001; Phase 2: F1,10 = 13.4, p = .004) but not in 
the perseverance test (p ≥ .6).  
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On correct responses to criterion (Fig. 6.3), there was a significant main effect of 
drug (F1,37 = 15.4, p < .0001) as well as significant test phase × drug (F2, 74 = 3.41, p < 
.05) and test phase × drug × test condition interactions (F4, 74 = 2.8, p < .05) over the 
three test phases. SB242084 decreased correct trials to criterion in the full reversal 
(Phase 1: F1,14 = 14.2, p < .01) and learned non-reward tests (Phase 1: F1,10 = 33.2, p < 
.0001; Phase 2: F1,10 = 13.4, p < .01) but not in the perseverance test (p ≥ .6). 
 
 
 
 
Figure 6.4. Effect of SB242084 on omissions to criterion in the three test phases of 
the full reversal (A) learned non-reward (B) and perseverance tests (C) of the 
operant procedure. Broken line represents mean performance in the initial spatial 
discrimination phase. Asterisk denote differences at which p < .05 (*p <.05, **p< 
.02). Significant main effects of test phase (F2, 74 = 22.6, p < .0001) test condition 
(F2,37 = 3.7, p = .033) and drug (F1,37 = 32.2, p < .0001) as well as a significant test 
phase × test condition interaction (F4,74 = 2.8, p = .031).  
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SB242084 decreased omissions to criterion, most prominently in the full 
reversal and learned non-reward tests (Fig. 6.4). ANOVA showed a significant main 
effect of drug (F1,37 = 16.8, p < .0001) and test phase × drug interaction (F4,74 = 4.5, p < 
.05). SB242084 significantly decreased omissions to criterion in the first (F4,41 = 13.9, p 
< .001) and second (F4,41 = 13.6, p < .001) but not the third test phase (p = .53). 
However, the drug × test condition interaction did not reach significance.  
SB242084 did not affect incorrect responses to criterion (Fig. 6.5). However, 
there was a significant effect of test condition (F2,37 = 12.4, p < .0001) and test phase × 
condition interaction (F4,74 = 4.5 p < .01). Animals made more incorrect responses in the 
full reversal test than in the learned non-reward (p < .0001) and perseverance tests (p = 
.05), and more incorrect responses in the perseverance test than in the learned non-
reward test (p < .01). In the learned non-reward test, animals made more incorrect 
responses in the first than the second (p = .002) and third test phases (p = .001). There 
were no effects of test phase on incorrect responses in the full reversal and perseverance 
tests. 
Finally, SB242084 significantly decreased all latency indices (Table 6.1; pellet 
retrival: F1, 36 = 16.6, p < .0001, nosepoke-hole response: F1,36 = 10.6, p = .002, trial 
initiation: F1, 36 = 11.4, p = .002). There were no significant effects of test condition (all 
p ≥ .188) or drug × test condition interaction on any latency measures (all p ≥ .288).  
 
 
 Group  
 Vehicle SB242084 p. 
Trial initiation 6.18 ± .19 5.25 ± .20 .002 
Nosepoke-hole response  4.24 ± .20 3.67 ± .13 .002 
Pellet retrieval 2.02 ± .05 1.70 ± .05 .0001 
No effects of condition (p ≥ .19) or drug × condition interactions (p ≥ .29). 
Table 6.1. Mean latencies (± SEM) in the operant task collapsed over the three test phases 
and three test conditions. 
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6.3.3 Experiment 3: SB242084 and maze reversal learning	  
 
Four animals were excluded after failing to respond in the spatial discrimination 
test, and one animal was excluded when becoming ill due to dehydration after a 
problem with the water-dispenser. Two animals failed to complete the full reversal test 
within 250 trials (one in each drug condition). There were no significant main effect of 
drug or drug × test condition interaction on probe-trials to criterion, early-errors or late-
errors. 
SB242084 facilitated and retarded performance in perseverance and learned 
non-reward tests, respectively, while failing to affect learning in the full reversal test 
(Fig. 6.6). There was a significant main effect of test condition (F2,61  =  13.1, p <. 0001) 
and drug × test condition interaction (F2, 61 = 3.1, p = .05) on trials to criterion (Fig. 
Figure 6.5. Effect of SB242084 on incorrect responses to criterion in the three 
test phases of the full reversal (A) learned non-reward (B) and perseverance 
tests (C) of the operant procedure. No effect of drug or drug × test condition 
interactions. Significant effect of test condition (F2,37 = 12.4, p < .0001) and 
phase × test condition interaction (F4,74 = 4.5, p < .01).	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6.5A). Animals required more trials to reach criterion in the full reversal test than in the 
perseverance (p < .001) and learned non-reward tests (p < .0001).  
Separate one-way ANOVAs showed that SB242084 decreased trials to criterion 
in the perseverance test (F1,20 = 4.5, p < .05), while increasing trials to criterion in the 
learned non-reward test (F1,22 = 4.4, p < .05). SB242084 did not effect trials to criterion 
in the full reversal test (F1,19 = 1.8, p = ns).  
There was also a significant main effect of test condition (F2, 61 = 9.6, p < .0001) 
and drug × test condition interaction (F2, 61 = 3.5, p < .05) on incorrect trials to criterion 
(Fig. 6.5B). Animals made more incorrect responses to criterion in the full reversal test 
than in the perseverance (p < .01) and learned non-reward tests (p < .0001). SB242084 
decreased the number of incorrect responses made in the perseverance test (F1, 20 = 6.0, 
p < .05). Conversely, SB242084 treated animals made more incorrect responses in the 
learned non-reward test, although the difference failed to reach significance (F1, 22 = 3.0, 
p = ns).  
There were a significant effect of test condition on correct responses to criterion 
(Fig. 6.5C; F2,61 = 13.5 p < .0001) but no significant effects of drug or drug × test 
condition interaction. Animals required more correct responses to criterion in the full 
reversal test than the perseverance and learned non-reward tests (p < .0001).  
A concomitant facilitation of learning in the perseverance test where the novel 
response option is correct, and impairment of learning in the learned non-reward test 
were the novel response option is incorrect, is indicative of an effect on novelty 
attraction. Novelty place recognition and attraction of SB242084 treated animals was 
therefore assessed in the maze. 
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Figure 6.6. Effect of SB242084 on trials (A), incorrect responses (B), and correct 
responses (C) to criterion in the three test conditions of the maze procedure. Asterisk 
denote differences at which p < .05. Broken line represents mean performance in the 
initial spatial discrimination phase.  (A) Trials to criterion. Significant effect of test 
condition (F2,61  =  13.1, p < .0001) and test condition × drug interaction (F2, 61 = 3.1, p = 
.05). SB242084 decreased trials to criterion in the perseverance test (F1,20 = 4.5, p = .046), 
and increased trials to criterion in the learned non-reward test (F1,22 = 4.4, p = .047). (B) 
Incorrect responses. Significant effect of test condition (F2, 61 = 9.6, p < .0001) and test 
condition × drug interaction (F2, 61 = 3.5, p = .04). SB242084 decreased incorrect 
responses to criterion in the perseverance test (F1, 20 = 6.0, p = .02). (C) Correct 
responses. Significant effect of test condition (F2,59 = 10.4, p < .0001). 
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6.3.4 Experiment 4: Effect of SB242084 on maze novelty place attraction  
 
Animals spent more time in the novel arm and made more arm-entries into the 
novel arm, but SB242084 failed to affect both of these measures (Table 6.2). 
There were no effects of maze-configuration or drug × maze-configuration 
interaction on entries into the novel or old arms. There was significant effects of phase 
on proportion of time (F1,26 = 12.3, p < .01) and proportion of arm-entries made into the 
novel arm (F1,26 = 3.8, p < .0001). There were no effects of drug (p ≥ .16) or drug × 
phase interactions (≥ .19) on proportion of time spent in the novel arm or arm entries 
into the novel arm.  
SB242084 did not affect the total time spent in the novel arm (SB242084 M: 
254.0 ± 16.9, Vehicle M: 244.8 ± 22.9) or old arms (SB242084 M:  175.18 ± 13.7, 
Vehicle M: 150.4 ± 15.9). However, SB242084 increased the total number of arm 
entries (SB242084 M: 62.8 ± 4.6; p < .05, Vehicle M: 41.3 ± 2.1) presumably due to 
increased activity levels (see Experiment 1).   
 
 
 
 
 
 
 
 
 
 
 
** p < . 01 
 
 
 
 
 Proportion of time (%) Proportion of entry counts (%) 
 Pre-shift Post-shift Change Pre-shift Post-shift Change 
Vehicle 30.0 ± 2.8 45.6 ± 4.2 + 15.6 34.2 ± 1.4 47.6 ± 2.7 +13.3 
SB242084 35.5 ± 3.5 43.0 ± 3.1 +7.4 33.7 ± 1.4 42.0 ± 2.0 +8.3 
Total 32.8 ± 2.3 44.3 ± 2.6 +11.5** 34.0 ± 1.0 44.8 ± 1.7 +9.5** 
Table 6.2. Effect of SB242084 on novelty recognition and attraction. Proportion of time 
and proportion of entries (± SEM) before a 45° shift (pre-shift) and after a 45° shift 
(post-shift) in vehicle and SB242084 treated animals. 
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6.4 DISCUSSION 
 
The experiments in this chapter show that SB242084 has variable effects on 
reversal learning, perseverance and learned non-reward depending on task parameters.  
SB242084 was found to improve operant visuospatial reversal learning in the mouse, 
consistant with recent observations from a similar operant procedure in the rat 
(Boulougouris et al., 2008). Additionally, these effects are shown to be due to decreased 
interference from learned non-reward, rather than perseverance.  
However, these effects did not generalise across testing paradigms. SB242084 
failed to influence maze egocentric reversal learning, apparently to be due to opposing 
facilitating and impairing affects on perseverance and learned non-reward. One 
potential explanation for this pattern of results is that 5-HT2CR antagonism enhances 
choice for a novel response option in the maze. However, SB242084 failed to affect 
performance in a novelty place recognition test, suggesting that the results are related to 
learning.  
 
6.4.1 Locomotor activity 
 
SB242084 increased activity levels at 0.5 mg/kg, roughly doubling the activity 
over a 90 min test session. It had similar effects on activity in animals pre-treated with 
the 5-HT2A/2C R antagonist mCPP. The hypoactivity effects of mCPP are consistent with 
previous work in the rodent showing that mCPP, at doses relevant to the current study, 
decreases activity levels in the rat (Kennett and Curzon, 1988; Lucki et al., 1989) and 
mouse (Gleason et al., 2001) although the effect is not always significant (Dalton et al., 
2004; Fletcher et al., 2009; Heisler and Tecott, 2000). In the mouse, SB242084 at 0.3 
and 1 mg/kg causes 30-40% elevations in activity over 90 min test sessions (Fletcher et 
al., 2009. The more potent elevation observed here may be related to the extensive 
habituation prior to drug-challenge in the study by Fletcher et al. (2009) and lack of 
habituation in the current experiment.  
 
6.4.2 Operant task 
 
In the operant procedure, SB242084 facilitated learning in the full reversal and 
learned non-reward tests, but did not affect performance in the perseverance test. The 
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facilitation was observed as decreases in trials, correct responses and omissions to 
criterion. SB242084 did not affect incorrect responses to criterion, late-errors, or early-
errors. This suggests that SB242084 facilitates operant visuospatial reversal learning in 
the mouse by a specific increase in the ability to overcome non-rewarded, rather than 
rewarded, associations. 
The facilitated learning observed in the learned non-reward test after SB242084 
might be explained by a decrease in novelty attraction. This is unlikely, as a decrease in 
novelty attraction would cause a parallel retardation of learning in the perseverance test, 
where the novel response option is correct. Moreover, a decrease in novelty attraction is 
not sufficient to explain the manipulations facilitating effects on learning, as learning 
also was improved in in the full reversal test, where no novel stimulus was introduced.  
A common phenomenon observed in the current study as well as by many others 
is a ‘serial reversal effect’ (Boulougouris et al., 2008; Clarke et al., 2007; Mackintosh, 
1983), i.e. an increased speed of learning across repeated reversals. This ‘serial reversal 
effect’ was shown to be restricted to the learned non-reward and full reversal tests while 
absent in the perseverance test. This indicates that facilitated reversal learning with 
repeated testing results from an increasing ability to overcome learned non-reward. 
SB242084 decreased omissions to criterion in the learned non-reward and full 
reversal test. The lack of effect in the perseverance test may result from a small number 
of omissions, and raises the possibility of floor effects. The observed effects of 
SB242084 on omissions are similar to its effect in the 5-CSRTT (Fletcher et al., 2007; 
Higgins et al., 2003; Winstanley et al., 2004). Decreasing activity at the 5-HT2CR has 
also previously been linked to enhanced motivation, with systemically SB242084 
treated mice showing delayed break-points on a progressive ratio schedule for food 
reinforcement (Simpson et al., 2011), an effect believed to be related to the striatal 
hyperdopamineragic state induced by SB242084 (De Deurwaerdère et al., 2004). 
However, SB242084 at 2 mg/kg and 6 mg/kg does not affect food intake in the rat 
(Kennett et al., 1997) and 0.5 mg/kg of SB242084 does not affect performance on 
progressive ratio schedules for food and sucrose reinforcers in the mouse (Fletcher et 
al., 2010). 0.5 mg/kg of SB242084 also fails to affect food and sucrose intake (Fletcher 
et al., 2009; Hewitt et al., 2002; Dalton et al., 2006). This suggests that SB242084, at 
the current dosing protocol, is without affect on motivation to feed and work for food 
reinforcers.   
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Moreover, if omissions index motivation for sucrose, at least three predictions 
can be made. Just as motivation, omissions should remain stable, and not differ 
significantly across the three test phases, the three test conditions, or tests that require 
new learning and retention phases that require no new learning. None of these 
predictions are supported by the data. On the other hand, if omissions were related to 
learning and learned non-reward, the predictions are that omissions should decrease 
across subsequent test phases in the SB242084 experiment (a serial reversal effect), be 
made in tests that require new learning but not retention phases requiring no new 
learning, and be greater in tests that has a component of learned non-reward (full 
reversal and learned non-reward tests) than tests that has no component of learned non-
reward (perseverance and retention tests). All of these predictions are supported by the 
data (Fig 6.4). This indicates, as previously suggested, that omissions can be considered 
is a component of learning and learned non-reward, produced by a reluctance to 
approach previously non-rewarded response options (Tait and Brown, 2007). 
SB242084 decreased correct responses to criterion in the full reversal and 
learned non-reward tests while failing to influence incorrect responses to criterion. 
Correct and incorrect responses can both be produced by either avoidance or approach 
of previously non-rewarded and rewarded stimuli. However, incorrect responses to 
criterion could be thought of as measure of responding at the previously rewarded CS 
and hence linked to perseverance, while correct responses to criterion could be thought 
of as a measure of responding at the previously non-rewarded CS and thereby linked to 
learned non-reward. This is also suggested by the data, with animals requiring more 
incorrect responses to criterion in the full reversal and perseverance tests than in the 
learned non-reward test, and more correct responses to criterion in the learned non-
reward and full reversal tests than the perseverance test (Fig. 6.3). A decreased number 
of correct rather than incorrect responses could thus be interpreted as indicative of an 
effect on learned non-reward rather than perseverance. 
SB242084 also decreased pellet collection, response and magazine latencies in 
all test conditions. As shown in Experiment 1, as well as by others (Fletcher et al., 2009; 
Martin et al., 2002), SB242084 induces hyperactivity in the rodent. Thus, hyperactivity, 
or a related effect on motor performance, could explain the effect of SB242084 on 
magazine, response, and pellet retrieval latencies.  
The facilitating effects of systemic 5-HT2CR antagonism on reversal learning 
may appear to contradict the retarding effects of 5-HT depletions (Clarke et al., 2007; 
	   129	  
Danet et al., 2009, 2010). This discrepancy has previously been explained by 
incomplete 5-HT depletions causing 5-HT2CR supersensitivity (Roberts 2011; 
Boulougouris and Robbins 2010). This is supported by observations of PCPA-induced 
5-HT depletions causing a downregulation of 5-HT2CR pre-mRNA editing resulting in a 
30% elevation in expression of the unedited receptor isoform with at least a four-fold 
increase in affinity for 5-HT relative to edited isoforms (Gurevich et al., 2002). It is also 
supported by the observation that PCPA-induced 5-HT depletions potentiates mCPP-
induced self-grooming in the rat (Graf et al., 2003).  
The SB242084-induced facilitation of reversal learning though decreased 
learned non-reward also contradict findings of 5,7-DHT induced OFC 5-HT depletions 
causing perseverative reversal deficits, but not learned non-rewarded related deficits, 
using the ID/ED-task in the marmoset (Clarke et al., 2007). The dissimilar effects in this 
study are likely to be related to the use of a different species in a rather different test 
paradigm.  
However, the reversal learning deficits produced by 5-HT depletions may not be 
related to altered activity at the 5-HT2CR. Within the PFC, higher levels of the 5-HT2AR 
than the 5-HT2CR have been detected (Pompeiano et al., 1994), as well as high to 
moderate levels of the 5-HT6R (Gérard et al., 1996; Lacroix et al., 2004) and the 5-
HT7R (Béïque et al., 2004) which like the 5-HT2CR are involved in reversal learning 
(Fone et al., 2008; McLean et al., 2009). Altered activity at these receptors rather than 
the 5-HT2CR could therefore account for the reversal deficits observed following 5-HT 
depletions. This idea is further supported by electrophysiological responses to 5-HT 
within the PFC of the 5-HT2CR KO mouse. Microiontophoretically-applied 5-HT 
potently inhibits pyramidal-neuron firing in the OFC of both anesthetised wild-type and 
5-HT2CR KO mice (Rueter et al., 2000). This suggests that the impairing effects of 
OFC-specific 5-HT depletion on reversal learning are related to altered activity at other 
receptors than the 5-HT2CR. 
Moreover, the reversal learning improvement following 5-HT2CR antagonism 
may not by related to altered 5-HT activity. Systemic SB242084 facilitates reversal 
learning but fails to influence dialysate levels of 5-HT within the PFC (Gobert et al., 
2000; Millan et al., 1999) and has no affect on raphe nuclei cell firing when 
administered on its own (Boothman et al., 2003, 2006). This suggests that 5-HT2CR 
antagonism facilitates reversal learning through non-5-HT related mechanisms. 
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Alternatively, SB242084 could enhance reversal learning by increasing DA-
signaling within the ventral striatum. This is however unlikely, since NAc-lesions have 
no effect on operant visuospatial (Castañé et al., 2009; Burke and Mair, 2001) and 
olfactory reversal learning in the rat (Schoenbaum et al., 2003) or visual, spatial and 
motor reversal learning in the macaque (Stern and Passingham, 1985). Importantly, 
SB242084, which facilitate reversal learning when administered systemically, has no 
affect on reversal learning when administered into the NAc (Boulougouris and Robbins, 
2010). 
Furthermore, the 5-HT2CR constitutively inhibits DA-signaling within the DStr 
(Abdallah et al., 2008; Alex et al., 2005) and an SB242084-induced elevation in DStr 
DA could possibly affect reversal performance. However, elevated DA-levels in the 
DStr are associated with retarded rather than improved reversal learning (Clatworthy et 
al., 2009). Also, SB242084 at doses relevant to the current study has no effect on SNc 
neuron firing or dialysate levels of DA in the DStr (Gobert et al., 2000; Millan et al., 
1999).  
Systemic SB242084 also increases PFC DA-content, which could have pro-
cognitive consequences (Stefani and Moghaddam, 2006), and it may be that this is 
related to the improved reversal performance. This is however contradicted by work 
showing that OFC-specific infusion of SB242084, which is likely to be without effect 
on PFC DA-levels (Pozzi et al., 1999), facilitates reversal learning (Boulougouris and 
Robbins, 2010). 
In sum, 5-HT2CR antagonism through SB242084 facilitates serial operant 
visuospatial reversal learning in the mouse by decreasing the interference from 
previously non-rewarded rather than rewarded associations. These effects are observed 
as decreases in trials, correct responses and omissions to criterion. The effects of 
SB242084 on learning are likely to be unrelated to altered DA and 5-HT signalling 
within the PFC and striatum.  
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6.4.3 Maze task 
 
SB242084 had opposing effects on perseverance and learned non-reward in the 
egocentric maze task. SB242084 decreased trials and incorrect responses to criterion in 
the perseverance test, but increased trials to criterion in the learned non-reward test. 
Additionally, the opposing effects of SB242084 on perseverance and learned non-
reward appear to summate into no overall effects on egocentric full reversal learning.  
An increase in novelty attraction would predict a performance facilitation in the 
perseverance test, where the novel response option is correct, and a parallel 
performance impairment in the learned non-reward test, where the novel response 
option is incorrect. The observed opposing effects of SB242084 in the perseverance and 
learned non-reward tests could therefore be explained by elevated novelty attraction.  
There are as yet no evidence for a role of the 5-HT2CR in novelty attraction. The 
5-HT2CR is however involved in anxiety, with SB242084 increasing punished 
responding in the Geller-Seifer and Vogel conflict tests and time spent in the open-arms 
in the elevated plus-maze (Kennett et al., 1994, 1997; Martin et al., 2002). It might be 
that anxiolysis could influence performance in the current task by decreasing the 
anxiety related to entering a novel arm and thereby explain the opposing effects of 
SB242084 in the perseverance and learned non-reward tests. However, in Experiment 4, 
SB242084 failed to affect both the proportion of entries and proportion of time spent in 
the novel-arm. Hence, with no evidence supporting a role of the 5-HT2CR or an effect of 
SB242084 on novelty attraction, as well as a lack of effect of SB242084 on novelty 
place recognition and attraction, the observed results in the perseverance and learned 
non-rewarded tests are unlikely to be related to increased novelty attraction.  
SB242084 selectively decreased the number of trials and incorrect responses in 
the perseverance test. The SB242084-induced facilitation of operant lever reversal in 
the rat has previously been discussed in terms of anticompulsive effects (Boulougouris 
et al., 2008; Boulougouris and Robbins 2010; Roberts, 2011) as both perseverative 
responding and compulsivity can be thought of as behaviours maintained despite no 
longer being predictive of reward (Dalley et al., 2011; Izquierdo and Jentsch, 2012). 
Accordingly, mCPP-induced compulsive grooming (Graf et al., 2003) and 
retardation of maze spatial alternation (Tsaltas et al., 2005, 2009) have both been found 
to be reduced through pretreatment with SB242084, and systemic or intra-OFC 
infusions of the 5-HT2CR antagonist RS102221 decreases excessive lever-pressing in 
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the signal-attenuation paradigm (Flaisher-Grinberg et al., 2008). The effect of systemic 
and intra-OFC infusions of SB242084 in operant visuospatial reversal learning are 
believed to be related to similar anticompulsive effects (Boulougouris et al., 2008; 
Boulougouris and Robbins 2010). The data on the role of the 5-HT2CR in compulsivity 
is however equivocal. Similar to SB242084, the 5-HT2CR agonists can attenuate 
compulsive behaviour in the marble burying and schedule induced polydipsia 
paradigms (Bös et al., 1997; Martin 1998), and these effects can be blocked by 
SB242084 (Egashira et al., 2011). 
 
6.4.4 General discussion 
 
The current results indicate discrepancies between tasks in terms of mode of 
problem solving. That is, while responding in the operant task appear to be guided 
primarily by the use of non-reinforced associations, responding in the maze loads more 
strongly upon associations of reward. In the operant serial task, animals required more 
trials to criterion in the learned non-reward and full reversal tests than in the 
perseverance test. In the maze task, however, animals required more trials in the full 
reversal test than both the perseverance and learned non-reward test. These differences 
may be related to some of the differences in tasks parameters referred to in Chapter 2, 
Discussion.  
The chapter also presents clear differences in the effect of SB242084 on maze 
egocentric and operant visuospatial reversal learning, perseveration and learned non-
reward. First, SB242084 facilitated reversal learning in the operant task, but had no 
effect on reversal learning in the maze task. Second, SB242084 decreased perseverance 
in the maze task, but had no effect on perseverance in the operant task. Third, 
SB242084 facilitated the ability to overcome learned non-reward in the operant task, but 
retarded the same measure in the maze task.  
The most obvious difference was observed in the learned non-reward test. There 
are no published data on 5-HT2CR specific compounds and learned non-reward. There is 
however a rich literature on non-specific 5-HT2CR antagonist in the closely related 
paradigm of latent inhibition, which like learned non-reward assesses the ability to 
overcome associations of non-reinforcement. Here, SB242084 was observed to cause an 
increase of low baseline learned non-reward in the maze task, but a decrease of high 
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baseline learned non-reward in the operant task. These opposing baseline dependent 
effects are similar to the effect of 5-HT2CR antagonists on latent inhibition. 
First, compounds with 5-HT2CR antagonist properties can induce or potentiate 
latent inhibition at low baseline levels where limited or no latent inhibition is displayed 
by vehicle-treated controls. These effects have been observed following treatment with 
the atypical antipsychotics clozapine (Shadach et al., 2000; Trimble et al., 1998) and 
olanzapine (Dunn et al., 1994), the SSRI fluoxetine (Jakob 1995) and the putative 
antipsychotic S16924  (Millan et al., 1999). These compound all display potent 
antagonist affinity at the 5-HT2CR (Meltzer, 2010; Middlemiss and Tricklebank, 1992; 
Millan et al., 1999; Ni and Miledi, 1997; Pälvimäki et al., 2003). 
Second, 5-HT2CR antagonists can also reduce or block latent inhibition at high 
baseline levels where strong latent inhibition is displayed by vehicle-treated controls. In 
this situation, the non-selective 5-HT2CR antagonists clozapine, fluperlapine, sertraline, 
risperidone, amisulpride, ritansarin and amperozide all decreases latent inhibition 
(Barrett et al., 2004; Cassaday et al., 1993a; Dunn et al., 1991; Loskutova et al., 1990; 
Shadach et al., 2000).  
These opposing baseline-dependent effects on latent inhibition have nevertheless 
been suggested to be unrelated to activity at the 5-HT2CR, and instead produced by the 
compounds concurrent antagonism at the 5-HT2AR and the D2R (Schadach et al., 2000). 
The suggestion has been that D2R antagonism prevails at low baseline levels, causing 
potentiated latent inhibition, but 5-HT2AR antagonism prevails at high baseline levels, 
causing attenuated latent inhibition (Schadach et al., 2000). This is however 
contradicted by the ability of fluoxetine to increase latent inhibition without showing 
affinity for the D2R (Pälvimäki et al., 2003). It is also contradicted by findings that 5-
HT2AR antagonism through SR46349B and ICI169369 potentiates, rather than 
attenuates, latent inhibition using a protocol yielding latent inhibition in controls 
(McDonald et al., 2003). Hence, while there are no studies of 5-HT2CR selective 
compounds within paradigms of latent inhibition, non-selective 5-HT2CR antagonists 
can have opposing effects on the strength of non-reinforced associations, with 5-HT2CR 
antagonists elevating latent inhibition at low baseline levels (paralleling the observed 
effect of SB242084 in the maze task) and attenuating latent inhibition at high baseline 
levels (paralleling the observed effect of SB242084 in the operant task).  
A further cross-task discrepancy is the effect of SB242084 on full reversal 
learning. Here, SB242084 facilitated reversal learning in the operant task, yet failed to 
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affect reversal learning in the maze task. If anything, the direction of effect in the maze 
was in the opposite direction with SB242084-treated animals requiring more trials to 
criterion in the full reversal test. The effects of SB242084 on operant visuospatial 
reversal learning has been shown to be OFC-dependent with intra-OFC infusions, but 
not intra-NAc or intra-mPFC infusions, improving the performance in the rat 
(Boulougouris and Robbins, 2010). Chapter 4 indicates that operant visuospatial 
reversal learning, but not maze egocentric reversal learning, is dependent upon the 
integrity of the OFC. Hence, the effect and lack of effect upon reversal learning in the 
operant and maze tasks, respectively, could be explained by the tasks relative loading 
upon the OFC.   
The effect in the operant paradigm would suggest that 5-HT2CR antagonism is of 
limited therapeutic efficacy for executive functioning in schizophrenia. SB242084 
caused a specific decrease in learned non-reward, and schizophrenic patient show no 
learned irrelevance deficits within attentional set-shifting (Elliot et al., 1995, 1998), and 
has in other paradigm been shown to express attenuated latent inhibition (Baruch et al., 
1988; Williams et al., 1998) and learned irrelevance (Young et al., 2005). Further 
pharmacologically produced decrements in learned non-reward through 5-HT2CR 
antagonism could therefore be of detrimental effect. The effect of SB242084 in the 
operant task nevertheless suggests that 5-HT2CR antagonism may be therapeutic in 
disorders showing cognitive flexibility impairments believed to be related to deficits in 
overcoming irrelevant or non-reinforced associations, such as Parkinson’s disease 
(Slabosz et al., 2007) and OCD (Kaplan et al., 2006; Swerdlow et al., 1999). 
Although SB242084 failed to affect reversal learning in the maze procedure, its 
effects in the learned non-reward and perseverance tests would be indicative of 
therapeutic efficacy in schizophrenia. Thus, both the pathology related attenuation of 
non-reinforced associations, as well as the pathology related augmentation of 
perseverance may, be opposed by 5-HT2CR antagonism through SB242084.  
In sum, it appears that SB242084 facilitates operant serial visuospatial reversal 
learning in the mouse by decreasing the influence of previously non-rewarded 
associations. In the maze task, however, SB242084 was without affects on reversal 
learning, apparently due to opposing facilitation in the perseverance test and impairment 
in the learned non-reward test.   
Most work investigating the role of the 5-HT2CR in relation to the pathology and 
treatment of the cognitive deficits of schizophrenia has used subtype-selective 
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compounds. An alternative approach is to use to the 5-HT2CR KO mouse. Although 
constitutive loss of the 5-HT2CR has some different cortical and striatal consequences to 
acute antagonism, additional electrophysiological work has been done in this mutant 
mouse which may give clues for the mechanism behind altered reversal performance 
following reduced function at the 5-HT2CR. Studies of such mice are the focus of the 
experiments reported in Chapter 7. 
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CHAPTER 7 
REVERSAL LEARNING IN 5-HT2C RECEPTOR KNOCK-OUT MICE 
 
 
7.1 INTRODUCTION 
 
The great majority of studies investigating the role of the 5-HT2CR in cognition 
have been done pharmacologically, with relatively few studies using the 5-HT2CR 
knock-out (KO) mouse. Although the neurochemical and low-level behavioural 
consequences of 5-HT2CR deletion show substantial overlap with the effects of 5-
HT2CR antagonism through SB242084, inconstancies are observed, which may be 
related to additional loss of constitutive receptor activity in the mutant, developmental 
compensations, or to potential inverse agonist activity of SB242084.  
The 5-HT2CR KO has so far not been discussed as a possible instrument for 
assessing behaviours relevant to the pathology of schizophrenia. The 5-HT2CR KO do 
however show dopaminergic and glutamatergic signalling abnormalities within the PFC 
and striatum that may be of relevance for reversal learning and the cognitive deficits of 
schizophrenia.  
 
7.1.2 The 5-HT2CR KO mouse 
  
The 5-HT2CR KO mouse was generated by inserting a nonsense mutation into 
exon 5 of the 5-HT2CR gene (htr2c), producing a stop codon within the receptors fifth 
putative transmembrane segment and deleting the C-terminal end of the protein. 
Introducing the mutation into the corresponding position of the rat 5-HT2CR 
complementary DNA resulted in mRNA failing to produce functional receptors in 
Xenopus oocytes. The mutation was subsequently introduced into the mouse genome 
via homologous recombination in 129-ES (embryonic stem) cells (Tecott et al., 1995). 
The 5-HT2CR is X-linked (Yu et al., 1991). Breeding of wild-type (WT) males with 
heterozygous females therefore produce male offspring either hemizygous KO or 
hemizygous WT, with the benefit of single litters of age-matched WT and KO male 
mice.  
However, mutations causing constitutive loss of specific components in 5-HT 
systems often cause adaptations additional to the mutation. For example, 5-HT1BR KO 
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mice show reduced response to 5-HT2CR agonists (Clifton et al., 2003), and 5-HTT KO 
mice show region-specific up- and down-regulation of the 5-HT1AR and 5-HT1BR 
(Fabre et al., 2000; Li et al., 2000), as well as decreased levels and altered expression 
patterns of the 5-HT2AR in the PFC and striatum (Li et al., 2003; Rioux et al., 1999), 
and increased 5-HT2CR density in the amygdala, but decreased 5-HT2CR mRNA in the 
habenula (Li et al., 2003). 
There is, nevertheless, little evidence for adaptive changes in the 5-HT2CR KO 
mouse. Quantitative receptor autoradiography of the 5-HT2CR KO mouse brain show no 
regional differences in density or mRNA expression of 5-HTT protein and 5-HT 
receptors (López-Giménez et al., 2002). The 5-HT2CR KO mouse does however show 
slight but significant global reductions in expression of the 5-HTT, the 5-HT1B/1DR and 
the 5-HT7R (López-Giménez et al., 2002). Furthermore, the inhibition OFC pyramidal 
neuron cell firing produced by sub-region specific infusions of the 5-HT2A/2CR agonist 
DOI is supressed by the 5-HT2AR antagonist M100907 in wild-type but not 5-HT2CR 
KO mice, indicating that the 5-HT2CR KO mouse may show a compensatory down-
regulation in 5-HT2AR antagonist affinity (Rueter et al., 2000). 
 
7.1.3 Neurophysiology and behaviour of the 5-HT2CR KO mouse 
 
Similar to the effects of SB242084 in WT mice, the 5-HT2CR KO mouse shows 
increased locomotor activity levels. The mutants also exhibit elevated food anticipatory 
activity (Hsu et al., 2010), as well as novelty- and cocaine-induced locomotor activity 
(Rocha et al., 2002). Others have found that the 5-HT2CR KO mouse show elevated 
activity when assessed over 24-hours (Nonogaki et al., 2003), during the first 30 min of 
a 60 min test session (Hill et al., 2010), and a 30% elevation in activity over a 90 min 
test session is observed when data from five experiments are summed (Fletcher et al., 
2009). The hyperactivity of 5-HT2CR KO mice is milder than that produced by 
SB242084, which is in accordance with the weaker elevation of mesoaccumbal DA-
signalling observed in the 5-HT2CR KO mouse relative to that produced by SB242084 
(Abdallah et al., 2009; Gobert et al., 2000).    
Although standard in vivo microdialysis revealed no baseline abnormalities in 
DA-dialysate levels within the DStr and NAc of 5-HT2CR KO mice (Rocha et al., 
2002), differences are evident using no-net flux quantitative microdialysis (Abdallah et 
al., 2008). In the 5-HT2CR KO mouse, SNc neuron tonic firing and bursting are 
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increased by 20% and 50%, respectively, and there is a near 100% elevation in DStr 
DA-dialysate levels. Tonic and burst firing of VTA DA-cells are however unaffected, 
but there is a modest but significant increase in DA-levels within the NAc which is 
likely to be related to observed increases in activity (Abdallah et al., 2008). As reversal 
learning is dependent upon both the integrity (Kirkby, 1969; Ragozzino et al., 2001) and 
DA-signalling within of the DStr (Clarke et al., 2011; Clatworthy et al., 2009), these 
aberrations are likely to be of consequence for learning in tasks requiring cognitive 
flexibility.  
5-HT has an inhibitory effect on neuronal activity within the OFC, mPFC and 
DStr, with microiontophoretic application of 5-HT or the 5-HT2A/2CR agonists DOI and 
mCPP supressing neuronal firing in the rat (Ashby et al., 1990; Ashby and Wang, 1990; 
El Mansari and Blier, 1997; Zghoul and Blier, 2003). These effects have been suggested 
to be mediated by 5-HT2CRs within the OFC. Accordingly, the mCPP and DOI-induced 
OFC-inhibition are not blocked by ritanserin (Bergqvist et al., 1999), which show 
higher affinity for the 5-HT2AR over the 5-HT2CR. However, mCPP-induced inhibition, 
but not DOI-induced inhibition, is blocked by clozapine and risperidone. As mCPP, 
clozapine and risperidone all show greater affinity for the 5-HT2CR over the 5-HT2AR, 
the effects are suggested to be related to activity at the 5-HT2CR (Bergqvist et al., 1999). 
This suggestion is nonetheless contradicted by work in the 5-HT2CR KO mouse. 5-
HT2CR KO mice do not differ from WTs in the inhibitory response to microphonoretic 
5-HT, DOI and higher levels of mCPP when applied in the OFC or the head of the 
caudate nucleus, indicating that the inhibitory effects of 5-HT primarily are mediated by 
the 5-HT2AR (Rueter et al., 2000). 
However, constitutive loss of the 5-HT2CR results in glutamatergic 
supersensitivity in the OFC and DStr (Reuter et al., 2000). In the 5-HT2CR KO, 
significantly less of the AMPAr agonist quisqualate is required to activate pyramidal 
glutamatergic OFC neurons. Glutamatergic supersensitivity may also be related to the 
elevated DA-levels in the DStr of the 5-HT2CR KO mouse, as quisqualate infusions 
increase levels of dialysate DA in the caudate nucleus of the rat (Imperato et al., 1990) 
and cat (Barbeito et al., 1990). AMPAr supersensitivity within the OFC and DStr is 
likely to have consequences for performance in tasks of cognitive flexibility, as these 
areas are activated in human fMRI studies of probabilistic reversal learning (Remijnse 
et al., 2005; Rogers et al., 2000) and the degree of OFC activation positively correlates 
with reversal performance (O’Doherty et al., 2001).  
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The 5-HT2CR is also expressed in the hippocampus (Wright et al., 1995), where 
serotonergic afferents from the raphe nuclei facilitate long-term potentiation (LTP; Bliss 
et al., 1983) that supports spatial learning (Davis et al., 1992; Jeffery and Morris, 2004). 
The 5-HT2CR KO mouse shows diminished LTP induction in dentate gyrus synapses of 
the medial perforant path, but normal LTP induction in synapses between dentate mossy 
fibers and CA3, CA3 and CA1, and CA1 and the subiculum (Tecott et al., 1998). 
However, the 5-HT2CR KO mouse also show increased expression of BDNF within the 
dentate gyrus (Hill et al., 2010), which could have pro-cognitive effects (Bekinschtein et 
al., 2011). 
Despite these differences, relatively few cognitive abnormalities have been 
found in in the 5-HT2CR KO mouse. The mutant shows normal context discrimination 
acquisition, and normal acquisition of appetitive lever-pressing (Tecott et al., 1998) and 
also do not differ from WT controls in the forced swim test, prepulse-inhibition, or 
working and reference memory in the radial arm maze (Hill et al., 2011). However, 
similar to SB242084 treated animals, the 5-HT2CR KO mouse shows an anxiolytic 
profile in the elevated zero-maze, elevated plus-maze, mirrored chamber, open-field, 
emergence-neophobia and novel-object tests (Heisler et al., 2007; Tecott et al., 1998). 
Others have nevertheless observed no differences between 5-HT2CR KO mice and WT 
controls in the elevated plus-maze and emergence neophobia (Hill et al., 2011). 
The 5-HT2CR KO mouse does however show some impairments of performance 
in the water maze (Tecott et al., 1998). Here the mutant displays normal acquisition of a 
visuospatial discrimination. However, when removing the platform and monitoring 
preferences in swimming location, 5-HT2CR KO animals fail to show a preference for 
the previous platform location (Tecott et al., 1998). Furthermore, the 5-HT2CR KO 
mouse has been suggested a model the compulsive symptoms of OCD, as the mutant 
shows compulsive-like behaviour of chewing non-nutritive clay and failure to habituate 
head-dipping behaviour in a cheese-board task (Chou-Green et al., 2003). There have as 
yet been no studies of executive functioning in the 5-HT2CR KO mouse. The current 
chapter therefore investigated the effects of 5-HT2CR deletion on cognitive flexibility. 
Experiment 1 assessed the 5-HT2CR KO mouse in the operant visuospatial task, while 
Experiment 2 used the egocentric maze task.  
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7.2 METHOD 
 
7.2.1 Genotyping and breeding 
 
The animals were bred at the University of Sussex with the original progeny of 
5-HT2CR KO mice being a gift from L. Tecott. Wild-type male mice were crossed with 
females heterozygous for the X-linked 5-HT2CR mutation of a C57BL6/J background 
generating male WT and KO offspring. Genotyping was achieved using PCR on tissue 
samples from ear punches. The wild-type allele was detected using primers of the 5-
HT2CR gene sequences flanking the Neo insertion: m5h2c (5′-
AGTTGATGTTCATCTCAGGTGGC-3′) and 3N2 (5′-
GGGTCCTATAGATCGAGGTACC-3′). The mutant allele was detected using primers 
complimentary to neomycin resistance gene (Neo) sequences: NeoD (5′-
CACCTTGCTCCTGCCGAGAAA-3′) and NeoH (5′-
AGAAGGCGATAGAAGGCGATG-3′). Breeding animals had been backcrossed for 
more than 20 generations. Animals were 10-24 weeks old (age-matched for genotype) at 
the beginning of the experiments. 
 
7.2.2 Experiment 1: Operant experimental design and statistical analyses 
 
The experiment used 24 male mice (11 WTs; 13 KOs) weighing a mean 26.7g at 
the start of the experiment. The experiment used a within-subjects design in which each 
animal completed a full reversal test, followed by a perseverance and learned non-
reward test. The order of the perseverance and learned non-reward tests were 
counterbalanced across genotypes. Performance in the simple discrimination and 
reversal phases were analysed using one-way between-subjects ANOVAs with 
genotype as the independent variable. The perseverance and learned non-reward tests 
were analysed using 2 × (within-subjects: test condition) 2 × (between-subjects: 
genotype) 2 (between-subjects: test order) mixed ANOVAs.  
 
7.2.3 Experiment 2: Maze experimental design and statistical analyses 
 
The experiment used 33 male mice (18 WTs; 15 KOs) weighing a mean 25.9g at 
the start of the experiment. Animals were run in two batches, with each animal being 
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tested every other day. The experiment used a repeated measures design, with each 
animal completing an initial spatial discrimination followed by a full reversal test. 
Animals subsequently completed a learned non-reward and a perseverance test, with the 
order of the perseverance and learned non-reward tests counterbalanced across 
genotypes. Animals failing to reach criterion within 250 trials were assigned a trial-
score of 250 for that test condition and not given further trials.  
A large number of predominantly KO animals failed to complete criterion across 
all test conditions within the 250 trial-limit. Therefore, genotype differences in 
proportion achieving criterion within each stage was initially investigated by analysing 
the distribution of animals failing or passing through chi-square distributed analysis. 
The data from each test condition was subsequently analysed through one-way between-
subjects ANOVAs with genotype as the independent variable. Behavioural analyses 
only included animals attempting a given stage (Leeson et al., 2009; Jazbec et al., 
2007).  
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7.3 RESULTS  
 
 
7.3.1 Experiment 1: 5-HT2CKO and operant reversal learning 
 
 
5-HT2CR KO animals showed facilitated performance in the full reversal and 
learned non-reward tests but did not differ from wild-type controls in the perseverance 
test (Fig. 7.1A-D).	  	  
In the full reversal test, 5-HT2CR KO animals made significantly fewer trials 
(Fig. 7.1A; F1,22 = 4.5, p < .05) and omissions to criterion (Fig 7.1C; F1,22 = 4.8, p < .05) 
than WT animals. 
There was also a significant genotype × test condition interaction on trials to 
criterion in the perseverance and learned non-reward tests (F1,20 = 4.6, p < .05). 5-
HT2CR KO animals required significantly fewer trials to criterion in the learned non-
reward test (Fig. 7.1A; F1,22 = 6.0, p < .05) but not in the perseverance test (F1,22 = 0.4, p 
= ns). There were no significant main effects or genotype or genotype × test condition 
interactions on any latency indices (Table 7.2).  
There were no significant differences between genotypes on retention of a 
learned response. 5-HT2CR KO animals required significantly less correct responses to 
criterion in spatial discrimination (Table 7.1; F1,22 = 5.3, p < .05). However, genotype 
failed to effect the number of trials (F1,22 = 3.9, p = ns) incorrect responses (F1,22 = 0.24, 
p = ns), and omissions to criterion (F1,22 = 3.8, p = ns).  
 
 
 
 
 
 Group  
 WT 5-HT2CR KO         p 
Trials 245.4 ± 41 152.3 ± 26.1 ns 
Correct 120.6 ± 19.5 70.5 ± 11.4 .031 
Incorrect 36.4 ± 4.7 33.2 ± 4.3 ns 
Omissions 106.6 ± 27.3 48.6 ± 14.6 ns 
Table 7.1. Mean responses of WT and 5-HT2CR KO animals in the spatial 
discrimination of the operant task. 
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Figure 7.1.  Effect of 5-HT2CR KO in the operant procedure. (A) Trials to criterion. 
Significant main effect of genotype in the full reversal test (F1,22 = 4.5, p < .046) and 
genotype × test condition interaction in the non-reward and perseverance tests (F1,20 = 4.6, 
p < .045). 5-HT2CR KO mice required fewer trials in the non-reward test (F1,22 = 6.0, p = 
.023). (B) Correct responses. No effect of genotype in the full reversal test (F1,22 = 2.0, p = 
.17).  No effect of genotype (F1,20 = 1.7, p = .2) or the genotype × test condition interaction 
(F1,20 = 4.0, p = .06)  in the perseverance and learned non-reward tests. (C) Omissions. 
Significant effect of genotype in full reversal test (F1,22 = 4.8, p = .04). No effect of 
genotype (F1,20 = 4.0, p = .059) or genotype × test condition interaction (F1,20 = 3.1, p = 
.094) in the learned non-reward and perseverance tests. (C) Incorrect responses. No effect 
of genotype in the full reversal test (F1,22 = 0.3, p = .59). No effect of genotype (F1,20 = 
1.5, p = .23) or genotype × test condition interaction (F1,20 = 1.2, p = .28) in the 
perseverance and learned non-reward tests.   
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7.3.2 Experiment 2: 5-HT2CR KO and maze reversal learning	  
 
In the maze, 5-HT2C KOs showed retarded performance relative to WT animals. 
This was particularly evident in the perseverance test, but also observed in spatial 
discrimination acquisition. 
Attrition rates. Significantly more 5-HT2CR KO mice (N = 8) than WT mice (N 
= 2) failed to complete the four test conditions (Fig. 7.2; x2 = 7.5, p < .01). Although no 
animals failed to complete the spatial discrimination or the learned non-reward tests, 
more 5-HT2CR KO (N = 4) than WT animals (N = 1) failed to complete the 
perseverance test (x2 = 4.2, p < .05). Further, more 5-HT2CR KO mice (N = 4) than WT 
mice (N = 1) failed to complete the full reversal test, although this difference remained 
non-significant  (x2 = 2.8, p = ns).  
 Trials and responses. 5-HT2CR KO animals required more trials (F1,31 = 6.1, p < 
.05) and made more incorrect responses to criterion in the initial spatial discrimination 
(Table 7.3; F1,31 = 6.1, p < .05).  There was also a trend for 5-HT2CR KO animals to 
perform worse in the subsequent full reversal test, showing increased trials and incorrect 
responses to criterion, although both these differences failed to reach significance (Fig. 
7.3; trials, F1,31 = 4.0, p = ns; incorrect, F1,31 = 3.7, p = ns). 
  
 Group  
 WT 5-HT2CR KO p 
Trial initiation 6.29 ± .33 6.38 ± .30 ns 
Nosepoke-hole response  3.75 ± .26 3.59 ± .22 ns 
Pellet retrieval 2.31 ± .08 2.39 ± .12 ns 
Table 7.2. Mean latencies (± SEM) in the operant task collapsed over the three test 
phases and three test conditions. 
 
No significant effects of condition (p ≥ .76) or genotype × condition interactions 
(p ≥ .72). 	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5-HT2CR KO mice showed deficits in the perseverance test, requiring more trials 
(F1,31 = 5.8, p < .05) and as well as making more incorrect responses to criterion 
compared to WT animals (F1,31 = 4.4, p < .05). There were no effects of genotype in the 
learned non-reward test (Fig. 7.3; p ≥ .20)  
To explore whether the deficits observed in the perseverance and full reversal 
test could be accounted for by differences within discrimination learning, the 
performance within these two test conditions were analysed using the initial 
discrimination data as covariates. When accounting for initial egocentric discrimination 
performance, the effect of genotype in the perseverance test remained significant (trials, 
F1,25 = 7.6, p < .01; incorrect responses, F1,25 = 4.2, p = .05). The genotype differences 
in the full reversal test could however be accounted for by the initial spatial 
discrimination performance (trials, F1,30 = 0.6, p = ns; incorrect, F1,30 = 0.6, p = ns). 
Figure 7.2. Attrition at each learning stage of WT and 5-HT2CR 
KO animals in the maze procedure. Asterisk denote group 
difference at p < .05.   
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 WT 5-HT2CR KO p 
Trials 55.2 ± 7.2 85.5 ± 10.3 .019 
Correct 37.2 ± 4.6 49.5 ± 5.7 ns 
Incorrect 17.9 ± 3.0 35.9 ± 7.1 .019 
Table 7.3. Mean responses of WT and 5-HT2CR KO animals to criterion in the spatial 
discrimination of the maze task. 
Figure 7.3. Performance of WT and 5-HT2CR KO animals in the full reversal, perseverance 
and learned non-reward tests of the maze procedure. (A) Trials to criterion. Significant 
effect of genotype in the perseverance test (F1, 26 = 5.8, p = .023) and near-significant effect 
in the full reversal test (F1,31 = 4.0, p = .055). No effect of genotype in the learned non-
reward test (F1,23 = 1.8, p = .20). (B) Correct responses. No effects of genotype (p ≥ .20). 
(C) Incorrect responses. Significant effect of genotype in the perseverance test (F1, 26 = 4.4, 
p = .045) and near-significant effect in the full reversal test (F1,31 = 3.7, p = .062). No effect 
of genotype in the learned non-reward test (F1,23 = 0.7, p = .40). 
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7.4 DISCUSSION 
	  
The experiments in this chapter shows that constitutive loss of the 5-HT2CR has 
variable effects on reversal learning, perseverance and learned non-reward depending 
on the nature of the task. The 5-HT2CR KO mouse exhibited facilitated visuospatial 
operant reversal learning. This facilitation was associated with decreased interference 
from previously non-rewarded rather than rewarded associations, and parallels the 
decreased trials, correct responses and omissions observed in SB242084 treated mice 
using the same procedure (Chapter 6). 
Conversely, the 5-HT2CR KO mouse showed discrimination and perseverative 
impairments in the maze. These deficits were expressed as increases in trials and 
incorrect responses to criterion. The performance in the full reversal condition did not 
differ from WT controls.  Generally, the performance of the 5-HT2CR KO in the maze 
task was the opposite to that observed from SB242084 treated animals using the same 
procedure (Chapter 6). 
 7.4.1	  Operant task 	  
In the operant task, 5-HT2CR KO mice showed facilitated performance in the full 
reversal and learned non-reward tests but did not differ from WTs in the perseverance 
test.  
The facilitated reversal learning was associated with a decrease in omissions to 
criterion, indicating that it might be explained as a product of elevated motivation. The 
5-HT2CR KO mouse is hyperphagic by 5 weeks of age, and develops obesity at 5-6 
months of age (Nonogaki et al., 1998; Tecott el al., 1995). These animals also show 
elevated break-points on progressive ratio schedules when responding for cocaine 
(Rocha et al., 2002). Nevertheless, 5-HT2CR KO mice do not differ from WT controls in 
lever-press extinction for cocaine (Rocha et al., 2002), on wet-mash intake over a 90 
min test session (Fletcher et al., 2009) or on progressive ratio schedules when 
responding for food and sucrose reinforcers (Fletcher et al., 2010). The similar latencies 
for trial-initiation, nosepoke-hole response and pellet retrieval in KO and WT animals 
further indicate that motivation is unaffected. The large number of omissions in test 
conditions that comprise a component of learned non-reward (the full reversal and 
learned non-reward tests) as opposed to test conditions including no component of 
learned non reward (the perseverance test) indicates, as previously suggested, that a 
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high number of omissions are related to associations of learned non-reward (Tait and 
Brown, 2008) and that a motivational explanation can be discounted. 
The neurophysiological effects of reduced activity at the 5-HT2CR are well 
explored using 5-HT2CR selective compounds. Although these studies show that the 5-
HT2CR is implicated in the regulation of DA, 5-HT, ACh, and NA in the PFC, striatum 
and brainstem (Gobert et al., 2000; Boothman et al., 2006; Pozzi et al., 1998), there is 
little to suggest that any of these mechanisms are involved in the facilitation of reversal 
learning following reduced activity at the 5-HT2CR (see Chapter 6, Discussion). 
A possible mechanism is however suggested by electrophysiological studies in 
the OFC of the 5-HT2CR KO mouse. In the mutant, significantly less of the AMPAr 
agonist quisqualate is required to activate pyramidal glutamatergic neurons within the 
OFC (Rueter et al., 2000), and it may be that facilitated glutamatergic signalling 
through the AMPAr within the OFC is the mechanism behind improved cognitive 
flexibility. Potentiation of AMPAr transmission through treatment with positive 
modulators of the AMPAr has wide-ranging pro-cognitive effects (Black, 2005). In the 
rat, these include a selective enhancement of LTP-formation within the PFC (Black et 
al., 2000), an attenuation of the attentional set-shifting deficits produced by subchronic 
PCP (Broberg et al., 2009), and a selective improvement of reversal learning in the 
bowl-digging procedure (Woolley et al., 2009). It may be that the facilitated reversal 
learning observed following reduced activity at the 5-HT2CR is mediated by a similar 
mechanism. This would be in accordance with work showing that the degree of OFC 
activation positively correlates with reversal learning performance (O’Doherty et al., 
2001). It would also be line with work showing that the 5-HTT KO rat, which show 
enhanced reversal learning through decreased learned non-reward (Nonkes et al., 2011), 
also show an OFC-overactivation (Nonkes et al., 2010). However, there are as yet no 
published studies looking at the effects of positive modulation at the AMPAr on the 
ability to overcome non-reinforced associations.  
 7.4.2	  Maze task  
 
In the maze task, the 5-HT2CR KO mouse showed perseverative impairments, 
observed as increased attrition rates, trials to criterion, and incorrect responses to 
criterion in the perseverance test. 5-HT2CR KO mice did not differ from controls in the 
full reversal test. The direction of effect of 5-HT2CR KO in the learned non-reward test 
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of the maze procedure was similar to the effect of 5-HT2CR KO in the learned non-
reward test of the operant procedure. 
The 5-HT2CR KO mouse shows decreased anxiety, and spends more time in the 
open quadrant of an elevated zero maze and in the centre of an enclosed open field. 
These mice also spend more time investigating a novel object and have reduced 
latencies to enter a brightly lit novel environment (Heisler et al., 2007; Tecott et al., 
1998). The anxiolytic profile could potentially affect performance in the perseverance 
and learned non-reward conditions by increasing the tendency to enter a novel arm. If 
an anxiolytically mediated increase in novelty-attraction affected the performance in 
this task, the prediction would be that 5-HT2CR KO animals should show a concomitant 
facilitation of learning in the perseverance test, where the novel response option is 
correct, and a retardation of learning in the learned non-reward test, where the novel 
response option is incorrect. However, the performance of the 5-HT2CR KO mice in the 
learned non-reward and perseverance tests in the maze task are, if anything, in the 
opposite direction predicted by an augmentation of novelty attraction. In sum, a 5-
HT2CR KO induced increase in novelty-attraction is unlikely to explain effects upon 
learning in the perseverance and learned non-reward tests. 
In the present experiment, the 5-HT2CR KO mouse also showed deficits in two-
choice egocentric spatial discrimination acquisition, observed as an increase in trials 
and incorrect responses to criterion. Although an analysis of covariance suggested that 
this deficit could account for the non-significant increases in trials and incorrect 
responses to criterion in the full reversal test, this impairment did not account for the 
deficits observed in the perseverance test.  
Impaired spatial learning in the 5-HT2CR KO mouse has previously been 
observed in the water-maze and explained by altered function in the dentate gyrus 
(Tecott et al., 1998). The 5-HT2CR is expressed in this area (Klempin et al., 2010) and 
spatial learning is dependent upon its integrity (Conrad and Roy, 1993; McNaughton et 
al., 1989; Schuster et al., 1997; Tilson et al., 1988; Walsh et al., 1986). LTP-induction 
in the medial perforant path of the dentate gyrus appears to be supported by 5-HT and 
5-HT2CR activation, as LTP-formation is suppressed both by global 5-HT depletions 
through intraventricular 5,7-DHT (Bliss et al., 1983) and in the 5-HT2CR KO mouse 
(Tecott et al., 1998). Since LTP-formation within the perforant path of the dentate gyrus 
correlate with spatial learning in the water maze (Jeffery and Morris, 2004) and 
blocking LTP-formation in the medial perforant path retards water maze performance 
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(Davis et al., 1992), the observed retardation of discrimination learning in 5-HT2CR KO 
mice could be related to the suppressed hippocampal LTP-formation. 
The 5-HT2CR KO mouse also showed marked perseverative impairments in the 
maze task. Constitutive loss of the 5-HT2CR resulted in a selective increase in attrition 
rates, trials to criterion, and incorrect responses to criterion in the perseverance test. 
However, this perseverative impairment failed to influence learning in the full reversal 
test, where 5-HT2CR KO mice performed as well as controls. This might be related to a 
slight non-significant performance facilitation in the learned non-reward test.   
The perseverative impairment is in agreement with some studies of the 5-HT2CR 
KO mouse and 5-HT2CR selective compounds in paradigms of compulsive behaviour. 
Compulsive behaviour, as assessed in the marble-burying paradigm, is attenuated by 5-
HT2A/2CR agonists such as mCPP, DOI, Ro60-0175, Ro60-0332, and WAY161503 (Bös 
et al., 1997; Njung'e et al., 1991), and this attenuation can be blocked by SB242084 
(Egashira et al., 2011). The selective 5-HT2CR agonists Ro 60-0332 and Ro 60-0175 
also reduce schedule-induced polydipsia, which has been explained in terms of 
compulsivity (Martin et al., 1998). It is also consistent with the 5-HT2CR KO mutants 
compulsive-like chewing of non-nutritive clay and failure to habituate head-dipping 
behaviour in a cheese-board task. The observed increases in compulsive responding 
have been suggested to relate to the elevated striatal dopaminergic-tone seen in the 5-
HT2CR KO mouse (Chou-Green et al., 2003).  
Hence, the perseverative deficits of the 5-HT2CR KO could be related to 
increased dopaminergic activity in the DStr. The caudate nucleus is activated by 
reversal learning (Rogers et al., 2000) and electrolytic lesions retard visual maze 
reversal learning in the rat (Kirkby 1969). However, unlike other brain regions, there is 
ample evidence for a role of the caudate nucleus in rodent egocentric spatial learning. 
Lidocaine-induced inactivation impairs egocentric but not visuospatial discrimination in 
the T-maze (Packard and McGaugh, 1996). Moreover, caudate-lesions or caudate-
inactivation leave allocentric two-choice spatial discrimination and working memory 
intact, while causing deficits in egocentric two-choice spatial discrimination, working 
memory and reversal learning (Brasted et al., 1997; Cook and Kesner, 1988; De 
Leonibus et al., 2005; Kesner et al., 1993; Mitchell and Hall, 1988; Packard and 
McGaugh, 1996; Palencia and Ragozzino, 2004; Potegal et al., 1969; Ragozzino et al., 
2002). The 5-HT2CR is strongly expressed in the caudate nucleus (Clemett et al., 2000; 
Eberle-Wang et al., 1997; Pazos and Palacios 1985) and the 5-HT2CR KO mouse shows 
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elevated levels of SNc neuronal firing and DA-dialysate levels in the DStr (Abdallah et 
al., 2008), potentially produced by AMPAr supersensitivity in the head of the caudate 
nucleus (Barbeito et al., 1990; Imperato et al., 1990; Reuter et al., 2000). Selective DA-
depletion in the head of the caudate nucleus retards visual reversal learning in the 
marmoset (Clarke et al., 2011), and it has been suggested that increased striatal 
dopaminergic activation may lead to perseveration (Clarke et al., 2011). In the 
marmoset, visual reversal learning is also impaired by amphetamine (Mason et al., 
1992) and by the D3R agonist 7-OH-DPAT (Smith et al., 1999). In the rat, visuospatial 
reversal learning is impaired by the D2/3R agonist quinpirole (Boulougouris et al., 2009) 
as well as by amphetamine (Idris et al., 2005). In humans, DA-agonist treated but not 
unmedicated Parkinson patients show impaired performance in a probabilistic reversal 
learning task (Cools et al., 2001; Swainson et al., 2000). Using a similar probabilistic 
reversal task, increased DA-activity at D2R and D3R in the caudate nucleus, observed as 
an increase in methylphenidate induced [11C]-raclopride displacement, is negatively 
correlated with reversal performance (Clatworthy et al., 2009). Thus, it may be that the 
perseverative impairment of the 5-HT2CR mutant could be explained by elevated DA-
levels in the caudate nucleus.  
Interestingly, the elevated DA-signalling within the DStr of the 5-HT2CR KO 
mouse is paralleled by similar DA-elevations in schizophrenic patients (Bird et al., 
1979; Crow et al., 1979). Also, the potentiated striatal DA-release observed following 
amphetamine in schizophrenic patients is most strongly observed in the head of the 
caudate nucleus (Kegeles et al., 2006), where the 5-HT2CR KO mouse also shows potent 
glutamatergic supersensitivity (Rueter et al., 2000) 
 7.4.3	  General discussion 
 
Similar to the effects of SB242084 descibed in Chapter 6, the current chapter 
presents discrepant effects of 5-HT2CR KO on operant visuospatial and maze egocentric 
reversal learning, perseverance and learned non-reward. That the 5-HT2CR KO mouse 
both shows improved reversal performance in the former and increased perseveration in 
the latter is consistant with pharmacological data showing that both 5-HT2CR agonists 
and antagonists can attenuate (Graf et al., 2003; Tsaltas et al., 2005, 2009; Flaisher-
Grinberg et al., 2008) or augment (Njung'e et al., 1991; Egashira et al., 2011; Martin et 
al., 1998; Bos et al., 1997) compulsive behaviour. It may be that the discrepant finding 
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across the two tasks is related to the tasks tapping different brain systems and 
subpopulations of the 5-HT2CR.  
In this chapter, three potential abnormalities in the 5-HT2CR mutant which could 
affect discrimination and reversal learning performance have been discussed. The 5-
HT2CR KO mouse display glutamatergic pyramidal neuron supersensitivity within the 
OFC as well as glutamatergic striatal supersensitivity and elevated DA-levels in the 
caudate nucleus of the DStr. The 5-HT2CR KO mouse also shows reduced LTP-
induction in the medial perforant path of the dentate gyrus. These abnormalities could 
differentially contribute to the manipulations effect on learning in the two tasks. 
The first possibility is that both the facilitated operant reversal learning and 
perseverative maze impairment is related to altered activity in the OFC. Thus, increased 
activity in the OFC through glutamatergic pyramidal neuron supersensitivity could be 
beneficial in the operant task, which is dependent on the integrity of the OFC, but may 
cause an ‘overactivation’ in the maze task, which shows less dependence upon the OFC 
(see Chapter 5). This interpretation would be in accordance with previous findings from 
the 5-HTT KO rat. Similar to SB242084 treated and 5-HT2CR KO mice, the 5-HTT KO 
rat show improved reversal learning through decreased interference from learned non-
reward in a two-choice auditory go/no-go task (Nonkes et al., 2011). This suggestion 
would also be in agreement with work showing a positive correlation of OFC activation 
reversal performance (O’Doherty et al., 2001). 
The 5-HTT KO rat does however also show perseverative-like responding in a 
Pavlovian reinforcer devaluation paradigm, a deficit associated with a OFC-
overactivation as indicated by elevated subregion-specific cFos-activity (Nonkes et al., 
2010). OFC-hyperactivations have also been associated with psychopathologies 
showing reversal learning deficits, such as ADHD (Rubia et al., 2009), cocaine 
addiction (Bolla et al., 2003), major depression (Drevets et al., 1992), and OCD (Saxena 
et al., 1999; Swedo et al., 1989). Thus, the facilitated reversal learning as well as the 
increased perseveration could both be related to increased OFC-activity.  
A second possibility is that the egocentric maze task is more dependent on the 
DStr and DStr DA-signalling than the operant task. As the 5-HT2CR KO mouse show 
elevated DA-signalling within the DStr, and increased DA-levels in the caudate nucleus 
might be related to perseveration (Clarke et al. 2011; Clatworthy et al., 2009; Chou-
Green et al., 2003), the elevated DA-levels could account for the perseverative deficits 
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in the maze. This could also explain the egocentric-specific retardation of spatial 
discrimination learning of 5-HT2CR KO mice.  
Lastly, it has been suggested that the reduced LTP-formation in the dentate 
gyrus observed in 5-HT2CR KO mice produces an altered spatial search strategy in tasks 
of discrimination learning (Tecott et al., 1998). One possibility is that this abnormality 
causes increased use of allocentric cues, or an alternative decrease in the use of an 
egocentric response strategy. This would be in agreement with the facilitated and 
retarded learning, respectively, of the 5-HT2CR KO mouse in the operant and maze 
tasks. 
The idea that different subpopulations of 5-HT2CRs have different and opposing 
effects on discrimination and reversal learning, perseverance, and learned non-reward 
could be further investigated using subregion-specific infusions of SB242084. These 
ideas are discussed further in Chapter 9. 
In sum, the 5-HT2CR KO mouse displays facilitated operant visuospatial reversal 
learning through decreased interference from learned non-reward, but show 
perseverative and discrimination learning deficits in the egocentric maze task. These 
differences may relate to the tasks different loading upon glutamatergic- and 
dopaminergic-signalling in the OFC and striatum.  
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CHAPTER 8 
5-HT2C ANTAGONISM AND VISUAL REVERSAL LEARNING IN THE RAT 
 
 
8.1 INTRODUCTION 
 
Clinical tests of cognitive functioning in schizophrenia, including reversal 
learning, generally use visual cues and are computer-administered (Ceaser et al., 2008; 
Jazbec et al., 2007; Leeson et al., 2009; Murray et al., 2008; Pantelis et al., 1997, 1999, 
2004, 2009; Tyson et al., 2004). Prevalent preclinical assays are however often very 
different, which may result in the cost of lost predictive and construct validity and 
ultimately decreased translation between animal and human. One approach to increasing 
the validity of preclinical tasks could be to design and use assays closely resembling the 
neuropsychological tests used with human participants (Bussey et al., 2008).  
On this view, visual touch-screen tests have been developed for cognitive testing 
in the rodent, paralleling the computerised visual reversal tasks used with schizophrenic 
patients. In such procedures, computer graphic stimuli are presented on a touch-screen 
and infrared beams surrounding the screen detect nosepoke responses towards stimuli. 
Reversal learning protocols in this set-up are sensitive to PFC-lesioning in the mouse 
(Brigman et al., 2008; Graybeal et al., 2011) and rat (Bussey et al., 1997) and 
pharmacological and genetic manipulations elevating 5-HT signalling in the mouse 
(Brigman et al., 2010). 
Recently, a 3-stimulus serial discrimination, reversal learning, and attentional 
set-shifting protocol has been developed using the touch-screen apparatus and tested 
with rats treated with the 5-HT2CR antagonist SB242084, the 5-HR2CR agonist 
WAY163909, and the 5-HT2AR antagonist M100907 (Alsiö et al., 2011). The protocol 
originates from a procedure initially used to assess cocaine treated vervet monkeys in 
the Wisconsin Test Apparatus, and involves simultaneous discriminations between three 
separate visual stimuli (Jentsch et al., 2002; Lee et al., 2007). In an initial 
discrimination, one stimulus is designated as CS+ while two other stimuli are 
designated as CS-. Following reversal, the previous CS+ become a CS-, and one of the 
previous CS-‘s becomes the new CS+. The third stimulus remains as a CS- during both 
discrimination and reversal learning. Animals are exposed to several of these reversals, 
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and novel stimuli replace the previous stimuli at the beginning of each new 
discrimination. In this paradigm, 1 mg/kg of SB242084 increased the number of 
incorrect responses to criterion in both reversal learning and attentional set-shifting, 
while M100907 improved reversal learning by decreasing the number of incorrect 
responses to criterion in reversal two only. M100907 also improved attentional set-
shifting, while WAY163909 was without affect on any measure of learning (Alsiö et al., 
2011).  
It has been suggested that the simultaneous presentation of three stimuli have at 
least four added benefits over standard two-choice tasks. First, rats are prone to 
adopting spatial response strategies in visual tasks. These spatial biases could be 
reduced by rewarding repetitive responding towards a spatial location at 33% in a 3-
stimulus task, relative to 50% in a 2-stimulus task. Second, relative to a 2-stimulus task, 
a 3-stimulus task allows less of a possibility of problem solving through configural or 
non-discriminatory forms of learning. Third, a 3-stimulus task is more difficult than a 2-
stimulus task and therefore provides increased room for detection of pro-cognitive 
effects. Fourth, it makes analyses of response strategies based on perseveration and 
learned non-reward easier (Gilmour et al., 2012).  
Moreover, the touch-screen apparatus and visual dimension may also be superior 
to the spatial dimension for assessing reversal learning. When using nosepoke-holes, 
levers or mazes, animals are trained using the same stimuli that are used for testing. In 
the touch-screen apparatus, interference from training on testing is minimal as animals 
are trained using different stimuli from those used in later testing.  
The experiment in the current chapter investigated the effects of SB242084 on 
touch-screen visual reversal learning in the rat. Experiment 1 used a modified version of 
the 3-stimulus serial protocol developed by Alsiö et al. (2011) to assess rats treated with 
three doses of SB242084 (0.1, 0.5, and 1.0 mg/kg) in discrimination and reversal 
learning. Experiment 2 used a 2-stimulus task with one full reversal only in a protocol 
more closely resembling the operant procedure in this thesis as well as previous 
protocols where SB242084 has been found to improve reversal performance in the rat 
(Boulougouris et al., 2008; Boulougouris and Robbins, 2010).  
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8.2 METHOD 
 
8.2.1 Drug 
 
SB242084 (Eli Lilly, Indianapolis, IND, USA) was initially dissolved in PEG400 
(Fisher Scientific, Loughborough, UK) at 20% of the final required volume, which was 
then made up by 10% (w/v) hydroxypropyl-beta-cyclodextrin (Sigma-Aldrich, Poole, 
UK). Stock solution was aliquoted and frozen at -80°C in vials of quantities required for 
each test day. SB242084 was administered intraperitoneally (i.p.) at doses of 0.1, 0.5, 1.0 
mg/kg in a volume of 10 ml/kg 20 min prior to testing. 
 
8.2.2 Animals 
 
Experiment 1 and Experiment 2 used separate groups of 46 male Lister hooded 
rats (Harlan, UK). Animals were housed in groups of four within individually ventilated 
plastic cages containing sawdust with ad libitum access to water under a 12:12h light-
dark period (lights on: 07:00h). Animals were food deprived and their body-weights 
were maintained at about 85% of their free feeding weight. Feeding was done each day 
1h after testing. Animals were weighed each day of drug-administration, and all animals 
were weighed once weekly. The experiments were conducted in accordance with the 
UK Animals (Scientific Procedures) Act 1986. 
 
8.2.3 Apparatus 
 
The experiments used 16 operant chambers (Med Associates, Georgia, VT, 
USA; 30 cm × 39 cm × 29 cm) placed in sound-attenuating wooden boxes with fans for 
the purpose of ventilation and masking external noise. A central magazine connected to 
an external pellet dispenser delivering 45mg sucrose pellet (Sandown Scientific, 
Middlesex, UK). A houselight was located near the ceiling directly above the magazine. 
A tone-generator was placed near the ceiling in the farther end of the chamber next to 
the houselight. The opposite side of the chamber contained a touch-sensitive screen 
(IT150-IR, Craft Data Ltd, Chesham UK; 30 cm × 22.5 cm), which was covered with a 
3-hole (Experiment 1) or a 2-hole (Experiment 2) Perspex mask creating three or two 
response-windows (8 × 8 cm) through which the animals could respond. The response-
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windows were spaced 2.5 cm apart in the 2-hole mask and 1.5 cm apart in the 3-hole 
mask. Responses were detected by the breaking of infrared beams lining the screen and 
were associated with a computer-generated tone. Below the monitor (1.5 cm) was a 
protruding metal ‘shelf’ (30 cm × 5 cm). This shelf was attached by a hinge at 90° 
relative to the chamber, and could swing downwards at 90° but was counter-weighed to 
automatically return to its position. The shelf was intended to force animals to stop and 
rear-up towards the stimuli head first, and thereby facilitate attention towards the stimuli 
and decrease accidental choices. The schedules were programmed in and run by Ratos 
in-house software. Animals were observed using cameras located in the ceiling of each 
operant chamber. 
 
8.2.4 Procedure 
 
8.2.4.1 Experiment 1: 3-stimulus visual reversal learning 
 
Training stage 1. The training and testing was conducted in accordance with a 3-
stimuli reversal learning protocol from Cambridge University (Adam Mar). Animals 
initially received a single 45 min session of Pavlovian and instrumental training. The 
session began with the delivery of a 45mg sucrose pellet paired with a 1s tone and the 
onset of the magazine-light. The tone and onset of magazine-light were coupled with 
delivery of pellet reward throughout all phases of both experiments. The tone was 
longer and higher in frequency than the tone associated with a touch-screen response. 
Collection of pellet reward caused the magazine-light to turn off, and the presentation of 
a white square (6 cm × 6 cm) positioned 1 cm from the bottom of the screen in one of 
three response-windows. Across each bin of 15-trials, the white square was presented 
equal number of times in each response-window but the same response-window was 
never used for more than two consecutive trials. Touching the white-square caused the 
stimulus to disappear immediately, and led to pellet delivery coupled with the 1s tone 
and the onset of the magazine-light. If the animal failed to touch the white-square within 
30s, a pellet was delivered coupled with the 1s tone and the onset of the magazine-light, 
the white-square disappeared, and an omission was recorded. When the animal collected 
the pellet reward the magazine-light was extinguished and a new trial was initiated. 
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Training stage 2. As stage 1, a session began with the delivery of a pellet reward 
coupled with a 1s tone and the onset of the magazine-light. A nosepoke in the magazine 
turned the magazine-light off and caused the presentation of the white square one out of 
three response-windows position 2 cm from the bottom of the screen. Touching the 
stimulus resulted in pellet delivery, and a new trial started when the pellet reward was 
collected. The criterion was ≥ 100 correct responses in a single 45 min session.  
Training stage 3. A 5s ITI was now introduced. Collection of pellet reward 
caused the magazine light to turn off and the initiation of a 5s ITI when the chamber 
remained dark. When the ITI had elapsed, the magazine-light began flashing at a rate of 
1 Hz to distinguish it from the steady magazine-light associated with pellet delivery. A 
nosepoke in the magazine turned the flashing light off and initiated a new trial. The 
session ended after 45 min or 100 trials, and the criterion was 100 correct trials in 45 
min.  
Training stage 4. As stage 3, however, responses in unlit response-windows 
were now non-rewarded. If the animal touched an unlit response-window, the stimulus 
was immediately removed, the houselight was turned on for a 5s time-out, and an 
incorrect response was recorded. After the animal collected the pellet reward after a 
correct trial, or after the 5s time-out has elapsed following an incorrect trial, a 5s ITI 
was initiated when the chamber remained dark. After the ITI had elapsed, the magazine-
light began flashing at 1 Hz and new trial started when the animal nosepoked in the 
magazine. The session ended after 45 min or 100 trials, and criterion was ≥ 75 correct 
responses in a 45 min session. 
3-stimulus visual discrimination and reversal learning. After trial initiation, 
three different stimuli (one stimulus designated as CS+, and the other two stimuli 
designated as CS-‘s) were now presented in the three response-windows. The six 
possible spatial stimuli configurations occurred an equal number of times over every 30 
trials but never reoccurred for more than two consecutive trials. If the animal touched 
the CS+, all stimuli disappeared and a pellet reward was delivered. If the animal 
touched a CS-, the stimuli were removed, the houselight switched on during a 5s time-
out, and an incorrect response was recorded. After the animal collected the pellet reward 
after a correct trial, or after the 5s time-out had elapsed following an incorrect trial, a 5s 
ITI was initiated. After the ITI had elapsed, the magazine-light began flashing at 1 Hz 
and a new trial started when the animal nosepoked in the magazine. The session ended 
after 45 min or 100 correct trials. The criterion in this and all subsequent tests was ≥ 9 
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correct responses over 10 trials twice. Contrary to previous experiments in this thesis, 
the experiments in this chapter used a rolling trial-count for criterion. Thus, rather than 
following the completion of a 10-trial bin, a new chance of reaching criterion began as 
soon as an animal no longer could reach criterion over the next 10 trials.    
 
8.2.4.2 Experiment 2: 2-stimulus visual reversal learning 
 
In a second experiment the procedure was adapted to more closely parallel the 
protocols in this thesis and the protocol used by Boulougouris et al. (2007, 2008, 2009, 
2010). In the test phase, animals were required to respond at the stimuli within 10s and 
trials per session were limited to 100. A comparison of the different parameters in the 
two experiments is shown in Table 8.1. The training was done using a protocol of 
previous reversal tasks at Eli Lilly. The initial Pavlovian and instrumental training of 
Experiment 1 was omitted.  On the first day, animals were exposed to the apparatus for 
40 min in the dark with the fan on and the magazine loaded with pellets. Magazine 
training began on day 2. 
Training stage 1. A session began with the houselight and magazine-light on 
and the delivery of a pellet reward. Collection of pellet reward caused the magazine-
light to go off and the initiation of a 5s ITI. After the ITI, the magazine lit-up, coupled 
with a 0.5s tone and pellet reward. Collection of pellet reward initiated the 5s ITI. The 
touchscreen remain off throughout the session. Animals were given 50 trials, and the 
criterion was 50 correct responses in 50 min.  
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Training stage 2. The houselight was again kept on throughout the session. A 
trial began with the onset of the magazine-light. A nosepoked in the magazine turned 
the magazine-light off and lead to the appearance of two white squares in each of the 
two touch-screen response-windows. Touching a white-square stimulus caused 
immediate removal of the stimuli, delivery of pellet reward coupled with a 0.5s tone and 
the illumination of the magazine-light. Pellet collection caused the magazine-light to 
turn off and the beginning of a 5s ITI. The magazine-light was lit-up following the 5s 
ITI, and a nosepoke in the magazine initiated a new trial. The criterion was ≥ 40 correct 
responses for two consecutive days.  
Training stage 3. Now the houselight was turned off throughout the session and 
a single white-square stimulus was presented. The white-square was presented in one 
pseudorandom response-window, with the location across trials being generated by the 
software. Touching the white-square lead to delivery of pellet-reward, magazine-light 
turning on, and a 0.5s tone. Responses at in the blank second response-window were 
associated with a 5s time-out when the houselight was kept on. Animals received two 
days of training on this schedule.  
Training stage 4. Animals could now omit responses. Failure to respond on the 
touch-screen within 10s caused the immediate removal of the stimulus and the onset of 
a 5s ITI when the chamber was kept dark. After this ITI, the magazine was lit-up and a 
trial was initiated when the animal nosepoked in the magazine. Everything else was 
identical to the previous training stage. Animals received a further two days of training 
on this schedule. 
 Experiment 1 
3-stimulus serial reversal 
Experiment 2 
2-stimulus reversal 
Trials per session Unlimited 100 
Correct per session 100 100 
Incorrect per session Unlimited 100 
Omissions  NA > 10s 
Criterion 2 ×9 correct over 10 trials 
twice in one session 
2 ×9 correct over 10 trials 
twice in one session 
Table 8.1. Comparison of experimental parameters of Experiment 1 and Experiment 2 
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2-stimulus visual discrimination and reversal learning. After trial initiation, two 
stimuli (one stimulus designated as CS+, and one stimulus designated CS-) were 
presented in the two response-windows. The sequence of spatial stimuli configuration 
across trials were randomly generated by the software but remained identical across 
sessions. If the animal touched the CS+, all stimuli were removed and a pellet reward 
was delivered. If the animal touched the CS-, all stimuli were removed, the houselight 
was switched on for a 5s time-out and an incorrect response was recorded. If the animal 
failed to respond within 10s, the stimuli were removed, the 5s ITI was initiated, and an 
omission was recorded. After the animal nosepoked to collect the pellet reward after a 
correct trial, or after the 5s time-out had elapsed following an incorrect trial, a 5s ITI 
was initiated. After the ITI had elapsed, the magazine-light was turned on and a new 
trial started when the animal nosepoked in the magazine. The session ended after 45 
min or 100 trials. As in Experiment 1, the criterion was ≥ 9 correct responses over 10 
trials twice. When the criterion was reached, animals were challenged with a reversal on 
the next day.  
 
8.2.5 Experimental design and statistical analysis 
 
Experiment 1 used a serial design with new stimuli-triplets presented in each 
new discrimination phase (Fig. 8.1). The stimuli in each discrimination and reversal 
challenge were identical to the stimuli used by Alsiö et al. (2011). After completing an 
initial three-choice discrimination drug-free, animals were matched for trials to criterion 
and assigned to a drug dose (vehicle, 0.1, 0.5, or 1 mg/kg). Animals subsequently 
completed two more three-choice visual discriminations followed by reversals. Animals 
were dosed in reversal 1, reversal 2 and visual discrimination 3. Animals completed 
visual discrimination 1, visual discrimination 2, and reversal 3 drug-free.  
In Experiment 2, animals initially completed a two-choice discrimination drug-
free, and were subsequently matched for trials to criterion and assigned to a drug dose 
for reversal testing (vehicle, 0.1, 0.5, or 1 mg/kg). The stimuli used in Experiment 2 
were chosen as rats previously have been shown to have minimal spontaneous visual 
biases for this stimuli-pair (Bussey et al., 2008). 
The dependent variables for both experiments were trials to criterion, incorrect 
responses to criterion, correct responses to criterion, latency to respond towards the 
stimuli and latency for retrieval of pellet reward. In Experiment 1, incorrect responses 
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towards the previous CS+ were classified as perseverative errors, while incorrect 
responses toward the constant CS- were classified as learning errors. In the reversal 
phases of both Experiment 1 and Experiment 2, incorrect responses were further coded 
as early-errors and late-errors corresponding to before and after animals had reached 
random responding. Thus, in Experiment 1, early-errors were the number of incorrect 
responses made before achieving ≥ 3 correct responses over 10 trials twice. In 
Experiment 2, early-errors were the number of incorrect responses made before 
achieving ≥ 5 correct responses over 10 trials twice. Late-errors were errors made after 
reaching < 3 or < 5 correct responses over 10-trials twice in Experiment 1 and 
Experiment 2, respectively. Lastly, the proportion of responses in each response-
window and towards each visual stimuli in the first and last day of each visual 
discrimination were analysed for spatial and visual biases. The data for the three 
reversal phases of Experiment 1 were analysed by 3 (within-subjects: reversal phase) × 
4 (between-subjects: drug dose) mixed ANOVAs. The data for the third visual 
discrimination test in Experiment 1, and the reversal phase of Experiment 2, were 
analysed by one-way between-subjects ANOVAs with drug dose as the independent 
variable. Significant interactions were followed by LSD post-hoc comparisons. 
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Figure 8.1. The experimental procedures of the 3-stimulus serial 
reversal learning (A) and 2-stimulus reversal learning (B) 
experiments. The stimuli were of the same contingencies for each 
phase of the experiments for all animals.  
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8.3 RESULTS 
 
8.3.1 Experiment 1: SB242084 and 3-stimulus visual reversal learning 
 
SB242084 did not affect learning in a visual discrimination, but caused a general 
disruption of performance in the reversal phases. SB242084 decreased stimuli-response 
times, consistent with previous experiments in this thesis. The SB242084-induced 
impairment was associated increased trials, incorrect responses and correct responses to 
criterion. SB242084 also increased late-errors, but decreased early-errors. Moreover, no 
serial-reversal effects were observed, and SB242084 had dose dependent effects in 
reversal 2, but not in reversal 1. Animals previously dosed with SB242084 also showed 
reversal impairments in the drug-free third reversal, particularly animals previously 
treated by the highest 1 mg/kg dose of SB242084.  
There were no main effects of SB242084 when dosed in the third visual 
discrimination (trials: F3,29 = 0.8, p = ns, correct responses: F3,29 = 0.7, p = ns, incorrect 
responses: F3,29 = 0.8, p = ns, response latency: F3,29 = 2.3, p = ns, pellet latency: F3,29 = 
0.9, p = ns), and drug dose did not affect total days of testing (F3,29 = 0.8, p = ns).  
SB242084 did however disrupt performance in the reversal phases. There were 
significant main effects of reversal phase (F2,58 = 105.9, p < .0001) and dose (F3,29 = 5.2, 
p < .01) and a significant dose × reversal phase interaction (F6,58 = 2.7, p < .05) on trials 
to criterion (Fig. 8.2A). At 0.1 mg/kg, SB242084 increased trials to criterion in the first 
reversal only (p < .05). 0.5 mg/kg increased trials to criterion in the second reversal only 
(p < .05). 1 mg/kg increased trials to criterion in all reversals, including the drug-free 
third reversal (p ≤ .012).  
Similarly, there were significant main effects of reversal phase (F2,58 = 90.1, p < 
.0001) and dose (F3,29 = 5.2, p < .01) and a significant dose × reversal phase interaction 
(F6,58 = 2.3, p < .05) on correct responses to criterion (Fig. 8.2B). 0.1 mg/kg of 
SB242084 had no effects on correct responses to criterion. 0.5 mg/kg increased correct 
responses to criterion in the second reversal only (p < .05). 1.0 mg/kg increased correct 
responses to criterion in all reversals, including the drug-free third reversal  (p ≤ .017).  
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Figure 8.2. Effect of SB242084 on trials, correct, and incorrect responses to criterion in 3-
stimulus serial touch-screen visual reversal learning in the rat. Asterisks denote significant 
difference from vehicle (*p < .05, **p < .01). (A) Trials to criterion. Main effects of 
reversal phase (F2,58 = 105.9, p < .0001) and dose (F3,29 = 5.2, p = .004) and dose × reversal 
phase interaction (F6,58 = 2.7, p = .02). (B) Correct responses. Main effects of reversal 
phase (F2,58 = 90.1, p < .0001) and dose (F3,29 = 5.2, p = .005) and dose × reversal phase 
interaction (F6,58 = 2.3, p = .046). (C) Incorrect responses. Main effects of reversal phase 
(F2,58 = 117.3, p < .0001) and dose (F3,29 = 5.6, p = .004) and dose × reversal phase 
interaction (F6,58 = 3.0, p = .013). 
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Figure 8.3.  Effect of SB242084 on learning errors and perseverative errors to criterion in 3-
stimulus serial touch-screen visual reversal learning in the rat. Asterisks denote significant 
difference from vehicle (*p < .05, **p < .01). (A) Learning errors. Main effect of reversal phase 
(F2,58 = 93.3, p < .0001) and dose × reversal phase interaction (F6,58 = 3.9, p = .002). (B) 
Perseverative errors. Main effects of reversal phase (F2,58 = 153.1, p < .0001) and dose (F3,29 = 
4.1, p = .015) and a significant dose × reversal phase interaction (F6,58 = 3.0, p = .014). 
Figure 8.4. Effect of SB242084 on early-errors and late-errors in 3-stimulus serial touch-screen 
visual reversal learning in the rat. Errors made before achieving ≥ 3 correct responses over 10 
trials twice were coded as early-errors, and errors made after achieving < 3 correct responses 
over 10 trials twice were coded as late-errors. Asterisks denote significant difference from 
vehicle (*p < .05, **p < .01). (A) Early errors. Significant reversal phase (F2,58 = 31.4, p < 
.0001) and dose × reversal phase interaction (F6,58 = 3.5, p = .005). (B) Late errors. Significant 
reversal phase (F2,58 = 120.4, p < .0001) dose (F3,29 = 6.0, p = .003) and dose × reversal phase 
interaction (F6,58 = 2.9, p = .015). 
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There were also significant main effects of reversal phase (F2,58 = 117.3, p < 
.0001) and dose (F3,29 = 5.6, p < .01) and a significant dose × reversal phase interaction 
(F6,58 = 3.0, p < .05) on incorrect responses to criterion (Fig. 8.2C). 0.1 mg/kg of 
SB242084 increased incorrect responses in the first reversal only (p < .05). 0.5 mg/kg 
increased incorrect responses in the second reversal only (p < .05). 1 mg/kg of 
SB242084 increased incorrect responses to criterion in all reversals, including the drug-
free third reversal  (p ≤ .024).  
On learning errors to criterion (Fig. 8.3A), there was a significant main effect of 
reversal phase (F2,58 = 93.3, p < .0001) and a significant dose × reversal phase 
interaction (F6,58 = 3.9, p < .01). 0.1 mg/kg of SB242084 increased learning errors to 
criterion in the first reversal only (p < .01). 0.5 mg/kg increased learning errors to 
criterion in the first and second reversals (p < .05). Similarly, 1.0 mg/kg increased 
learning errors in the first (p < .05) and second (p < .01) reversals. There were no effect 
of SB242084 on learning errors to criterion in the drug-free third reversal.  
On perseverative errors to criterion (Fig. 8.3B), there were significant main 
effects of reversal phase (F2,58 = 153.1, p < .0001) and dose (F3,29 = 4.1, p < .05) and a 
significant dose × reversal phase interaction (F6,58 = 3.0, p < .05). SB242084 failed to 
affect perseverative errors to criterion in the first reversal. 0.1 mg/kg of SB242084 
increased perseverative error in the third drug-free reversal only (p < .05). 0.5 mg/kg 
increased perseverative errors in the second reversal only (p < .05). 1 mg/kg increased 
perseverative errors in the second reversal (p < .01) as well as the drug-free third 
reversal (p < .01).  
Next, incorrect response before (early-errors) and after (late-errors) achieving 
random responding was analysed for the three reversals. SB242084 decreased the 
number of early-errors, but increased the number of late-errors. For early-errors (Fig. 
8.4A), there was a significant main effect of reversal phase (F2,58 = 31.4, p < .0001) and 
dose × reversal phase interaction (F6,58 = 3.5, p < .01). In reversal one, SB242084 
decreased the number of early errors at 0.1 mg/kg (p < .05) and at 1 mg/kg (p < .01). 0.5 
mg/kg decreased early-errors in the drug-free reversal three only (p < .05). For late-
errors (Fig. 8.4B), there was significant main effects of reversal phase (F2,58 = 120.4, p < 
.0001) and dose (F3,29 = 6.0, p < .01) and a dose × reversal phase interaction (F6,58 = 2.9, 
p < . 05). 0.1 mg/kg of SB242084 increased late-errors in the first reversal only (p = 
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.01). 0.5 mg/kg increased late-errors in the second reversal only (p < .05). 1 mg/kg 
increased late-errors in all three reversals (p ≤ .025).  
There was also a significant main effect of reversal phase (F2,58 = 3.6, p < .05) 
and a significant dose × reversal phase interaction (F6,58 = 5.2, p < .0001) on stimuli 
response latencies (Fig. 8.5A). 0.1 mg/kg and 0.5 mg/kg of SB242084 decreased 
response latencies in the second reversal (p < .05). 1 mg/kg of SB242084 decreased 
response-latencies in the first and second reversals (p < .05). There were no effects of 
dose in the third drug-free reversal. SB242084 failed to affect pellet retrieval latencies 
(Fig. 8.5B; p ≥ .24). 
Animals previously treated with SB242084 were impaired in the drug-free third 
reversal, and the impairment was most apparent in animals previously treated with 1 
mg/kg. This deficit was further explored through a separate one-way ANOVA using 
performance when dosed in the third visual discrimination as a covariate. Prior 
discrimination performance could not account for this reversal deficit, with the 1 mg/kg 
group still showing a significant increase in trials (p < .05) and correct responses to 
criterion (p < .05). However, the effect on incorrect responses to criterion fell just above 
significance (p = .07). 
 
 
 
Figure 8.5. Effect of SB242084 on stimuli response and pellet retrieval latencies in the 3-
stimulus serial touch-screen visual reversal learning task in the rat. Asterisks denote significant 
difference from vehicle (*p < .05, **p < .01). (A) Stimuli response latencies. Main effect of 
reversal phase (F2,58 = 3.6 p = .034) and significant dose × reversal phase interaction (F6,58 = 
5.2 p < .0001). (B) Pellet retrieval latencies. No effect of dose or dose × reversal phase 
interaction (p ≥ .24). 
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8.3.2 Experiment 2: SB242084 and 2-stimulus visual reversal learning 
 
In a similar way to its effect to its effect in the 3-stimulus experiment, 
SB242084 also impaired 2-stimulus reversal learning. The impairment was associated 
with increased trials, correct responses, and late-errors to criterion, as well as decreased 
early-errors and decreased stimuli response and pellet retrieval latencies. 
On trials to criterion, there was no overall effect of dose (Fig. 8.6A; F3,42 = 2.4, p 
= ns) but a significant dose linear effect (F1,42 = 7.1, p = .01) with trials to criterion 
increasing with increasing dose. On correct responses to criterion (Fig. 8.6B), there was 
a significant effects of dose (F3,42 = 3.4, p < .05) as well as a significant dose linear 
effect (F1,42 = 10.1, p < .01). Only 1.0 mg/kg of SB242084 increased the number of 
correct responses to criterion relative to vehicle treated controls (p < .05). There were 
no effects of SB242084 on incorrect responses to criterion (Fig. 6C; F3,42 = 0.1, p = ns) 
or omissions to criterion (Fig. 6D; F3,42 = 0.9, p = ns).  
On early-errors (Fig. 8.6E), there was no effect of dose (F3,42 = 2.2, p = ns) but a 
significant dose linear effect (F1,42 = 5.8, p < .05), with early-errors decreasing with 
increasing dose. On late-errors (Fig. 8.6F), there was a significant effect of dose (F3,42 = 
2.9, p < .05) as well as a dose linear effect (F1,42 = 8.1, p < .01). 0.5 mg/kg and 1 mg/kg 
of SB242084 increased the number of late-errors relative to vehicle-treated controls (p < 
.05).  
There was also a significant main effect of dose on stimuli response latencies 
(Fig. 8.6G; F3,42 = 5.7, p < .01), with all doses decreasing the time taken to respond (p ≤ 
.01). There was also a significant effect of dose on pellet retrieval latencies (Fig. 8.6H; 
F3,42 = 3.8 p < .05), with 0.5 mg/kg (p < .05) and 1 mg/kg (p < .01) of SB242084 
decreasing the time taken for collection of pellet reward. 
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Figure 8.6. Effect of SB242084 on 2-choice touch-screen visual reversal learning in 
the rat. Asterisks denote significant difference from vehicle (* p < .05, ** p < .01) 
Broken line represents mean performance in the visual discrimination phase. (A) 
Trials to criterion. No effect of dose (F3,42 = 2.4, p = .079) but a significant dose 
linear effect (F1,42 = 7.1, p = .01). (B) Correct responses. Significant dose (F3,42 = 3.4, 
p = .03) and dose linear effects (F1,42 = 10.1, p = .003). (C) Incorrect responses. No 
dose (F3,42 = 0.1, p = .95) or dose linear effects (F1,42 = 0.2, p = .66). (D) Omissions. 
No dose (F3,42 = 0.9, p = .45) or dose linear effects (F1,42 = 2.0, p = .16). (E) Early-
errors. No effect of dose (F3,42 = 2.2, p = .10) but a significant dose linear effect (F1,42 
= 5.8, p = .02). (F) Late-errors. Significant dose (F3,42 = 2.9, p = .045) and dose linear 
effects (F1,42 = 8.1, p = .007).  (G) Stimuli response latencies. Significant effect of 
dose (F3,42 = 5.7, p  = .002). (H) Pellet retrieval latencies. Significant effect of dose 
(F3,42 = 3.8, p = .016). 
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8.3.3 Spatial and visual biases 
 
In Experiment 1, animals showed a consistent spatial bias towards the central 
response-window throughout the three visual discriminations (Table 8.2). In visual 
discrimination 1, animals had an initial bias to respond towards the incorrect Helicopter 
stimulus. In visual discrimination 2 and 3, animals had biases for the correct Key and 
Arrow stimuli, respectively. Relative to Experiment 1, animals in Experiment 2 had 
limited or no overall spatial or visual biases (Table 8.3). 
 
 
 
 Visual discrimination 1 
 Left Centre Right 
First day 31% 55% 13% 
Last day 29% 48% 22% 
 Boat Shoe Helicopter 
First day 27% 21% 41% 
Last day 29% 59% 11% 
 Visual discrimination 2 
 Left Centre Right 
First day 20% 57% 23% 
Last day 28% 42% 24% 
 Flower Key Goblet 
First day 35% 41% 24% 
Last day 28% 56% 10% 
 Visual discrimination 3 
 Left Centre Right 
First day 33% 43% 23% 
Last day 35% 42% 23% 
 Bike Arrow Zebra 
First day 35% 54% 11% 
Last day 30% 60% 10% 
Table 8.2. Spatial and visual biases on the first and last day of visual discrimination 1 
to 3 in Experiment 1. The correct stimulus is shown in the central column (bias > 33%). 
 
Bold denote significant biases (p <. 01) 
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8.4 DISCUSSION 
 
Using the visual touch-screen procedure, SB242084 was found to impair 
performance in both 3-stimulus serial reversal learning and 2-stimulus reversal learning 
in the rat. These deficits were expressed as increased trials, correct and incorrect 
responses to criterion. SB242084 decreased early-errors to criterion, but increased late-
errors to criterion, as well as inducing faster response latencies and pellet retrieval 
times. Together, this suggests that SB242084 impairs performance by elevating motor 
impulsivity. It may be that the touch-screen apparatus has a greater sensitivity to 
manipulations of impulsivity than other protocols used in this thesis.  
 
8.4.1 3-stimulus and 2-stimulus visual reversal learning 
 
The 3-stimulus reversal task has been suggested to have four added benefits over 
traditional 2-stimulus tasks. First, as rodents are prone to adopting spatial response 
strategies when challenged with visual discriminations, adding a third stimulus could 
attenuate spatial biases by lowering reinforcement rates for repetitive responding 
towards a specific spatial location (Gilmour et al., 2012). Thus, spatially biased 
responding is rewarded at 50% in a 2-stimulus task, but only at 33% in the 3-stimulus 
 Visual discrimination 1 
 Left 
45% 
43% 
Right 
55% 
57% 
First day 
Last day 
 Plane Spider 
First day 53% 
70% 
47% 
30% Last day 
Table 8.3. Spatial and visual biases on the first and last day of the visual 
discrimination in Experiment 2. The correct stimulus was the plane (bias > 50%) 
 
Bold denote significant biases (p <. 05) 
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task. Converse to this prediction, greater spatial biases were observed in the 3-stimulus 
task (Table 8.2) than in the 2-stimulus task (Table 8.3). One potential explanation is that 
spatial biases are more readily determined by task difficulty than spatial reinforcement 
rates. Thus, with increasing task demands, animals revert to the use of spatial response 
strategies. A further possible method for decreasing reinforcement rates for spatial 
biases without using a third stimulus would be to use two stimuli randomly appearing in 
two of three available response-windows.  
Next, a 3-stimulus task should allow less of a possibility of adopting configural 
or non-discriminatory response strategies. It is difficult to interpret if animals in the 3-
stimulus task use less configural approaches than animals in the 2-stimulus task. 
However, the stimuli biases in Tables 8.2 and 8.3, would suggest that non-
discrimination based responding may be present in the 3-stimulus task. Animals show 
high and low responding towards the non-rewarded Helicopter stimulus on the first and 
last day, respectively, of visual discrimination 1. In the same discrimination, responses 
towards the second non-rewarded Shoe stimulus are largely unaffected between the first 
and last day. This suggests that animals primarily learn to avoid the Helicopter stimulus, 
and that animals may reach criterion by other strategies than discriminating between the 
three stimuli.  
In visual discriminations 2 and 3 of Experiment 1, rats directed most responses 
towards two of the three available stimuli, effectively making these discriminations 2-
choice rather than 3-choice (Table 8.2). Following trial initiation, animals either quickly 
turn to the right, placing their paws on the shelf between the central and left visual 
stimuli, or quickly turn to the left placing their paws on the shelf between the central 
and right visual stimuli. Discrimination learning therefore often involves only two of 
the three available response-windows, and two of the three visual stimuli, as animals 
seldom stretch out to view the third distant response-window and stimuli.  
This is also the likely cause of the low numbers of early-errors in in the second 
and third reversals of Experiment 1 (Figure 8.4). As animals respond towards two of the 
three stimuli, one of which is rewarded, they quickly reach a level of random 
responding. In order to avoid stimuli biases in the 3-stimulus task, further studies 
investigating stimuli-triplets that are equally discriminable are required, as previously 
has been done with stimuli-pairs (Bussey et al., 2008). 
Moreover, it has been suggested that the 3-stimulus task adds task difficulty with 
the benefit of increased room for detection of compounds cognitive enhancing effects. 
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The current results suggest that this is dependent on the stimuli presented. As the correct 
Helicopter stimulus in the first reversal of the 3-stimulus task is the most easily 
discriminated, the difficulty of this reversal do not differ greatly from the difficulty of 
the reversal in the 2-stimulus task. However, the second reversal is more difficult, 
presumably as the correct Flower stimulus is difficult to discriminate from the incorrect 
Key stimulus, as well as a possible bias for responding towards the incorrect Key 
stimulus. Again, work is required to determine triplets of stimuli that are equally 
discriminable. Of further note is that added task difficulty has effects beyond leaving 
room for cognitive improvement, as it also can alter the functional role of brain-regions 
involved in reversal learning, such as the OFC (McDonald et al., 2007; Kim and 
Ragozzino et al., 2005).  
Lastly, the primary reason for using three rather than two stimuli is that it should 
give a better discernment of stimulus perseveration versus stimulus avoidance (Gilmour 
et al. 2012). However, as both previously non-rewarded but now rewarded, previously 
rewarded but now non-rewarded, and stimuli remaining non-rewarded, are presented 
simultaneously within each trial, there are few indications of responses being guided by 
stimuli avoidance versus stimuli approach strategies.  
It should be noted that others have suggested that responses towards the third 
consistently non-rewarded stimulus provides a control for random responses that would 
normally occur during a search for an alternative response strategy, while responses 
towards the previously rewarded but now non-rewarded stimulus are strictly 
perseverative (Lee et al., 2007). In view of this, adding a third stimulus gives a better 
measure of perseverative responding with little consideration of learned non-reward. 
Nevertheless, as three stimuli of previously acquired contingencies are presented 
simultaneously, any one of them may still guide stimulus response selection. 
The touch-screen visual dimension has previously been used to assess 
perseverance and learned non-reward by replacing the previously correct or incorrect 
stimuli across reversal trials in the marmoset (Clarke et al., 2007). It may be that this 
approach is superior to the 3-stimuli simultaneous procedure used in the current chapter 
for testing perseverance and learned non-reward. The protocol used by Clarke et al. 
(2007) to test perseverance and learned non-reward in the visual dimension also carries 
an advantage over the spatial dimension. In the spatial dimension, stimuli occur on a 
continuum. For example, the left nosepoke-hole is only left in relation to the right 
nosepoke-hole. This is not relevant in the touch-screen apparatus when visual stimuli 
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are used.   
8.4.2 Effect of SB242084 on visual reversal learning in the rat 
SB242084 did not affect performance when administered in the visual 
discrimination phase of Experiment 1 but impaired the performance in the reversal 
phases of both experiments. The lack of effect in the third visual discrimination may be 
related to stimuli biases. As animals show a bias towards the correct Arrow stimulus in 
the third visual discrimination, the few trials required to reach criterion may mask any 
effects of SB242084.  
SB242084 impaired most indices of learning in the reversal phases, including 
trials to criterion, incorrect responses to criterion and correct responses to criterion. In 
the 3-stimulus task, SB242084 increased both perseverative and learning errors to 
criterion, and these impairments were associated with faster response times and pellet 
collection latencies. SB242084 treated animals also made fewer early-errors, but more 
late-errors. This suggests that SB242084 induces random responding within these tasks. 
It also indicates that the SB242084-induced impairment not primarily relates to deficits 
in overcoming previous associations of reward or non-reward, but is rather a product of 
impulsive responding.  
In the 5-CSRTT, SB242084 causes elevated motor impulsivity observed as 
increased premature responding in both rats and mice. Doses of 0.1 mg/kg and 0.5 
mg/kg increase premature responses and decrease correct response latencies 
(Winstanley et al., 2004) as well as decreasing omissions and reward retrieval latencies 
in the rat (Fletcher et al., 2007; Higgins et al., 2003). Although the effects are more 
modest in the mouse, 0.3 mg/kg of SB242084 increase premature responses at longer 
ITIs (Fletcher et al., 2007). These effects are believed to be related to the facilitating 
effects of SB242084 on mesoaccumbal DA-signalling (Fletcher et al., 2007).  
It is not however not clear if an SB242084-induced elevation of motor impulsivity can 
be dissociated from an SB242084-induced elevation in activity. Premature responses in 
the 5-CSRTT are always coupled with decreased response latencies and/or pellet 
retrieval latencies (Winstanley et al., 2004; Higgins et al., 2003; Fletcher et al., 2009). 
Moreover, SB242084 has dose-dependent effects on activity levels that overlap and 
match the dose-dependent effects of SB242084 on impulsive responding in the 5-
CSRTT (Fletcher et al., 2009). Also, both the SB242084-incuded elevation of 
impulsivity and the SB242084-induced hyperactivity are believed to be caused by the 
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increased DA-levels in the NAc.  
The touch-screen procedure may have a greater sensitivity to manipulations of 
impulsivity than other procedures in this thesis. After trial initiation in the touch-screen 
procedure, rats quickly turn around and rear by placing their paws on the shelf with 
their noses approximately 1-2 cm from the screen. Correct responses are typically 
preceded by side-to-side head movements as animals scan stimuli repeatedly before 
making a response. In relation to the size of the animals, the rat touch-screen chambers 
are smaller than the mouse nosepoke-hole chambers, and animals make faster responses 
in the visual touch-screen task (≈ 3s) compared to the visuospatial nosepoke-hole task 
(≈ 5s). It is possible that the visual procedure has a greater sensitivity to manipulations 
of accumbal dopaminergic levels and impulsivity, which would mask any effects of 
SB242084 on prefrontally mediated executive functioning and reversal learning.
 Interestingly, animals previously treated with SB242084 showed altered 
performance in the third drug-free reversal phase of Experiment 1. Here, animals 
previously treated with the highest 1 mg/kg dose showed increased trials, correct, 
incorrect, perseverative errors and late-errors to criterion, while 0.1 mg/kg increased 
perseverative errors only. 0.5 mg/kg on the other hand, significantly decreased early-
errors compared to vehicle treated controls. The effects on trials and correct responses 
to criterion were independent of the performance when dosed in the preceding third 
visual discrimination. The deficits were not paralleled by decreased response latencies 
or pellet retrieval latencies. Furthermore, these deficits were selective to perseverative-
errors and late-errors, without effect on early-errors and learning-errors to criterion. 
This would suggest that the impaired performance in the third reversal not primarily 
relate to increased impulsivity. 
Prior to the last drug-free reversal test, animals had received a mean 23 (± 0.9) 
drug treatments. These effects may therefore relate to subchronic treatments with 
SB242084. As yet, there are no studies of subchronic or chronic treatments with 5-
HT2CR selective compounds and cognition or 5-HT2CR expression. In the rat, 
subchronic treatment with the non-selective 5-HT2CR antagonist clozapine has no effect 
on whole brain or PFC levels of 5-HT2CR mRNA in the rat (Buckland et al., 1997), 
although 30-50% decreases in 5-HT2CR mRNA or 5-HT2CR binding in the 
hippocampus, cerebellum, cortex (Buckland et al., 1997) and choroid plexus (Hietala et 
al., 1992; Kuoppamäki et al., 1993, 1994) have been observed. Behaviourally, chronic 
treatment with the non-selective 5-HT2CR citalopram (Pälvimäki et al., 1996) has 
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facilitating effects on probabilistic lever reversal learning in the rat, opposite to the 
effect observed here (Bari et al., 2010). Also, chronic treatments with the non-selective 
5-HT2CR  antagonist fluoxetine (Pälvimäki et al., 1996) decreases early-errors to 
criterion in a 2-stimulus visual touch-screen reversal task in the mouse, which is in 
accordance with the current effects of SB242084. However, performance in the late-
phase of the experiment was unaffected (Brigman et al., 2010). Thus, although no 
studies have investigated the effect of 5-HT2CR selective compounds on cognition and 
5-HT2CR functioning, chronic treatment with non-selective 5-HT2CR antagonists can 
affect 5-HT2CR expression and reversal performance. 
It should be noted that the 5-HT2CR also appears to be involved in LTP-
formation within visual cortex. 5-HT promotes LTP-formation in areas of high 5-HT2CR 
expression of the rat visual cortex (Kojic et al., 2000), while the 5-HT2A/2CR antagonist 
ketanserin and the 5-HT2CR antagonist mesulergine block LTP-induction in visual 
cortical slices of the rat (Komatsu, 1996; Kojic et al., 1997). These effects could 
potentially influence the performance in the current tasks. 
Lastly, a primary advantage of the touch-screen apparatus has been suggested to 
be its face validity in relation to clinical tasks (Bussey et al., 2008, 2011). However, as 
opposed to human subjects, visual response strategies are not prepotent in the rodent. 
The prepotent visual strategy used by human subject is paralleled by prepotent spatial 
response strategies in the rodent. This is supported by the relatively high number of 
trials required to reach criterion in the current tasks compared to other tasks in this 
thesis. It may therefore be that the increased face validity of the touch-screen apparatus 
come at a cost of decreased predictive and construct validity.  
To sum up, SB242084 impairs 3-stimulus and 2-stimulus touch-screen reversal 
learning in the rat. These deficits may be related to increased motor impulsivity. More 
work is required to determine stimuli-triplets which are equally and readily 
discriminable. It has been suggested that the 3-stimulus task give indications of 
response strategies based on perseverance and learned non-reward (Gilmour et al., 
2012). However, a better method may be to replace previously correct or incorrect 
stimuli across reversal trials, an approach previously used in the marmoset (Clarke et 
al., 2007).  
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CHAPTER 9 
DISCUSSION AND CONCLUSIONS 
 
 
9.1 INTRODUCTION 
 
In Chapter 1, two main aims of the experiments presented in this thesis were stated:  
 
(3) Develop assays for investigating reversal learning, perseverance and learned 
non-reward in the mouse. 
 
(4) Use these tasks to assess the cognitive mechanisms for altered performance after 
manipulations to brain systems recognised to be involved in reversal learning 
and relevant for human psychopathology, with a specific focus on 
schizophrenia.  
 
The purpose of this chapter is to review the results presented in Chapter 4-8 of 
this thesis and discuss the implications of these results for the issues raised in Chapter 1. 
It will also discuss the implications of the results for understanding reversal learning, its 
clinical relevance, the limitations of the paradigms used in this thesis, as well as future 
directions for using reversal learning as a measure of cognitive flexibility in the rodent. 
 
9.2 REVERSAL LEARNING, PERSEVERANCE AND LEARNED NON-REWARD  
As described in Chapter 1, interpretations of the data obtained in reversal 
paradigms often assume that appetitive, previously rewarded, associations have 
exclusive control over response behaviour in tasks of cognitive flexibility. Previous 
work, however, suggests that non-reinforced associations also have a prominent role in 
discrimination and reversal paradigms. In this thesis, I have developed paradigms for 
assessing reversal learning, perseverance and learned non-reward in the mouse. The 
data presented from these paradigms support the idea that learned non-reward can have 
a strong influence on reversal learning in the mouse (see Table 9.1 for a summary of the 
experimental results in this thesis). In Chapter 4, NMDAr antagonism through acute 
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PCP induced a reversal learning impairment in the maze task. This impairment was 
associated with decreased ability to overcome both learned non-reward and 
perseverance. In Chapter 6, prior administration of the selective 5-HT2CR antagonist 
SB242084 facilitated reversal learning in the operant task, and this facilitation was 
associated with a selective increase in the ability to overcome the effects of learned non-
reward. In the maze task, SB242084 decreased perseverance but increased learned non-
reward, perhaps therefore explaining the lack of observable effects on the full reversal 
learning. In Chapter 7, 5-HT2CR KO mice showed improved reversal learning in the 
operant task, an improvement associated with a selective facilitation in the ability to 
overcome learned non-reward.  
It is therefore likely that reversal learning in these procedures is sensitive to 
manipulations that influence either the ability to overcome previously established 
reinforced or well as non-reinforced associations, or a mixture of these two effects. 
 
 
 
 
 
 
 Acute 
PCP 
OFC 
lesion 
mPFC 
lesion 
5-HT2CR 
KO 
5-HT2CR 
antagonist 
Operant visuospatial reversal learning      
Discrimination n/a n/a n/a No effect n/a 
Full reversal No effect Impaired Impaired Improved Improved 
Perseveration No effect Impaired Impaired No effect No effect 
Non-reward No effect Impaired Impaired Improved Improved 
      
Maze egocentric reversal learning      
Discrimination n/a n/aΨ n/a Impaired n/a 
Full reversal Impaired No effect n/aϕ No effect No effect 
Perseveration Impaired No effect n/a Impaired Improved 
Non-reward Impaired No effect n/a No effect Impaired 
      
Operant visual reversal learning      
Discrimination n/a n/a n/a n/a No effect 
Full reversal n/a n/a n/a n/a Impaired 
Table 9.1. Summary of the experimental results presented in chapters 4-8.  
Ψ = OFC-lesioning retarded retention of a two-choice discrimination acquired pre-surgery.  ϕ = Animals with lesions 
extending both the mPFC  and OFC displayed a transient impairment. n/a = not tested. 
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9.3 VISUOSPATIAL, EGOCENTRIC SPATIAL, AND VISUAL REVERSAL 
LEARNING 
 
A common assertion is that reversal learning shows pronounced homology of 
functional neuroanatomy, pharmacology and transmitter systems across species and test 
paradigms (Bissonette and Powell, 2012; Keeler and Robbins, 2011). This position is 
challenged by the experiments reported in this thesis. The detailed pattern of effects 
failed to translate between the operant visuospatial, maze egocentric, and operant visual 
assays. In Chapter 4, PCP retarded maze egocentric reversal learning but had no effect 
on operant visuospatial reversal learning. In Chapter 5, OFC-lesions led to impaired 
visuospatial operant reversal learning but had no effect on egocentric maze reversal 
learning. In Chapters 6 and 8, SB242084 facilitated operant visuospatial reversal 
learning, failed to effect maze egocentric reversal learning, and impaired touch-screen 
visual reversal learning. In Chapter 7, 5-HT2CR KO mice showed improved operant 
visuospatial reversal learning but did not differ from control animals in the full reversal 
test of the egocentric maze task, paralleling the results of studies in Chapter 6. 
Relatively few studies have used mice in reversal learning, with fewer protocols 
using mice within the spatial dimension and fewer still using egocentric tasks. As 
discussed in the empirical chapters, the discrepant effects observed across the 
egocentric, visuospatial and visual tasks are nevertheless in accordance with the 
relatively common and diverse reports of dimension-specific olfactory, visual, and 
visuospatial reversal learning effects following manipulations of serotonergic, prefrontal 
and glutamatergic-systems in the rat and primate. Different protocols and sensory 
dimensions are likely to be sensitive to manipulations of different brain regions and 
transmitter systems in different species, which on a behavioural level may produce 
different effects on components relevant for successful reversal learning, including 
perseverance, learned non-reward, impulsivity and motor functioning. 
 
9.4 PREVALENT METHODS FOR ASSESSING PERSEVERATIVE RESPONSE 
TENDENCIES  
 
A common method for measuring tendencies of a perseverative response 
strategy is to analyse ‘early-errors’ and ‘late-errors’. Early-errors are though to 
represent incorrect responses made while responding is still biased towards the previous 
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CS+. It is believed that the number of incorrect responses made during this phase 
reflects the stability of the CS-US association, or perseveration. Incorrect responses 
made when responding no longer is biased towards the previous CS+, or late-errors, are 
considered to reflect general cognitive abilities related to attention and the acquisition of 
an alternative CS-US association. Although never made explicit, it may also be that 
late-errors are believed to involve learned non-reward. Hence, the prevalent view is that 
early-errors measures perseveration while late-errors are unrelated to perseveration.  
Experiments reported in this thesis show that late-errors can be prominent in a 
perseverance test, while early-errors can be a feature of a leaned non-reward test. In 
Chapter 4, PCP increased the number of early-errors to criterion in both the learned 
non-reward and perseverance tests of the maze task. However in Chapter 5, OFC lesions 
induced a perseverative reversal impairment by increasing the number of late-errors to 
criterion in the operant task. This could either be due to the perseverance and learned 
non-reward tests lacking in construct validity, or that early-errors and late-errors fail to 
measure perseverance and learned non-reward.  
In experiments cited in this thesis, early-errors and late-errors had been analysed 
in full reversal only, where previously correct and incorrect CSs are presented 
simultaneously across reversal trials. It is therefore plausible that both previously 
excitatory and inhibitory conditioning influences choice-behaviour in both early and 
late phases of learning. The paradigms developed in this thesis add to these protocols by 
analysing early-errors and late-errors in tests where the previously correct or incorrect 
CS is paired with novel stimulus.  
If a manipulation affects late-errors in one of the tests where novelty is a feature, 
as well as in a full reversal test which lack novel stimuli, a fitting interpretation would 
be that the effects on late-errors are related to shared features of these tests and 
unrelated to test differences. In Chapter 5, OFC-lesioning increased late-errors to 
criterion in both the perseverance and full reversal tests. The effect on late-errors is 
therefore most likely related to perseverance and unrelated to novelty. In Chapter 4, 
acute PCP caused a non-condition dependant increase in the number of early-errors. The 
increase in early-errors is therefore most likely related to both perseverance and learned 
non-reward and unrelated to novelty.  
These results suggest that early-errors and late-errors may not be good measures 
of the ability to overcome previous associations of reward or non-reward. However, 
early-errors and late-errors have other values, unrelated to perseveration and learned 
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non-reward. For example, matching patterns of responding during early and late phases 
of learning in two different reversal tasks may still indicate that the two tasks are solved 
using similar approaches or depend on similar underlying brain mechanisms.  
 
9.5 OMISSIONS  
 
In discrimination and reversal tasks, omissions are often included and discussed 
as controls for motivational or motor disturbances. Results reported in this thesis argue 
that omissions also can be a product of learning, most readily produced by associations 
of non-reward.  
If omissions primarily reflect motivational or motor effects, the number of 
omissions should be independent of the tasks cognitive components, with similar 
number of omissions being made in full reversal, perseverance, learned non-reward and 
retention tests. Moreover, there should be a stable number of omissions across 
subsequent reversal tests in serial designs. Both predictions are contradicted by results 
in this thesis, as well as by data from other reversal assays.   
In a serial operant lever reversal task, omissions decrease across subsequent 
reversal tests (Boulougouris et al., 2008). Similar effects were reported in Chapter 5 of 
this thesis. This shows that the number of omissions can be modulated by the number of 
reversals previously completed. 
Furthermore, in a bowl-digging paradigm, omissions are more prominent in a 
learned non-reward test, where the previous CS- is paired with a novel CS, than in a 
perseverance test, where the previous CS+ is paired with a novel CS (Tait and Brown, 
2008). This effect was also observed in the operant procedure of Chapters 5 and 6. This 
suggests that the number of omissions depends on cognitive components of the reversal 
test, and that a greater number of omissions can be made in tests with a component of 
learned non-reward. This indicates that omissions in tasks of reversal learning can be 
related to learning and learned non-reward. 
Notably, omissions are a primary measure of learning in other tasks of cognitive 
flexibility, including successive reversal learning paradigms (Burke et al., 2006; 
McEnaney and Butter, 1969; Nonkes et al., 2011; Schoenbaum et al., 2003) and latent 
inhibition (Bonardi et al., 2010; Lubow, 1989). Omissions should also be considered 
relevant for learning in simultaneous discrimination and reversal tasks.  
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9.6 IMPLICATIONS FOR TASK DESIGN, VALIDITY AND TRANSLATION 
 
Previous work, and experiments reported in this thesis, suggest that 
perseverance and learned non-reward constitute independent domains of reversal 
leaning and that the effect of a manipulation on the first cognitive domain may bear 
little relationship to the effect on the second cognitive domain. In Chapter 1, 
Discussion, it was suggested that this could have implications for how an effect on 
reversal learning is interpreted.  
For example, many studies discussed in this thesis assess full reversal only, but 
regard perseverance of main interest. Yet a manipulation affecting perseverance could 
also be without effect or have additional effects in the opposite direction on learned 
non-reward, potentially masking any perseverative effects on full reversal learning. This 
type of effect was observed in Chapters 6 and 7. In Chapter 6, SB242084 decreased 
perseverance but increased learned non-reward, but had no effect on full reversal 
learning in the maze task. In Chapter 8, 5-HT2CR KO mice showed perseverative 
deficits as well as a non-significant improvement in learned non-reward in the maze 
task, again producing no effects on full reversal learning. In both cases Occam’s Razor 
would suggest accepting the argument that opposing effects on perseveration and 
learned non-reward have led to no effect in the full reversal condition. 
Thus, if perseverative responding in a task of cognitive flexibility is to be 
assessed, a test of perseverance rather than a full reversal test where perseveration and 
learned non-reward are combined may be more suitable (Garner et al. 2006). This could 
also be viewed as comparable to the tests preceding the attentional set-shifting phase of 
the CANTAB ID/ED and rodent bowl-digging tasks. 
A second issue discussed in Chapter 1 is that the pathological psychiatric deficit 
and a putative therapeutic effect of treatment may act on separate cognitive 
mechanisms. For example, animal models of schizophrenia often show reversal learning 
impairments believed to be caused by increased perseveration. A variety of compounds, 
including the 5-HT2CR antagonist SB243213 (McLean et al., 2009) show predictive 
validity within these paradigms by attenuating the reversal impairment. It is therefore 
assumed that the compound blocks the models perseverative response deficits in such 
models.  
However, the impairment could also be blocked by an effect within a cognitive 
domain unrelated to the original deficit in the model. As a specific example, in a test of 
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full reversal learning only, 5-HT2CR antagonism may indicate efficacy against the 
assumed perseverative reversal learning deficits induced by the psychotomimetic PCP 
(McLean et al., 2009). 
Additional tests of perseverance and learned non-reward, however, suggest that 
stand-alone 5-HT2CR antagonism may have no effects or further detrimental effects on 
cognition in schizophrenia. 5-HT2CR antagonism improves reversal learning by 
decreasing the interference from previously non-rewarded associations (Chapter 5), and 
this mechanism appear to be unrelated to pathological deficit (Elliot et al., 1995, 1998).   
 
9.7 NEUROANATOMY AND NEUROCHEMISTRY 
 
There is evidence for reversal learning being dependent upon the integrity of the 
OFC, DStr, and hippocampus, and 5-HT-signalling within the OFC and DA-signalling 
in the DStr. Previous work suggests that these mechanisms may have different roles in 
discrimination learning, reversal learning, perseverance, and learned non-reward (Burke 
et al., 2009; Clarke et al., 2007, 2011; Nonneman et al., 1974; Tait and Brown, 2007). 
The manipulations used in the thesis can have multiple and variable effects on several 
of these brain regions and transmitter systems.  
Electrophysiological data show that the 5-HT2CR KO mouse have diminished 
LTP-formation in the medial perforant path of the dentate gyrus, and this mechanism 
has been used to explain the aberrant visuospatial learning of 5-HT2CR KO mice in a 
water maze task (Tecott et al., 1998). Specifically, the 5-HT2CR KO mouse fails to show 
a preference for the previous platform location when the platform is removed. Although 
these results cannot be inferred as demonstrating facilitated or impaired learning, it has 
been suggested that the 5-HT2CR KO mouse may show an altered spatial search strategy 
due to reduced LTP-formation in the dentate gyrus (Tecott et al., 1998). A tentative 
possibility is that the reduced hippocampal LTP-formation causes increased use of 
allocentric cues, or an alternative decrease in the use of an egocentric response strategy. 
This would be in agreement with the facilitated and retarded learning, respectively, of 
the 5-HT2CR KO mouse in the operant and maze tasks. 
A second interpretation of the data from Tecott et al. (1998) is that 5-HT2CR KO 
mice more readily investigates previously non-reinforced areas when the previously 
reinforced spatial location becomes non-reinforced. The behaviour of the 5-HT2CR KO 
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mouse in the water maze task would therefore be analogous to the mutants improved 
operant reversal learning and decreased learned non-reward observed in Chapter 7. 
However, there is currently little evidence for a role of hippocampal 5-HT or 
hippocampal 5-HT receptors in cognitive flexibility, and any abnormality in this area 
may be unrelated to the behaviours of the 5-HT2CR KO mouse in the water maze and 
the current maze and operant tasks. Nevertheless, as the integrity of the hippocampus is 
necessary for reversal learning (Nonneman et al., 1974), coupled with a role of 
hippocampal 5-HT in latent inhibition (Cassaday et al., 1993b) and the involvement of 
the 5-HT2CR in hippocampal LTP-formation associated with spatial learning (Jeffrey 
and Morris, 2004), further assessment of its role in cognitive flexibility is warranted. 
This would be most readily done using subregion-specific infusion of 5-HT subtype-
selective compounds in a reversal paradigm. 
Reversal learning is also dependent upon the DStr and DA-signalling in the 
DStr. Previous work in the rodent suggests that the DStr has limited or no involvement 
in allocentric spatial learning but is prominently involved in egocentric spatial learning, 
including egocentric reversals (e.g., Cook and Kesner 1988; Kesner et al. 1993; 
Mitchell and Hall 1988; Palencia and Ragozzino 2004; Ragozzino et al. 2002). This 
would indicate that DStr perturbations have greater consequence for learning in the 
maze task than in the operant task. In this region, increased DA-levels are seen in 
pathologies associated with reversal learning deficits, such as schizophrenia (Kegeles et 
al., 2006; Owen et al., 1978; Crow et al., 1978, 1979) and may cause perseverative 
impairments in the primate (Clarke et al., 2010; Clatworthy et al., 2005). This would be 
in agreement with the currently observed egocentric perseverative impairments of 5-
HT2CR KO and acutely PCP-treated mice (see also Abdallah et al., 2008; Carboni et al., 
1989).  
Thus, increased DA-signalling in the DStr is produced by constitutive loss of the 
5-HT2CR or PCP, it is also observed in schizophrenic patients, and it is associated with 
potential perseverative reversal impairments. Although little work has been done in the 
rodent, studies of how increased DA-signalling in the DStr could contribute to 
perseverative behaviours in the rat or mouse would be valuable. Based on the studies 
described here, an egocentric assay may be the most suitable to assess such 
impairments.  
The most thoroughly investigated brain region in reversal learning is the OFC, 
which has been shown to mediate the SB242084-induced improvement of visuospatial 
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reversal learning (Boulougouris and Robbins, 2010). The mechanism has been 
speculated to be altered OFC 5-HT signalling, as the facilitating effects of OFC-specific 
SB242084-infusions and global 5-HT depletions are apparently contradictory 
(Boulougouris and Robbins 2009; Roberts, 2011). These findings are only inconsistent 
if one assumes that both 5-HT2CR antagonism and 5-HT depletion affects reversal 
learning by reducing 5-HT signalling in the OFC. However, reduced activity at the 5-
HT2CR does not seem to affect OFC 5-HT signalling (Reuter et al. 2000). Alternatively, 
Chapter 7, Discussion, speculates that the prefrontal mechanism controlling for the 5-
HT2CR-related facilitation of reversal learning may be increased sensitivity at 
glutamatergic AMPAr’s in the OFC. 
Furthermore, other studies suggest that either increased OFC-activation 
(O’Doherty et al. 2003) or elevated 5-HT OFC-levels (Masaki et al. 2006) may facilitate 
reversal learning. However, it should be noted that these two mechanisms appear 
directly contradictory, as 5-HT inhibits OFC-activity (El Mansari and Blier, 1997; 
Rueter et al., 2000; Zghoul and Blier, 2003). The idea that increased OFC-activation 
facilitates reversal learning is also challenged by the increased OFC-activity observed in 
pathologies showing reversal impairments (Bolla et al. 2003; Drevets et al. 1992; Rubia 
et al. 2009; Saxena et al. 1999). Thus, although it seems likely that the facilitating 
effects of reduced 5-HT2CR-activity on visuospatial reversal learning is due to altered 
activity in the OFC, it is not clear if this is due to increased or decreased activity in this 
region. The role of the OFC and of OFC 5-HT2CRs in reversal learning should be 
explored using subregion-specific SB242084-infusions in separate tests of perseverance 
and learned non-reward. This could be done with parallel observations of PFC c-fos 
mRNA activation to assess the role of this receptor subtype on prefrontal activity.  
A further relevant region is the ventral striatum, and DA-signalling in the NAc. 
Although this region appears to have a minor role in the ability to overcome 
associations of reward and non-reward, it regulates locomotor activity and motor 
impulsivity, which could affect performance in reversal tasks. This may be most 
relevant for the currently observed effects of PCP in the maze task and of SB242084 in 
the touch-screen task. Mechanisms of altered signalling in the ventral striatum should 
also be considered when targeting the dorsal striatum. Interestingly, the major striatal 
dopaminergic abnormalities of the 5-HT2CR KO mice appear to be in the dorsal striatum 
(Adballah et al. 2008), while the main effect of systemically administered SB242084 is 
in the ventral striatum (Di Matteo et al. 1999). This may be due to differences in the 
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effect of chronic loss of receptor function and acute antagonism or additional inverse 
agonist activity of SB242084. These two models could potentially be used for separate 
analyses of the role of the two dopaminergic pathways in cognitive flexibility.  
In sum, the manipulations used in the thesis often have several and variable 
effects on brain mechanisms involved in discrimination learning, reversal learning, 
perseverance, and learned non-reward. This is most evident in the case of reduced 
activity at the 5-HT2CR. For example, if a manipulation that reduces activity at the 5-
HT2CR is assessed in a paradigm most sensitive to altered accumbal functioning, 
impulsivity or hyperactivity effects are likely to prevail and retarded learning may be 
observed. However, if the paradigm predominantly assays executive functioning, DStr 
or prefrontal mechanisms may prevail and altered ability to overcome previously non-
rewarded (OFC) or rewarded (DStr) associations could be observed.  
 
9.8 CLINICAL RELEVANCE  
 
As discussed in Chapter 1, impaired reversal learning has been observed in most 
neuropsychiatric disorders but most commonly in schizophrenia. However, conclusions 
regarding the relevance of the studies described in this thesis for understanding the 
pathology and treatment of the cognitive symptoms of schizophrenia are prevented 
foremost by the lack of studies assessing the specific cognitive causes of impaired 
reversal learning in clinical populations.  
Some work has nevertheless been done within the related paradigms of 
attentional set-shifting, learned irrelevance, and latent inhibition. Within attentional set-
shifting, schizophrenic patients show perseverative impairments without apparent 
deficits in learned irrelevance (Elliot et al. 1995, 1998), but often also show decreased 
learned irrelevance and latent inhibition when assessed in stand-alone tests (Gal et al., 
2005; Lubow and Gewirtz, 1995; Schmidt-Hansen et al., 2009; Young et al., 2005). 
Thus, the cognitive inflexibility deficits of schizophrenia are most likely perseverative, 
although an additional decrease in the interference from previously non-rewarded or 
irrelevant associations may be present. 
If this is accepted, the SB242084-induced attenuation of perseverance and 
augmentation of learned non-reward in the maze task would suggest that 5-HT2CR 
antagonism may have efficacy against the cognitive deficits of schizophrenia, as the two 
effects opposes both deficits associated with the condition. However, the selective 
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SB242084-induced attenuation of learned non-reward in the operant task would indicate 
that 5-HT2CR antagonism might have either no or even a detrimental effects in the 
treatment of schizophrenia, as irrelevant associations fail to contribute to patients 
cognitive inflexibility deficits (Elliot et al. 1995, 1998) or are already diminished in the 
pathology (Gal et al., 2005; Lubow and Gewirtz, 1995; Schmidt-Hansen et al., 2009; 
Young et al., 2005). 
Similarly, the perseverative reversal impairment of the 5-HT2CR KO mouse in 
the maze procedure suggests that constitutive loss of the receptor models the cognitive 
impairments of the disease. However, the attenuation of learned non-reward in 5-HT2CR 
KO mice in the operant task suggests that this mutant strain has little relevance as a 
model of the cognitive deficits of the disease. 
Moreover, OFC-lesioning mimics the perseverative reversal deficits of 
schizophrenic patient when assessed in the operant task, but does not seem to be 
relevant in the maze task, were it appears to be without effects.  
Acute PCP mimics the perseverative deficits of schizophrenic patients when 
assessed in the maze task, but also causes additional deficits in learned non-reward not 
yet observed in schizophrenic patients. Conversely, the behaviour of PCP-treated 
animals in the operant task would indicate that acute NMDAr antagonism has no 
relevance to schizophrenia, as few effects on learning were observed.  
Clearly, the clinical relevance of the experimental manipulations used in the 
present studies relation to the cognitive symptoms of schizophrenia can only be inferred 
with a better understanding of the kind of reversal learning deficit displayed by patients 
as well as the kind of task that carries the greatest resemblance in problem solving 
strategies to those used by humans.    
Experiments reported in this thesis show that different tasks and training 
methods can have differential effects on perseverance and learned non-reward, which in 
turn may affect the role of involved brain regions and transmitter systems. An example 
is 5-HT2CR antagonism. SB242084 facilitates reversal learning if the protocol primarily 
measures learned-non reward, as in the operant procedure, but has opposing effects on 
perseverance and learned non-reward if the task emphasises perseverance-related 
effects, as in the maze procedure. SB242084 can also impair reversal learning, 
especially if the task is sensitive to changes in impulsivity, as in the touch-screen 
procedure. For optimal translation, it might be important to match prevalent response 
strategies in human and animal tasks. For example, a preclinical task where response 
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behaviour primarily is guided by non-rewarded association is likely to have limited 
validity if responses in the clinical test procedure are primarily guided by reward. 
9.9 LIMITATIONS AND FUTURE DIRECTIONS 
The spatial tasks of reversal learning, perseverance and learned non-reward 
described here contain at least three confounds. The first is stimulus generalisation. In 
the spatial dimension, the left nosepoke-hole or left turning-direction is to the left in 
relation to the right nosepoke-hole or right turning-direction. This makes perseverance 
and learned non-reward testing in the spatial dimension susceptible to stimulus 
generalisation, so that all three tests might be considered tests of full reversal learning.  
A further component of the tasks is the converse of generalisation, novelty. 
Manipulations of novelty-attraction or novelty-recognition could affect performance in 
the perseverance and learned non-reward tests where the now correct or incorrect CS, 
respectively, is novel. It should nevertheless be noted that the procedures in this thesis 
control for novelty though both intrinsic features of the tests and additional 
experiments. An effect on novelty attraction or recognition should produce opposing 
effects in the perseverance and learned non-reward tests. Performance in a full reversal 
test can also control for the effect of novelty, as no novel stimuli is introduced in this 
test condition. Where these measures suggested that novelty may have influenced 
learning, animals were tested in a further place novelty recognition and attraction test.     
Moreover, when using two nosepoke-holes or two turning-directions, animals 
were habituated or pre-trained using the same stimuli that later figure with opposing 
contingencies in testing. This may cause interference additional to the contingencies 
learned in the initial spatial discrimination. It is also likely to be of further relevance in 
serial spatial protocols, where in later reversals, previous excitatory and inhibitory 
conditioning has taken place towards both the current CS+ and CS-. 
The limited availability of stimuli in the operant visuospatial procedure also 
creates a discrepancy between the full reversal, perseverance and learned non-reward 
tests when a serial design is used (Fig. 9.1). In the third full reversal test, animals are 
challenged by a contingency-shift previously experienced in the first full reversal test. 
In the third learned non-reward and perseverance tests, however, animals are challenged 
with shifts not previously experienced. Thus, it may not be appropriate to make 
interpretations about learning in the third full reversal test in relation to learning in the 
third perseverance and third learned non-reward tests.  
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Some of these limitations could be overcome by using more complex stimuli in 
the visual dimension. Generalisation would be a lesser issue if using equally 
discriminable visual stimuli. There would be fewer limitations on the number of 
available stimuli. Novel stimuli can replace old stimuli in the beginning of each new 
visual discrimination, and animals can be trained and tested on separate stimuli. This 
should decrease the influence of training and previous discriminations and reversals on 
later testing. It also makes the discrepancies of the full reversal, perseverance, and 
learned non-reward tests in operant visuospatial serial designs irrelevant. Two 
preliminary studies were described in Chapter 8 and could provide the foundation for 
experiments that used the same range of experimental tests, including those for 
perseveration and learned non-reward, that were described in earlier chapters using 
visuospatial paradigms.  
In Chapter 1, it was also discussed how novelty-attraction and avoidance has 
been assessed in attentional set-shifting (Chapter 1, Table 4). With reduced restrictions 
on the number of available stimuli, these types of novelty tests could also be introduced 
in a serial visual reversal learning protocol, as shown in Figure 9.2. 
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Figure 9.1. Example of contingency shifts in 
the operant serial reversal paradigm. In Test 1 
and Test 2 of the full reversal condition, animals 
are challenged with novel contingency shifts. 
The contingency shift of Test 3 of the full 
reversal condition is identical the contingency 
shift of Test 1 of the full reversal condition. All 
contingency shifts in the perseverance and 
learned non-reward conditions are novel. 
Figure 9.2. Visual between-subjects design for 
assessing full reversal, perseverance, learned 
non-reward, paralleling the visuospatial design 
in Figure 9.1. In a final novelty test, either the 
previously correct or incorrect stimulus remain 
of the same contingency and is paired with a 
novel stimulus of the opposite contingency.  
Enhanced novelty attraction should retard 
learning in novelty test 1 and facilitate learning 
in novelty test 2. A manipulation of 
perseverance should affect leaning in novelty 
test 1, but not novelty test 2. A manipulation of 
learned non-reward should affect learning in 
novelty test 2, but not novelty test 1.  	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9.10 SUMMARY 
 
The experiments presented in this thesis have provided evidence to support the general 
assertions that: 
 
1) Learned non-reward influences reversal learning in the mouse; 
 
2) The NMDAr, 5-HT2CR and PFC are involved in controlling spatial reversal 
learning, perseverance and learned non-reward in rodents; 
 
3) Few effects of PFC-lesioning, and NMDAr and 5-HT2CR antagonism in 
reversal learning generalise across visuospatial, egocentric spatial, and visual 
tasks. 
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